<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006047.pub5" GROUP_ID="BEHAV" ID="698505092314582654" MERGED_FROM="" MODIFIED="2016-10-11 11:42:23 +0100" MODIFIED_BY="Joanne Wilson" NOTES="&lt;p&gt;Liebe Barbara, wir waren uns bei diesem Punkt nicht ganz sicher, was der urspr&amp;#252;ngliche Grund war diese Grenzwerte zu w&amp;#228;hlen. Es wurde auch keine Begr&amp;#252;ndung oder Referenz im Methodenteil angegeben. Wir nehmen an, dass der Grund die ehemaligen CDC-Grenzwerte waren. Da wir keinen Zugriff auf die meisten der acht(?) Prim&amp;#228;rstudien mit dichot. Outcome haben, konnten wir auch nicht &amp;#252;berpr&amp;#252;fen ob unsere Behauptung wahr ist. K&amp;#246;nntest Du das noch einmal &amp;#252;berpr&amp;#252;fen? Falls Du das am Montag nicht mehr schaffst kannst Du uns auch die Prim&amp;#228;rstudien schicken und wir sehen selber nach.&lt;/p&gt;&lt;p&gt;Lisa und Laura&lt;/p&gt;" NOTES_MODIFIED="2016-10-11 11:32:39 +0100" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="F0022" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="8.0">
<COVER_SHEET MODIFIED="2016-10-11 11:32:39 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2016-06-15 20:23:03 +0100" MODIFIED_BY="[Empty name]">Household interventions for preventing domestic lead exposure in children</TITLE>
<CONTACT>
<PERSON ID="z1303280937296104860128207607784" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Barbara</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Nussbaumer-Streit</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>Barbara.nussbaumer-streit@donau-uni.ac.at</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department for Evidence-based Medicine and Clinical Epidemiology</DEPARTMENT>
<ORGANISATION>Danube University Krems</ORGANISATION>
<ADDRESS_1>Dr.-Karl-Dorrek-Str. 30</ADDRESS_1>
<ADDRESS_2/>
<CITY>Krems</CITY>
<ZIP>3500</ZIP>
<REGION/>
<COUNTRY CODE="AT">Austria</COUNTRY>
<PHONE_1>+43 (0)2732 893-2919</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2016-10-11 11:32:39 +0100" MODIFIED_BY="[Empty name]">
<PERSON ID="z1303280937296104860128207607784" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Barbara</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Nussbaumer-Streit</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>Barbara.nussbaumer-streit@donau-uni.ac.at</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department for Evidence-based Medicine and Clinical Epidemiology</DEPARTMENT>
<ORGANISATION>Danube University Krems</ORGANISATION>
<ADDRESS_1>Dr.-Karl-Dorrek-Str. 30</ADDRESS_1>
<ADDRESS_2/>
<CITY>Krems</CITY>
<ZIP>3500</ZIP>
<REGION/>
<COUNTRY CODE="AT">Austria</COUNTRY>
<PHONE_1>+43 (0)2732 893-2919</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="91D2B1F282E26AA201AFF012C099BD48" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Berlinda</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Yeoh</LAST_NAME>
<SUFFIX/>
<POSITION>Consultant Community Paediatrician</POSITION>
<EMAIL_1>berlinday@royalfarwest.org.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>Royal Far West</ORGANISATION>
<ADDRESS_1>PO Box 52</ADDRESS_1>
<ADDRESS_2/>
<CITY>Manly</CITY>
<ZIP>1655</ZIP>
<REGION>NSW</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>61 2 8966 8500</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="60094736931777252270120104123702" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Ursula</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Griebler</LAST_NAME>
<SUFFIX/>
<POSITION>Research Associate</POSITION>
<EMAIL_1>ursula.griebler@donau-uni.ac.at</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department for Evidence-based Medicine and Clinical Epidemiology</DEPARTMENT>
<ORGANISATION>Danube University Krems</ORGANISATION>
<ADDRESS_1>Dr.-Karl-Dorrek Str. 30</ADDRESS_1>
<ADDRESS_2/>
<CITY>Krems</CITY>
<ZIP>3500</ZIP>
<REGION/>
<COUNTRY CODE="AT">Austria</COUNTRY>
<PHONE_1>+43 2732 893 2914</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="z1302200139167257998117414456557" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Lisa</FIRST_NAME>
<MIDDLE_INITIALS>M</MIDDLE_INITIALS>
<LAST_NAME>Pfadenhauer</LAST_NAME>
<SUFFIX/>
<POSITION>PhD student</POSITION>
<EMAIL_1>pfadenh@ibe.med.uni-muenchen.de</EMAIL_1>
<EMAIL_2>lisa.pfadenhauer@gmail.com</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Institute for Medical Informatics, Biometry and Epidemiology</DEPARTMENT>
<ORGANISATION>Ludwig-Maximilians-University Munich</ORGANISATION>
<ADDRESS_1>Marchioninistr 13</ADDRESS_1>
<ADDRESS_2/>
<CITY>Munich</CITY>
<ZIP/>
<REGION>Bavaria</REGION>
<COUNTRY CODE="DE">Germany</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="z1503190729406204302890320710519" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Laura</FIRST_NAME>
<MIDDLE_INITIALS>K</MIDDLE_INITIALS>
<LAST_NAME>Busert</LAST_NAME>
<SUFFIX/>
<POSITION>Research Assistant</POSITION>
<EMAIL_1>busert@ibe.med.uni-muenchen.de</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Institute for Medical Informatics, Biometry and Epidemiology</DEPARTMENT>
<ORGANISATION>Ludwig-Maximilians-University Munich</ORGANISATION>
<ADDRESS_1>Marchioninistrasse 15</ADDRESS_1>
<ADDRESS_2/>
<CITY>Munich</CITY>
<ZIP>81377</ZIP>
<REGION/>
<COUNTRY CODE="DE">Germany</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="43936511308735444981120201135610" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Stefan</FIRST_NAME>
<MIDDLE_INITIALS>K</MIDDLE_INITIALS>
<LAST_NAME>Lhachimi</LAST_NAME>
<SUFFIX/>
<POSITION>Professor and Senior lecturer</POSITION>
<EMAIL_1>Stefan.Lhachimi@uni-bremen.de</EMAIL_1>
<EMAIL_2>stefan.lhachimi@gmail.com</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Research Group for Evidence-Based Public Health</DEPARTMENT>
<ORGANISATION>Leibniz Institute for Prevention Research and Epidemiology</ORGANISATION>
<ADDRESS_1>Achterstr. 30</ADDRESS_1>
<ADDRESS_2/>
<CITY>Bremen</CITY>
<ZIP>28359</ZIP>
<REGION/>
<COUNTRY CODE="DE">Germany</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="z1406180917468223408707466286831" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Szimonetta</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Lohner</LAST_NAME>
<SUFFIX/>
<POSITION>Research Fellow</POSITION>
<EMAIL_1>lohner.szimonetta@pte.hu</EMAIL_1>
<EMAIL_2/>
<URL>www.cochrane.pte.hu</URL>
<MOBILE_PHONE>+36 30 2501463</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Cochrane Hungary</DEPARTMENT>
<ORGANISATION>University of Pécs</ORGANISATION>
<ADDRESS_1>Rákóczi Str. 2.</ADDRESS_1>
<ADDRESS_2/>
<CITY>Pécs</CITY>
<ZIP>H-7623</ZIP>
<REGION/>
<COUNTRY CODE="HU">Hungary</COUNTRY>
<PHONE_1>+36 72 504 226</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="AB61F02382E26AA200AED5649D9D6048" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Gerald</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Gartlehner</LAST_NAME>
<SUFFIX/>
<POSITION>Director</POSITION>
<EMAIL_1>gerald.gartlehner@donau-uni.ac.at</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE>+436648153565</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Cochrane Austria</DEPARTMENT>
<ORGANISATION>Danube University Krems</ORGANISATION>
<ADDRESS_1>Dr.-Karl-Dorrek-Strasse 30</ADDRESS_1>
<ADDRESS_2/>
<CITY>Krems</CITY>
<ZIP>3500</ZIP>
<REGION/>
<COUNTRY CODE="AT">Austria</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2016-05-17 15:03:31 +0100" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="3" MONTH="5" YEAR="2016"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="3" MONTH="5" YEAR="2016"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="3" MONTH="9" YEAR="2018"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="2006"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2008"/>
<LAST_CITATION_ISSUE ISSUE="10" YEAR="2016"/>
</DATES>
<WHATS_NEW MODIFIED="2016-10-03 15:42:09 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2015-10-27 08:04:05 +0000" MODIFIED_BY="Barbara Nussbaumer">
<DATE DAY="29" MONTH="7" YEAR="2015"/>
<DESCRIPTION>
<P>Our update search identified one additional publication (Campbell 2012) of a study that has already been included (Campell 2011) in the last version of the review. This publication added information on blood lead levels at two-year follow-up. We also identified an ongoing study (HOME Study 2015) that will be finished by 2017. These findings did not change the conclusions of the review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2016-10-03 15:42:02 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="11" MONTH="5" YEAR="2015"/>
<DESCRIPTION>
<P>Review updated following a new search in May 2015 and a top-up search on 3 May 2016.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2015-12-08 15:18:57 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2015-12-08 15:18:57 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="23" MONTH="4" YEAR="2012"/>
<DESCRIPTION>
<P>Search dates corrected</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2014-12-16 09:39:59 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="17" MONTH="2" YEAR="2012"/>
<DESCRIPTION>
<P>Two new included studies. New risk of bias tables. New summary of findings table.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-12-16 09:39:56 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="20" MONTH="1" YEAR="2012"/>
<DESCRIPTION>
<P>New search.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-09-13 16:23:22 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="9" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2016-08-24 17:28:56 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2016-08-24 17:28:56 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2016-08-24 17:28:56 +0100" MODIFIED_BY="[Empty name]">
<NAME>None</NAME>
<COUNTRY CODE="NONE">Other</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2016-08-24 17:28:25 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2016-08-24 17:28:25 +0100" MODIFIED_BY="[Empty name]">
<NAME>World Health Organization (WHO)</NAME>
<COUNTRY CODE="CH">Switzerland</COUNTRY>
<DESCRIPTION>
<P>WHO, Evidence &amp; Policy on Environmental Health (EPE), financially supported the update of the review as part of a guideline development process with US $15,000.</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2015-12-09 11:35:00 +0000" MODIFIED_BY="[Empty name]">
<NAME>Danube University Krems, Department of Evidence-based Medicine and Clinical Epidemiology</NAME>
<COUNTRY CODE="AT">Austria</COUNTRY>
<DESCRIPTION>
<P>Lisa M Pfadenhauer and Laura K Busert attended the Cochrane Colloquium 2015 in Vienna; their participation fee was covered by the Department for Evidence Based Medicine and Clinical Epidemiology at the Danube University Krems.</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2016-10-10 17:06:43 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2016-09-16 10:49:48 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2016-06-15 20:24:01 +0100" MODIFIED_BY="[Empty name]">Household interventions for preventing domestic lead exposure in children</TITLE>
<SUMMARY_BODY MODIFIED="2016-09-16 10:49:48 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Why is this review important?</B>
</P>
<P>Lead poisoning at high levels can cause anaemia, multi-organ damage, seizures, coma and death in children. At chronic low levels it can lead to cognitive, psychological and neurobehavioural impairment. Researchers have studied many different educational and environmental household interventions to prevent lead exposure in children, such as parental education, removal of lead dust or home remediation work. However, it is not clear if and to what extent these interventions work in preventing lead exposure in children.</P>
<P>
<B>Who will be interested in this review?</B>
</P>
<P>- Parents and caregivers who want to prevent domestic lead exposure in children.</P>
<P>- Health professionals and decision-makers who are interested in methods to prevent domestic lead exposure in children.</P>
<P>
<B>What questions does this review aim to answer?</B>
</P>
<P>We wanted to find out if educational or environmental household interventions, or combinations of both, are effective in preventing or reducing domestic lead exposure in children up to 18 years of age. We were interested in looking at improvements in cognitive and neurobehavioural development, reductions in blood lead levels and household lead dust levels.</P>
<P>
<B>Which studies were included in the review?</B>
</P>
<P>We searched databases up to May 2016 for randomised controlled trials, or RCTs (where participants are randomly assigned to treatment and control groups, in this case with one group that does not receive any intervention and one or more other groups that do) and quasi-RCTs (where children are assigned to groups using methods that are not strictly random). We found 14 studies involving 2643 children that investigated educational or environmental interventions, or a combination of both, to reduce domestic lead exposure in children. Children in all studies were under six years of age. Thirteen studies took place in urban areas of North America, and one was in Australia. Most studies were performed in areas with low socioeconomic status. Boys and girls were equally represented in all studies. The duration of the intervention ranged from 3 months to 24 months in 12 studies, and 2 studies performed an intervention on a single occasion. Follow-up periods ranged from 6 months to 48 months. National or international research grants or governments funded 12 studies, and 2 studies did not report their funding sources.</P>
<P>
<B>What does the evidence from the review reveal?</B>
</P>
<P>We did not find any studies that evaluated effects on cognitive or neurobehavioural outcomes or adverse events in children. All studies reported on blood lead levels. The included studies found that educational interventions are not effective in reducing blood lead levels of young children; the quality of this evidence was moderate to high. Dust control interventions may lead to little or no difference in blood lead levels; however, future research might change these results because the quality of evidence was moderate to low for these interventions. There is currently insufficient evidence that soil abatement or combination interventions reduce blood lead levels, and further studies need to address this.</P>
<P>
<B>What should happen next?</B>
</P>
<P>More research is needed to find out what is effective for preventing children's exposure to lead. Studies should be carried out in different socioeconomic groups in high-, middle- and low-income countries to consider how interventions work in contexts shaped by different levels of industrialisation or environmental and occupational health safety regulations.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2016-10-06 13:37:29 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2016-09-14 09:36:50 +0100" MODIFIED_BY="[Empty name]">
<P>Lead poisoning is associated with physical, cognitive and neurobehavioural impairment in children, and trials have tested many household interventions to prevent lead exposure. This is an update of the original review, first published in 2008.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2016-09-16 10:08:54 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the effects of household interventions for preventing or reducing lead exposure in children, as measured by improvements in cognitive and neurobehavioural development, reductions in blood lead levels and reductions in household dust lead levels.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2016-10-06 13:34:51 +0100" MODIFIED_BY="[Empty name]">
<P>In May 2016 we searched CENTRAL, Ovid MEDLINE, Embase, nine other databases and two trials registers: the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) and ClinicalTrials.gov. We also checked the reference lists of relevant studies and contacted experts to find unpublished studies.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2016-09-14 09:38:52 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials (RCTs) and quasi-RCTs of household educational or environmental interventions, or combinations of interventions to prevent lead exposure in children (from birth to 18 years of age), where investigators reported at least one standardised outcome measure.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2016-10-06 12:36:54 +0100" MODIFIED_BY="[Empty name]">
<P>Two authors independently reviewed all eligible studies for inclusion, assessed risk of bias and extracted data. We contacted trialists to obtain missing information. We assessed the quality of the evidence using the GRADE approach.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2016-10-06 13:37:29 +0100" MODIFIED_BY="[Empty name]">
<P>We included 14 studies involving 2643 children: 13 RCTs (involving 2565 children) and one quasi-RCT (involving 78 children). Children in all studies were under six years of age. Thirteen studies took place in urban areas of North America, and one was in Australia. Most studies were in areas with low socioeconomic status. Girls and boys were equally represented in all studies. The duration of the intervention ranged from 3 months to 24 months in 12 studies, while 2 studies performed interventions on a single occasion. Follow-up periods ranged from 6 months to 48 months. Three RCTs were at low risk of bias in all assessed domains. We rated two RCTs and one quasi-RCT as being at high risk of selection bias and six RCTs as being at high risk of attrition bias. For educational interventions, we rated the quality of evidence to be high for continuous blood lead levels and moderate for all other outcomes. For environmental interventions, we assessed the quality of evidence as moderate to low. National or international research grants or governments funded 12 studies, while the other 2 did not report their funding sources.</P>
<P>No studies reported on cognitive or neurobehavioural outcomes. No studies reported on adverse events in children. All studies reported blood lead level outcomes.</P>
<P>We put studies into subgroups according to their intervention type. We performed meta-analyses of both continuous and dichotomous data for subgroups where appropriate. Educational interventions were not effective in reducing blood lead levels (continuous: mean difference (MD) 0.02, 95% confidence interval (CI) &#8722;0.09 to 0.12, I² = 0%; 5 studies; N = 815; high quality evidence (log transformed); dichotomous &#8805; 10.0 µg/dL (&#8805; 0.48 µmol/L): risk ratio (RR) 1.02, 95% CI 0.79 to 1.30; I² = 0%; 4 studies; N = 520; moderate quality evidence; dichotomous &#8805; 15.0 µg/dL (&#8805; 0.72 µmol/L): RR 0.60, 95% CI 0.33 to 1.09; I² = 0%; 4 studies; N = 520; moderate quality evidence). Meta-analysis for the dust control subgroup also found no evidence of effectiveness on blood lead levels (continuous: MD &#8722;0.15, 95% CI &#8722;0.42 to 0.11; I² = 90%; 3 studies; N = 298; low quality evidence (log transformed); dichotomous &#8805; 10.0 µg/dL (&#8805; 0.48 µmol/L): RR 0.93, 95% CI 0.73 to 1.18; I² = 0; 2 studies; N = 210; moderate quality evidence; dichotomous &#8805; 15.0 µg/dL (&#8805; 0.72 µmol/L): RR 0.86, 95% CI 0.35 to 2.07; I² = 56%; 2 studies; N = 210; low quality evidence). After adjusting the dust control subgroup for clustering in meta-analysis, we found no evidence of effectiveness. We could not pool the studies using soil abatement (removal and replacement) and combination intervention groups in a meta-analysis due to substantial differences between studies, and generalisability or reproducibility of the results from these studies is unknown. Therefore, there is currently insufficient evidence to clarify whether soil abatement or a combination of interventions reduces blood lead levels.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2016-09-16 09:36:35 +0100" MODIFIED_BY="[Empty name]">
<P>Based on current knowledge, household educational interventions are ineffective in reducing blood lead levels in children as a population health measure. Dust control interventions may lead to little or no difference in blood lead levels (the quality of evidence was moderate to low, meaning that future research is likely to change these results). There is currently insufficient evidence to draw conclusions about the effectiveness of soil abatement or combination interventions. No study reported on cognitive or neurobehavioural outcomes or adverse events. These patient-relevant outcomes would have been of great interest to draw conclusions for practice.</P>
<P>Further trials are required to establish the most effective intervention for preventing lead exposure. Key elements of these trials should include strategies to reduce multiple sources of lead exposure simultaneously using empirical dust clearance levels. It is also necessary for trials to be carried out in low- and middle-income countries and in differing socioeconomic groups in high-income countries.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2016-10-10 17:06:43 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2016-10-06 12:14:17 +0100" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2016-10-06 12:14:17 +0100" MODIFIED_BY="[Empty name]">
<P>Lead is a metal that has been used since prehistoric times. Over the years, its expansive distribution and mobilisation in the environment has resulted in increasing human exposure and uptake (<LINK REF="REF-Tong-2000" TYPE="REFERENCE">Tong 2000</LINK>). Lead poisoning is a serious and recognised health hazard with major socioeconomic implications (<LINK REF="REF-UNEP_x002d_UNICEF-1997" TYPE="REFERENCE">UNEP-UNICEF 1997</LINK>; <LINK REF="REF-Attina-2013" TYPE="REFERENCE">Attina 2013</LINK>). At high levels, lead poisoning in children can cause anaemia, multi-organ damage, renal damage, seizures, coma and death. At chronic low levels, lead toxicity causes significant cognitive, psychological and neurobehavioural impairment (<LINK REF="REF-UNEP_x002d_UNICEF-1997" TYPE="REFERENCE">UNEP-UNICEF 1997</LINK>; <LINK REF="REF-Tong-2000" TYPE="REFERENCE">Tong 2000</LINK>; <LINK REF="REF-Mason-2014" TYPE="REFERENCE">Mason 2014</LINK>).</P>
<P>Lead has been shown to account for 0.6% of the total global disease burden (<LINK REF="REF-Lim-2012" TYPE="REFERENCE">Lim 2012</LINK>). The burden of disease associated with lead exposure in Europe amounts to at least 1,053,000 disability adjusted life years (DALYs) per year, of which approximately 66% are due to housing-based exposures (<LINK REF="REF-Braubach-2011" TYPE="REFERENCE">Braubach 2011</LINK>). There are many potential sources of lead in the environment, including lead industries, mining and smelting; leaded petrol; lead-based paint; water piping, fixtures and solder; and consumer products and hobbies that use lead. Lead from these sources is most commonly found in paint, dust, soil or water. Risk factors for lead exposure include socioeconomic disadvantage; residence in an area with lead industry; renovation or deterioration of older houses containing lead-based paint; and residence in countries where leaded petrol or aviation fuel is still used (<LINK REF="REF-Tong-2000" TYPE="REFERENCE">Tong 2000</LINK>; <LINK REF="REF-Miranda-2011" TYPE="REFERENCE">Miranda 2011</LINK>).</P>
<P>Blood lead levels in the general population of developed countries have fallen significantly over the past 20 years with the phasing out of lead petrol and bans on the use of lead in paints and lead solder used in canned foods and other consumer products (<LINK REF="REF-Jacobs-2006" TYPE="REFERENCE">Jacobs 2006</LINK>). However, concern has now grown regarding chronic low level exposure within the environment (<LINK REF="REF-Tong-2000" TYPE="REFERENCE">Tong 2000</LINK>). The major source of environmental lead dust exposure in children in developed countries is lead-based paints and other lead hazards in housing. Older housing with peeling or flaking paint or current renovations can result in increased lead dust levels (<LINK REF="REF-EHU-2002" TYPE="REFERENCE">EHU 2002</LINK>).</P>
<P>Occupational and environmental exposures continue to be a serious global problem, especially in low- and middle-income countries, which may be rapidly industrialising (<LINK REF="REF-Tong-2000" TYPE="REFERENCE">Tong 2000</LINK>). People in these settings, especially children, may have higher levels of lead exposure due to unregulated industrial emission, weak environmental and occupational health safety regulations, and cottage (domestic) industries such as metal polishing and smelting (<LINK REF="REF-UNEP_x002d_UNICEF-1997" TYPE="REFERENCE">UNEP-UNICEF 1997</LINK>). Many countries have implemented or proposed legally binding restrictions on lead in paints for domestic use, and consequently this will become a less important source of exposure over time. Nevertheless, lead-based paints for household use are still available for purchase in several low- and middle-income countries such as Argentina, China, Ethiopia, Ghana, India, Malaysia and Tunisia (<LINK REF="REF-EHU-2002" TYPE="REFERENCE">EHU 2002</LINK>; <LINK REF="REF-Clark-2005" TYPE="REFERENCE">Clark 2005</LINK>; <LINK REF="REF-Adebanowo-2007" TYPE="REFERENCE">Adebanowo 2007</LINK>; <LINK REF="REF-UNEP-2013" TYPE="REFERENCE">UNEP 2013</LINK>). In view of rapid industrialisation and the persistence of lead in the environment, this is likely to remain a significant public health issue in these countries for many years (<LINK REF="REF-Tong-2000" TYPE="REFERENCE">Tong 2000</LINK>).</P>
<P>Children are at higher risk of lead toxicity. This is due to their increased intake of lead per unit of body weight compared with adults and their higher rate of physiological uptake (up to 50% compared with 10% to 15% in adults; <LINK REF="REF-UNEP_x002d_UNICEF-1997" TYPE="REFERENCE">UNEP-UNICEF 1997</LINK>). Young children often place objects in their mouths resulting in lead-contaminated dust and soil ingestion. Furthermore, a young child's developing body, and in particular the central nervous system, is more vulnerable to the effects of lead (<LINK REF="REF-Bellinger-2008" TYPE="REFERENCE">Bellinger 2008</LINK>; <LINK REF="REF-Mason-2014" TYPE="REFERENCE">Mason 2014</LINK>).</P>
<P>Dust is an important residential media for lead exposure and the strongest predictor of blood lead levels. Floor dust exceeding 0.431 mg/m² (40.0 µg/ft²) is currently recognised as hazardous (<LINK REF="REF-Dixon-2009" TYPE="REFERENCE">Dixon 2009</LINK>).</P>
<P>In 1991, the Centers for Disease Control and Prevention (CDC) defined blood lead levels of 10.0 µg/dL or more as a "blood lead level of concern" for children aged one to five years (<LINK REF="REF-CDC-1991" TYPE="REFERENCE">CDC 1991</LINK>). Recent studies, however, show that adverse effects on cognitive function in children are proportional at even lower blood lead levels (<LINK REF="REF-Canfield-2003" TYPE="REFERENCE">Canfield 2003</LINK>; <LINK REF="REF-Lanphear-2005a" TYPE="REFERENCE">Lanphear 2005a</LINK>; <LINK REF="REF-Kordas-2006" TYPE="REFERENCE">Kordas 2006</LINK>; <LINK REF="REF-Evens-2015" TYPE="REFERENCE">Evens 2015</LINK>), suggesting that there is no safe level of blood lead for children (<LINK REF="REF-CDC-2005" TYPE="REFERENCE">CDC 2005</LINK>; <LINK REF="REF-Grandjean-2010" TYPE="REFERENCE">Grandjean 2010</LINK>; <LINK REF="REF-CDC-2012" TYPE="REFERENCE">CDC 2012</LINK>). Therefore, in 2012 the CDC followed the advice of the Advisory Committee on Childhood Lead Poisoning Prevention (ACCLPP) to replace the term 'level of concern' with an upper reference interval value, which they defined as the 97.5th percentile of blood lead levels (currently 5.0 &#956;g/dL) from the National Health and Nutrition Examination Survey (NHANES), which includes US children aged one to five years (<LINK REF="REF-Wheeler-2013" TYPE="REFERENCE">Wheeler 2013</LINK>).</P>
<P>Of further concern, the effects of lead are thought to be largely irreversible, so reducing or eliminating lead from the body does not significantly improve the neuropsychological manifestations (<LINK REF="REF-Tong-2000" TYPE="REFERENCE">Tong 2000</LINK>). Chelation agents, currently the mainstay of treatment in children with blood lead concentrations greater than 45.0 µg/dL, reduce the mortality of severe acute lead encephalopathy, but they do little to remove the lead sequestered in bone (&gt; 94% of the body burden in adults, 70% of the body burden in children (<LINK REF="REF-O_x0027_Flaherty-1995" TYPE="REFERENCE">O'Flaherty 1995</LINK>)), nor do they reverse neuropsychological effects (<LINK REF="REF-Chisolm-2001" TYPE="REFERENCE">Chisolm 2001</LINK>; <LINK REF="REF-Rogan-2001" TYPE="REFERENCE">Rogan 2001</LINK>; <LINK REF="REF-Dietrich-2004" TYPE="REFERENCE">Dietrich 2004</LINK>). Due to the higher rate of bone turnover in young children, the average half-life of lead in blood is significantly longer (8 months to 11 months with acute exposure and 20 months to 38 months with prolonged exposure) than that of adults (15 days), and bone can be a prolonged source of lead in the blood (<LINK REF="REF-Manton-2000" TYPE="REFERENCE">Manton 2000</LINK>; <LINK REF="REF-Chisolm-2001" TYPE="REFERENCE">Chisolm 2001</LINK>).</P>
<P>
<LINK REF="REF-Chisolm-2001" TYPE="REFERENCE">Chisolm 2001</LINK> estimated that the cost of chelation therapy in children who were previously exposed to lead is higher than environmental interventions and is not likely to have significant long-term benefit. The ultimate goal for the management of this public health issue, then, should be to prevent toxicity in the first place by controlling lead hazards in the environment (<LINK REF="REF-Chisolm-2001" TYPE="REFERENCE">Chisolm 2001</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2016-09-16 10:05:10 +0100" MODIFIED_BY="[Empty name]">
<P>This review focuses on interventions for secondary prevention in children that are already exposed to lead sources. It includes interventions that aim to reduce existing lead exposure or prevent further lead exposure. Most research has focused on environmental and educational preventive interventions. Educational interventions address parental awareness by imparting knowledge of lead exposure pathways, hygiene, and household dust control measures to prevent ingestion of dust and soil (<LINK REF="REF-Campbell-2000" TYPE="REFERENCE">Campbell 2000</LINK>). Several papers have studied the effectiveness of educational interventions to encourage home cleaning, and these studies varied in the extent of cleaning activities and educational programmes. The results have not supported the effectiveness of education alone (<LINK REF="REF-Campbell-2000" TYPE="REFERENCE">Campbell 2000</LINK>).</P>
<P>Environmental prevention focuses on improvement in risk assessment, development of housing-based standards for lead-based paint hazards, as well as safe and cost-effective lead hazard reduction techniques (<LINK REF="REF-Campbell-2000" TYPE="REFERENCE">Campbell 2000</LINK>). Several studies have been published regarding various lead reduction techniques and their relative effectiveness and safety. These have studied both abatement (permanent elimination of lead sources through removal of paint and dust, replacement of lead containing structures, and covering of lead contaminated soil), and interim controls pending abatement (specialised cleaning, repairs, maintenance, painting, and temporary containment). Different randomised controlled trials (RCTs) have tested a variety of environmental lead hazard control interventions to decrease children's blood lead level and home dust lead levels, with most follow-up extending from six months to two years postintervention. Comparison of environmental interventions has been difficult due to variations in intervention types, blood collection techniques, adjustments for age and season, dust lead loading quantification and statistical analyses (<LINK REF="REF-Campbell-2000" TYPE="REFERENCE">Campbell 2000</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2016-09-16 10:07:00 +0100" MODIFIED_BY="[Empty name]">
<P>Removal of sources of lead, specialised cleanings, repairs and maintenance around the house (environmental interventions) aim to reduce exposure to domestic lead and lead dust. Educational interventions focused on parents aim to raise parental awareness of lead hazards and motivate them to reduce lead hazards for their children. Through education, parents should also learn about lead exposure pathways and how to clean their home to keep it in lead-safe condition. Enabling parents by educational means aims to reduce exposure to domestic lead and lead dust, thereby decreasing the risk of lead ingestion and ultimately lead poisoning.</P>
</THEORY>
<IMPORTANCE MODIFIED="2016-09-14 12:04:22 +0100" MODIFIED_BY="[Empty name]">
<P>Lead poisoning has long been linked with physical, cognitive and neurobehavioural impairment in children. Despite efforts to reduce environmental, occupational and industrial lead exposure worldwide, children living in areas with older housing and in low- and middle-income countries with weak industrial regulations continue to show evidence of lead exposure. There has been research on many household interventions, and it is important to examine their effectiveness.</P>
<P>This is an update of an original review by <LINK REF="REF-Yeoh-2008" TYPE="REFERENCE">Yeoh 2008</LINK>, which found no evidence of effectiveness for household interventions for education or dust control measures in reducing blood lead levels in children as a population health measure. The original review concluded there was insufficient evidence for soil abatement or combination interventions, and that further trials were required to establish the most effective intervention for the prevention of lead exposure. Hence, it is important to update this review looking for any advances in the area.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2016-09-16 10:09:02 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the effects of household interventions for preventing or reducing lead exposure in children, as measured by improvements in cognitive and neurobehavioural development, reductions in blood lead levels and reductions in household dust lead levels.</P>
</OBJECTIVES>
<METHODS MODIFIED="2016-10-10 16:17:55 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2016-10-06 12:21:53 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2016-09-16 10:10:13 +0100" MODIFIED_BY="[Empty name]">
<P>All RCTs or quasi-RCTs (which use a method of allocation that is not truly random, for example, by date of birth, medical record number, or order in which participants are included in the study such as alternation).</P>
<P>The main reason to focus on such study designs is to account for secular trends in blood lead levels. Children's blood lead levels have declined over the past three decades, and studies that attempt to test the effect of interventions in the absence of a control group may overestimate their effect because of the downward trend in blood lead concentrations. Furthermore, children's blood lead levels, which peak at about two years of age, typically decline as they mature primarily because they no longer exhibit as many mouthing behaviours. Thus, any observational study that enrolls children aged 18 months to two years may erroneously conclude that the intervention led to a reduction in blood lead levels even though children's blood lead levels would have declined anyway. Finally, children's blood lead levels peak during summer months; if the intervention does not account for seasonal variation it may under- or overestimate the effect of an intervention. </P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2016-09-14 12:06:36 +0100" MODIFIED_BY="[Empty name]">
<P>Children (from birth to 18 years of age) and their parents or caregivers.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2016-09-14 12:08:20 +0100" MODIFIED_BY="[Empty name]">
<P>Interventions that aim to reduce domestic lead exposure compared to no intervention or standard measures/recommendations. In this review, we classified interventions as follows.</P>
<OL>
<LI>Educational interventions. One or more educational sessions for parents that aim to raise parental awareness of lead exposure pathways and the dangers lead can have on their children as well as teaching them how to keep their home in lead-safe condition and how to prevent ingestion of dust and soil. Eligible educational interventions had to provide more than standard information via, for example, a brochure.</LI>
<LI>Environmental (household) interventions. These include specialised cleaning, repairs, maintenance, soil abatement (removal and replacement), painting, and temporary containment of lead hazards.</LI>
<LI>Combinations of the above interventions.</LI>
</OL>
<P>We excluded interventions involving nutritional supplementation.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2016-10-06 12:21:53 +0100" MODIFIED_BY="[Empty name]">
<P>We included the outcomes described below in this review.</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<OL>
<LI>Cognitive and neurobehavioural outcomes in children, assessed with standardised measures of outcome such as assessment of a child's intelligence quotient (IQ), development or behaviour. Suitable IQ measures were the Stanford Binet Intelligence Scale (<LINK REF="REF-Smith-1989" TYPE="REFERENCE">Smith 1989</LINK>), the Wechsler Intelligence Scale for Children (WISC) (<LINK REF="REF-Wechsler-1991" TYPE="REFERENCE">Wechsler 1991</LINK>), and the Wechsler Preschool and Primary Scale of Intelligence (WPPSI) (<LINK REF="REF-Wechsler-1989" TYPE="REFERENCE">Wechsler 1989</LINK>). An example of a suitable development measure is the Griffiths Mental Development Scales (<LINK REF="REF-Griffiths-1954" TYPE="REFERENCE">Griffiths 1954</LINK>; <LINK REF="REF-Griffiths-1970" TYPE="REFERENCE">Griffiths 1970</LINK>), and for behaviour, the Child Behaviour Checklist (<LINK REF="REF-Achenbach-1991" TYPE="REFERENCE">Achenbach 1991</LINK>).</LI>
<LI>Adverse events of the intervention in children (e.g. injuries or poisoning through cleansing agents).</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<OL>
<LI>Blood lead levels in children (venous blood sample or capillary blood sample; <LINK REF="REF-AAP-1998" TYPE="REFERENCE">AAP 1998</LINK>).</LI>
<LI>Household dust measures of lead exposure (e.g. lead loading of household floor dust).</LI>
<LI>Cost of intervention (e.g. cost of cleaning supplies, soil abatement or education).</LI>
</OL>
<P>Instruments were confined to those with at least one standardised outcome measure (such as blood lead level) used for intervention and control groups. We considered outcomes for any follow-up duration period (short term: 6 months to 18 months; long-term: longer than 18 months).</P>
<P>Blood lead levels in children from venous and capillary blood samples were assessed together, as one outcome of blood lead levels.</P>
<P>We used cognitive and neurobehavioural outcomes, adverse events, blood lead levels in children and household dust measures to populate <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK> and <LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>.</P>
</SUBSECTION>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2016-10-06 12:22:16 +0100" MODIFIED_BY="[Empty name]">
<P>The previous version of this review included studies up to January 2012. For this update, we revised the search strategies used in the original review (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>) by introducing additional search strings in which 'lead' was found in proximity to other terms (rather than searching for 'lead' as a single term), and we ran this revised strategy from 2012 to 2016. In addition, we added the Conference Proceedings Citation Index - Science (CPCI-S) as a substitute for searching for conference papers in ZETOC, two additional databases (Cochrane Database of Systematic Reviews (CDSR) and Database of Abstracts of Reviews of Effects (DARE)), and two trial registers (ClinicalTrials.gov and World Health Organization International Clinical Trials Registry Platform (WHO ICTRP)), which we searched from inception up to 2016 (see <LINK TAG="PRO_REV_DIFF" TYPE="SECTION">Differences between protocol and review</LINK>).</P>
<ELECTRONIC_SEARCHES MODIFIED="2016-10-06 12:22:16 +0100" MODIFIED_BY="[Empty name]">
<P>The Information Specialist of the Cochrane Developmental, Psychosocial and Learning Problems Group (CDPLPG) searched the databases and trials registers listed below on 3 May 2016. The search strategies used for this update and the previous update are in <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>. We report further search details, including the search dates and numbers of records retrieved by individual databases, in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>.</P>
<OL>
<LI>Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 4) in the Cochrane Library, which includes the CDPLPG Specialised Register.</LI>
<LI>Ovid MEDLINE (1946 to April week 3 2016).</LI>
<LI>Embase Ovid (1980 to 2016 week 18).</LI>
<LI>PsycINFO EBSCO (1806 to April week 4 2016).</LI>
<LI>CINAHL EBSCO (Cumulative Index to Nursing and Allied Health Literature; 1937 to 3 May 2016).</LI>
<LI>Sociological Abstracts ProQuest (1952 to 3 May 2016).</LI>
<LI>ERIC EBSCO (Education Resources Information Center; 1966 to 3 May 2016).</LI>
<LI>Science Citation Index Web of Science (SCI; 1970 to 2 May 2016).</LI>
<LI>CPCI-S Web of Science (CPCI-S; 1990 to 2 May 2016).</LI>
<LI>CDSR (2016, Issue 5) in the Cochrane Library.</LI>
<LI>DARE (2015, Issue 2) in the Cochrane Library.</LI>
<LI>LILACS (Latin American and Caribbean Health Science Information database; <A HREF="http://bases.bireme.br">bases.bireme.br</A>; searched 3 May 2016).</LI>
<LI>WHO ICTRP (<A HREF="http://apps.who.int/trialsearch/">apps.who.int/trialsearch</A>; searched 3 May 2016).</LI>
<LI>ClinicalTrials.gov (<A HREF="https://clinicaltrials.gov/">clinicaltrials.gov</A>; searched 3 May 2016).</LI>
</OL>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2016-09-26 08:01:26 +0100" MODIFIED_BY="[Empty name]">
<P>We examined the reference list of relevant studies, and contacted experts to determine whether any unpublished or ongoing trials existed. We did not identify any further studies.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2016-10-10 16:17:55 +0100" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2016-09-26 08:07:13 +0100" MODIFIED_BY="[Empty name]">
<P>For this update, we screened records using <LINK REF="REF-AbstrackR-2015" TYPE="REFERENCE">AbstrackR 2015</LINK> software. After pilot-testing the screening-process, two review authors screened titles and abstracts from the search independently (BY and SW prior to 2016; BNS, LMP, LKB, SKL, SL and GG in 2016). We resolved disagreements by consensus and in consultation with a third author (GR prior to 2016; UG in 2016) and discarded records that did not fulfil our inclusion criteria (see <LINK TAG="SELECTION_CRITERIA" TYPE="SECTION">Criteria for considering studies for this review</LINK>). We retrieved potentially relevant reports for full-text assessment. Pairs of review authors (BY and SW prior to 2016; BNS and SKL, LMP and LKB, SL and GG in 2016) independently screened full-text reports for eligibility. We resolved disagreements by consensus and in consultation with a third author (GR prior to 2016; UG in 2016).</P>
<P>
<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> shows how many full-text publications we excluded and why.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2016-10-06 12:25:27 +0100" MODIFIED_BY="[Empty name]">
<P>We stored records yielded by the electronic searches in reference management software (<LINK REF="REF-EndNote-2012" TYPE="REFERENCE">EndNote 2012</LINK>). We recorded and managed the results of abstract and full-text screening, including information on the reasons for exclusion at full-text assessment, in the Endnote database. We stored and managed records from trial registries in an Excel spreadsheet. We organised data using Review Manager (RevMan) version 5 (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). We developed and piloted data extraction forms a priori, extracting the information described below.</P>
<OL>
<LI>Methods: study design, study location or setting, recruitment, follow-up, intention-to-treat, power calculation.</LI>
<LI>Participants: eligibility criteria, participation rate, reason for non-participation, numbers analysed, number of dropouts/withdrawals, reasons for dropouts/withdrawals, baseline characteristics (sex, mean age, mean blood lead levels for each treatment group).</LI>
<LI>Interventions: brief descriptions of intervention (including frequency and duration of intervention events) and usual care provided.</LI>
<LI>Outcomes: timing of follow-up events, outcomes assessed and scales used.</LI>
<LI>Notes: information on funding, conflicts of interests and further information to aid understanding of the study.</LI>
</OL>
<P>Two authors (BY and SW prior to 2016; BNS and SL in 2016) independently completed data extraction forms for each study (14 included studies and 1 ongoing study). No disagreements arose.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2016-09-16 10:24:39 +0100" MODIFIED_BY="[Empty name]">
<P>In the previous version of this review (<LINK REF="REF-Yeoh-2014" TYPE="REFERENCE">Yeoh 2014</LINK>), two review authors (of BY, SW, GR and NL) assessed the risk of bias of included studies. For this update, two review authors (BNS and UG) assessed the 'blinding' domain in accordance with the updated methodological criteria in the<I> Cochrane Handbook for Systematic Reviews of Interventions </I>(<LINK REF="REF-Higgins-2011a" TYPE="REFERENCE">Higgins 2011a</LINK>), as 'blinding of participants and personnel' and 'blinding of outcome assessment'.</P>
<P>For each included study, we rated the following domains as being at high, low or unclear risk of bias.<BR/>
</P>
<OL>
<LI>
<B>Sequence generation </B>describes the method used to generate the allocation sequence to allow an assessment of whether it should produce comparable groups.</LI>
<LI>
<B>Allocation concealment</B> describes the method used to conceal the allocation sequence in sufficient detail to determine whether investigators or participants could have foreseen intervention allocations before or during enrolment.</LI>
<LI>
<B>Blinding of participants and personnel </B>describes all measures used, if any, to blind study participants and personnel from knowledge of which intervention a participant received.</LI>
<LI>
<B>Blinding of outcome assessment</B> describes all measures used, if any, to blind outcome assessors from knowledge of which intervention a participant received.</LI>
<LI>
<B>Incomplete outcome data </B>describes the completeness of outcome data, including attrition and exclusions from the analysis.</LI>
<LI>
<B>Selective outcome reporting </B>considers whether trialists reported on all relevant and pre-specified outcomes.</LI>
<LI>
<B>Other sources of bias </B>considers any important concerns about bias not addressed by the other domains (listed above) in the tool.</LI>
</OL>
<P>For cluster-randomised studies, we additionally looked at the risk of recruitment bias, baseline imbalance, loss to follow-up of clusters, and unit of analysis bias.</P>
<P>Where there was insufficient information in the published study regarding methodology or results in an extractable form, we (BNS and BY) contacted authors via email (and fax or phone call if required). If we did not receive a reply after the first contact, we sent one reminder. We did not score risk of bias on an additive basis.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2016-10-06 12:30:35 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Dichotomous data</HEADING>
<P>Where outcomes from either standardised instruments or diagnostic evaluations were expressed as proportions, we calculated the risk ratio (RR) with 95% confidence intervals (CIs). We chose to calculate the RR over the odds ratio (OR), because the OR is more difficult to interpret correctly and potentially misleading to the reader.</P>
<P>For dichotomous data, we performed the analysis on the number of children with blood lead levels at or above two thresholds: 10.0 µg/dL (0.48 µmol/L) and 15.0 µg/dL (0.72 µmol/L). We chose these cut-off points because most primary research to date has used them, although the recently updated CDC reference value of 5.0 µg/dL suggests that a lower threshold is indicated (<LINK REF="REF-CDC-2012" TYPE="REFERENCE">CDC 2012</LINK>). We did not calculate risk differences because they strongly depend on baseline risks and are not as stable as RRs (<LINK REF="REF-Higgins-2011b" TYPE="REFERENCE">Higgins 2011b</LINK>).</P>
<P>For additional methods archived for future updates of this review, please see <LINK REF="REF-Yeoh-2006" TYPE="REFERENCE">Yeoh 2006</LINK> and <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Continuous data</HEADING>
<P>Where standardised assessment tools generated a score as the outcome measure, we conducted comparisons between the means of these scores. We used post-treatment means and standard deviations (SD) in all meta-analyses. We used the mean difference (MD) of post-treatment means as the outcome measure of choice because all studies reported outcomes on the same scale. As blood lead level data are typically positively skewed, included studies often provided log transformation of lead data (presented as geometric means). To prepare data for meta-analysis, we performed a natural log transformation of all geometric means. We calculated SDs from geometric confidence intervals (CIs), where necessary, using the calculation for small sample size (<LINK REF="REF-Higgins-2011c" TYPE="REFERENCE">Higgins 2011c</LINK>), to integrate it in the meta-analysis. If trials provided arithmetic means and SDs, we contacted authors to clarify that the data were normally distributed, and if no clarification was available, we assumed that this was the case. We then converted arithmetic means and SDs to approximate means and SDs on the log transformed scale according to <LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK> before including them in the meta-analysis. Where raw data were available, we calculated post-treatment means and SDs on the log-transformed data. We also performed exponentiation of the results.</P>
<P>For additional methods archived for future updates of this review, please see <LINK REF="REF-Yeoh-2006" TYPE="REFERENCE">Yeoh 2006</LINK> and <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>.</P>
</SUBSECTION>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2016-10-10 16:17:55 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Cluster-randomised trials</HEADING>
<P>To determine the impact of possible unit of analysis errors arising from inadequate adjustment for cluster randomisation in published results by <LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>, we used a range of intraclass correlation coefficients (ICCs) to calculate a design effect to reduce the size of each trial to its 'effective sample size' (<LINK REF="REF-Higgins-2011d" TYPE="REFERENCE">Higgins 2011d</LINK>). We then used data generated from this approach in the meta-analysis. We used a range of ICCs (0.001, 0.01, 0.1, 0.2) due to no reliable ICCs being available from cluster trial authors, similar studies or resources that provided examples of ICCs (<LINK REF="REF-Ukoumunne-1999" TYPE="REFERENCE">Ukoumunne 1999</LINK>). We calculated design effects according to the equation: 1 + (M - 1) ICC, where M = 6, the average cluster size of households used in the study (<LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>). We calculated design effects using an ICC of 0.001 or less, resulting in no change in the sample sizes for intervention and control groups, so we did not use these data in further analyses.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Studies with multiple treatment groups</HEADING>
<P>We reported the results of each treatment group narratively because we could not integrate the only study consisting of multiple treatment groups into a meta-analysis (<LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>).</P>
<P>For methods archived for future updates of this review, please see <LINK REF="REF-Yeoh-2006" TYPE="REFERENCE">Yeoh 2006</LINK> and <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>.</P>
</SUBSECTION>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2016-09-14 12:41:00 +0100" MODIFIED_BY="[Empty name]">
<P>Where some data on trial methods or results were not available in the study reports, we contacted trial authors. Where no reply was forthcoming or full data were not made available, we included available data only in the meta-analysis, where possible.</P>
<P>For each study we assessed the participation rate (enrolled/eligible). We also stated the number of participants who were in the final analysis as a proportion of all randomised participants in each study and presented reasons for missing data (please see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> tables for more information).</P>
<P>For additional methods archived for future updates of this review, please see <LINK REF="REF-Yeoh-2006" TYPE="REFERENCE">Yeoh 2006</LINK> and <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>.<BR/>
</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2016-10-03 15:51:10 +0100" MODIFIED_BY="[Empty name]">
<P>We assessed consistency of results visually and by examining I² (<LINK REF="REF-Higgins-2002" TYPE="REFERENCE">Higgins 2002</LINK>), a quantity that describes the approximate proportion of variation in point estimates that is due to heterogeneity rather than sampling error. In addition, we used the Chi² test to assess the statistical significance of the heterogeneity. We considered a P value less than 0.10 as statistically significant. We also reported Tau², an estimate of the between-study variance in a random-effects meta-analysis.</P>
<P>We examined clinical heterogeneity by comparing PICO (patient/population/problem, intervention, comparator, outcome) definitions of included studies. We assessed methodological heterogeneity by comparing study designs.</P>
</HETEROGENEITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2016-09-14 12:42:00 +0100" MODIFIED_BY="[Empty name]">
<P>When two or more studies reported data that could be combined, we performed a meta-analysis. For any given outcome, we calculated the mean difference (MD) and risk ratio (RR) with 95% CIs for continuous and dichotomous data, respectively, using both the random-effects (DerSimonian and Laird) and fixed-effect (Mantel-Haenszel) models. We reported the results of the random-effects models because we assumed that the effects of secondary prevention are not identical across different populations and settings. The results of the random-effects and fixed-effect models, in general, were similar. We analysed data from RCTs separately from quasi-RCTs.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2016-09-14 12:43:02 +0100" MODIFIED_BY="[Empty name]">
<P>We organised studies into subgroups for clinically different interventions as described below.</P>
<OL>
<LI>Educational interventions.</LI>
<LI>Environmental (household) &#8211; dust control and soil abatement &#8211; interventions.</LI>
<LI>Combination &#8211; educational and dust control &#8211; interventions.</LI>
</OL>
<P>Please see <LINK REF="REF-Yeoh-2006" TYPE="REFERENCE">Yeoh 2006</LINK> and <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK> for additional subgroup analyses archived for future updates of this review.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2016-10-06 12:35:42 +0100" MODIFIED_BY="[Empty name]">
<P>We conducted a sensitivity analysis to assess the impact of the <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK> study on the results of the meta-analysis, as it had higher baseline blood levels than the other studies within the educational intervention subgroup.</P>
<P>Please see <LINK REF="REF-Yeoh-2006" TYPE="REFERENCE">Yeoh 2006</LINK> and <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK> for additional sensitivity analyses archived for future updates of this review.<BR/>
</P>
<SUBSECTION>
<HEADING LEVEL="3">Summary of findings table</HEADING>
<P>With the exception of cost of intervention, we assessed the quality of evidence for each outcome deemed critical for decision-making, using the GRADE approach (<LINK REF="REF-Guyatt-2011" TYPE="REFERENCE">Guyatt 2011</LINK>). As recommended by GRADE, we constructed a 'Summary of findings' table for the main interventions: education strategies for preventing domestic lead exposure in children, and environmental strategies (dust control) for preventing domestic lead exposure in children. We presented the results from the meta-analyses in the 'Summary of findings' tables (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>; <LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>). To judge the quality of evidence, we assessed risk of bias, inconsistency, indirectness, imprecision, and publication bias of the evidence base for each outcome. The judgement of quality of evidence was based on GRADE's four categories: high quality, when further research is very unlikely to change our confidence in the estimate of effect; moderate quality, when further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate; low quality, when further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate; or very low quality, when we are very uncertain about the estimate of the effect (<LINK REF="REF-Balshem-2011" TYPE="REFERENCE">Balshem 2011</LINK>; <LINK REF="REF-Guyatt-2011" TYPE="REFERENCE">Guyatt 2011</LINK>).</P>
</SUBSECTION>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2016-10-10 17:06:09 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2016-10-06 12:49:54 +0100" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2016-09-14 12:51:25 +0100" MODIFIED_BY="[Empty name]">
<P>We completed the literature search for the original version of this review at the end of May 2006, retrieving 12,308 titles. We rejected records at title and abstract stage if they were not primarily about lead exposure in children, were not RCTs or quasi-RCTs, or did not fulfil the inclusion criteria as outlined in <LINK TAG="SELECTION_CRITERIA" TYPE="SECTION">Criteria for considering studies for this review</LINK>. We retrieved and assessed the full-texts of 25 promising papers and of these, we identified 20 unique trials (with 5 reports being additional publications for these trials). Of the 20 separate trials identified, we included 12 and excluded 8. We did not identify any unpublished papers or ongoing papers (<LINK REF="REF-Yeoh-2008" TYPE="REFERENCE">Yeoh 2008</LINK>).</P>
<P>We updated the searches at the end of April 2010 and again at the end of January 2012. After excluding reports based on above methods at title and abstract stage, we identified two additional studies, bringing the included trials to 14 in the present review (see <LINK REF="REF-Yeoh-2014" TYPE="REFERENCE">Yeoh 2014</LINK>).</P>
<P>For the purposes of this update, we revised our original search strategy by introducing additional search strings in which 'lead' was found in proximity to other terms and reran our revised search from 2012 to 2016. We also added CPCI-S as a substitute for searching for conference papers in ZETOC, two additional databases (CDSR and DARE) to identify other reviews, and two trials registers (ClinicalTrials.gov and WHO ICTRP), which we searched using our revised strategy for all available years (see <LINK TAG="PRO_REV_DIFF" TYPE="SECTION">Differences between protocol and review</LINK>). This strategy yielded 2594 records from electronic searches and 80 records from citation tracking and searches of grey literature. After removing duplicates, we screened 2182 titles and abstracts for eligibility. We rejected 2164 records at title and abstract stage because they did not fulfil the inclusion criteria as outlined in <LINK TAG="SELECTION_CRITERIA" TYPE="SECTION">Criteria for considering studies for this review</LINK>. We retrieved and assessed the full-texts of 18 promising reports, and of these we excluded 16 (see <LINK TAG="EXCLUDED_STUDIES_DESCR" TYPE="SECTION">Excluded studies</LINK>). We identified one paper reporting additional information on a previously included study (<LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>) and one report of an ongoing study (the results of which will probably be available by the end of 2017) that met our eligibility criteria (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>).</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2016-10-06 12:49:54 +0100" MODIFIED_BY="[Empty name]">
<P>Please see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="4">Design</HEADING>
<P>This review includes 13 RCTs (<LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>; <LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>; <LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>; <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>; <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>; <LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>; <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>; <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>), along with 1 quasi-RCT (<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>). The trials correspond to 20 records and involved 2643 children under six years of age. All studies used a parallel-group design, with one study also performing the intervention on volunteers from the control group at a later date (<LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>). As there was no parallel control group in this second phase, we did not include these results in our review. Another study by <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK> included a matched control group in addition to the two randomised arms at the analysis stage. The study methods had pre-specified this group, but it was not part of the randomisation process so we could not include the results of this review. As a consequence, we included data only from the two randomised study arms (maintenance education group = treatment arm, and standard education group = control arm). Twelve studies used individuals or households (<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>; <LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>; <LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>; <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>; <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>; <LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>; <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>; <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>), and two studies used clusters (neighbourhoods and blocks of six households; <LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK> respectively), as the unit of allocation for randomisation.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Sample sizes</HEADING>
<P>Four studies had fewer than 100 participants (<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>; <LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>; <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>; <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>). Six studies had 100 to 200 participants (<LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>; <LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>; <LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>), and four studies had more than 200 participants (<LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>; <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Participants and setting</HEADING>
<P>Thirteen included studies took place in urban areas of North America; one study was performed in Broken Hill, Australia (<LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>). Most studies were performed in areas of low socioeconomic status, with a significant proportion of participants living in rental accommodation with below average household income levels. More than half of the included studies involved significant proportions of people identifying themselves as African-American or Hispanic. Boys and girls were equally represented in all studies.</P>
<P>Thirteen studies recruited participants from routine screening programmes, medical clinics, previous lead studies or community volunteers, and they excluded children who had clinical symptoms, were receiving treatment for lead toxicity (e.g. chelation) or had high blood lead levels requiring intervention (&gt; 20.0 µg/dL to 24.0 µg/dL; 0.97 µmol/L to 1.16 µmol/L) (<LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>; <LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>; <LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>; <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>; <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>; <LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>; <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>; <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>). <LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK> recruited participants from a lead poisoning clinic, and 15% of children were reported to have had previous treatment for lead toxicity.</P>
<P>Baseline mean blood lead levels varied across studies, with five studies reporting levels below 10.0 µg/dL (0.48 µmol/L) (<LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>; <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>; <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>), five reporting levels between 10.0 µg/dL and 14.0 µg/dL (0.48 µmol/L to 0.68 µmol/L) (<LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>; <LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK>; <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>; <LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>), three reporting levels between 15.0 µg/dL and 19.0 µg/dL (0.72 µmol/L to 0.92 µmol/L) (<LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>; <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>), and one reporting levels above 20.0 µg/dL (0.97 µmol/L) (<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>). See <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK> for more information.</P>
<P>With regards to age at baseline, the children had a mean age of less than 12 months in three studies (<LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>; <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>), 12 months to 24 months in four (<LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>; <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>), 24 months to 36 months in three (<LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>; <LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>), and more than 36 months in three (<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>; <LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>; <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>). One study did not report the mean age; the age range was six months to six years (<LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK>). See <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK> for more information.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Interventions</HEADING>
<P>The interventions used in the studies were either educational, environmental or a combination of both (for detailed information on the interventions used see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>). In studies using educational interventions, three studies used education alone (<LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>; <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>), and two studies used education plus provision of cleaning products (<LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>). Of the studies using environmental interventions, two studies used soil abatement (<LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>; <LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK>), and three studies used dust control interventions (<LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>, <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>; <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>). Four studies used a combination of lead dust control, education and/or hazard reduction interventions (<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>; <LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>; <LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>; <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>). See <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK> for more information.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Intervention integrity</HEADING>
<P>We contacted trial authors to provide additional information about intervention integrity. Authors reported general difficulties in providing consistent environmental and educational interventions in a community setting and inconsistent adherence to recommended housekeeping practices. Investigators did not measure adherence. We contacted all authors of included studies, and all responded.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Control</HEADING>
<P>One study used a placebo control group in which participants received household safety items, but no special education on lead prevention or any assistance with household cleaning (<LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>). Thirteen studies did not use any placebo intervention (<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>; <LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>; <LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>; <LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>; <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>; <LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>; <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>; <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>). Seven studies gave the control groups educational information on lead and methods on dust control and/or hazard reduction that were available to the general community with no additional input from the researchers (<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>; <LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>; <LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>; <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>). In three studies, both intervention and control groups received basic educational brochures or information about reduction of lead hazards separate to the intervention (<LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>). In two studies both groups received home lead assessment and feedback (<LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>; <LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>), and in another both groups received internal lead hazard reduction with the intervention group also receiving the intervention of interest &#8211; soil abatement (<LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Intervention duration</HEADING>
<P>For 12 studies the duration of the intervention ranged between 3 months and 24 months. In the two studies that used soil abatement intervention, the intervention was performed on a single occasion during the study (<LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>; <LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcomes</HEADING>
<P>No studies used any standardised cognitive and neurobehavioural outcomes or gathered standardised information on adverse events in children.</P>
<P>Blood lead level was the standardised outcome reported in all studies. Five studies reported household floor dust (<LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011;</LINK> see <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>).</P>
<P>Both continuous and dichotomous blood lead level data were available from seven studies (<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>; <LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>; <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>). Five studies provided only continuous data (<LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>; <LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>; <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>; <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>; <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>), one study provided only dichotomous data (<LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>), and one study reported results in terms of 'total effect' (<LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK>). Additionally, raw data were available for three studies (<LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>).</P>
<P>For continuous data, 7 of the 12 studies reported geometric means (<LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>; <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>; <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>), and five studies reported arithmetic means (<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>; <LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>; <LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>; <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>; <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>). <LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK> reported data as having a normal distribution. As no clarification was available for the remaining studies providing arithmetic means, we assumed that the data were normally distributed.</P>
<P>Limited data detailing study costs were available for six studies (<LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK>; <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>; <LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>; <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Follow-up duration</HEADING>
<P>The period of follow-up from baseline ranged from 6 months to 48 months, with most studies reporting blood lead levels at 3 months to 12 months postintervention. Three studies provided data at longer time points (<LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>; <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>). <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK> collected data up to 18 months postintervention with a follow-up publication at 48 months (<LINK REF="REF-Lanphear-2000" TYPE="REFERENCE">Lanphear 2000</LINK>). <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK> had follow-up data reported at four-month intervals up to three years postintervention. <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK> reported the blood lead levels after 24 months follow-up.</P>
<P>We used short-term postintervention data from the two long-term studies in our meta-analysis (6 months for <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK> and 18 months for <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>) to enable a more comparable follow-up period to other included studies. With regard to household dust level outcomes, we used six-month follow-up data for the two studies with available data (<LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Ongoing studies</HEADING>
<P>We identified one ongoing study, which is due to be completed in September 2017 (<LINK REF="STD-NCT00129324" TYPE="STUDY">NCT00129324</LINK>). This study enrolled pregnant women and their children, comparing a lead hazard control intervention to injury hazard control intervention and no intervention. Outcomes of interest will be blood lead levels and neurobehavioral outcomes in children.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2016-09-14 14:52:17 +0100" MODIFIED_BY="[Empty name]">
<P>Please see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>.</P>
<P>Across all versions of the review (<LINK REF="REF-Yeoh-2008" TYPE="REFERENCE">Yeoh 2008</LINK>; <LINK REF="REF-Yeoh-2012" TYPE="REFERENCE">Yeoh 2012</LINK>; <LINK REF="REF-Yeoh-2014" TYPE="REFERENCE">Yeoh 2014</LINK>), including this update, we assessed 45 full-texts reports for eligibility. Of these, we included 20 reports (14 studies) in the review, identified 1 ongoing study and excluded 24 reports (reasons for exclusion are provided in the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table). We excluded 8 of these studies in the previous version (<LINK REF="REF-Yeoh-2014" TYPE="REFERENCE">Yeoh 2014</LINK>) and 16 in this update.</P>
<P>For this update, we excluded 11 studies because of ineligible study design: five were observational studies (<LINK REF="STD-Farfel-1990" TYPE="STUDY">Farfel 1990</LINK>; <LINK REF="STD-Malcoe-2004" TYPE="STUDY">Malcoe 2004</LINK>; <LINK REF="STD-Dixon-2012" TYPE="STUDY">Dixon 2012</LINK>; <LINK REF="STD-NCT00000104" TYPE="STUDY">NCT00000104</LINK>; <LINK REF="STD-NCT00011674" TYPE="STUDY">NCT00011674</LINK>), two used qualitative research methods (<LINK REF="STD-Thomas-2013" TYPE="STUDY">Thomas 2013</LINK>; <LINK REF="STD-Feit-2014" TYPE="STUDY">Feit 2014</LINK>), two used a before-and-after design without a comparison group (<LINK REF="STD-Phoenix-2013" TYPE="STUDY">Phoenix 2013</LINK>; <LINK REF="STD-Wilson-2015" TYPE="STUDY">Wilson 2015</LINK>), one study was a systematic review (a former version of this Cochrane Review; <LINK REF="STD-Yeoh-2014" TYPE="STUDY">Yeoh 2014</LINK>), and one was a cross-sectional study (<LINK REF="STD-Whitehead-2014" TYPE="STUDY">Whitehead 2014</LINK>). We also excluded one study because it used an ineligible, historical control without randomisation (<LINK REF="STD-EPA-1997" TYPE="STUDY">EPA 1997</LINK>). We excluded a further three studies because they did not measure an outcome that was relevant for this Cochrane review: <LINK REF="STD-Butterfield-2011" TYPE="STUDY">Butterfield 2011</LINK> measured parent's self-efficacy and precaution adoption, <LINK REF="STD-Zimmermann-2006" TYPE="STUDY">Zimmermann 2006</LINK> investigated iron fortification as the intervention, and <LINK REF="STD-Maharaj-2007" TYPE="STUDY">Maharaj 2007</LINK> consisted of a discussion paper about the link between lead and asthma. Finally, we excluded one study because it did not answer a key question of the review: <LINK REF="STD-Untimanon-2012" TYPE="STUDY">Untimanon 2012</LINK> did not focus on preventing lead exposure but on contamination modes.</P>
<P>In the previous version of this review, we excluded three studies because they used retrospective or historical controls without randomisation (<LINK REF="STD-EPA-1996" TYPE="STUDY">EPA 1996</LINK>; <LINK REF="STD-Taha-1999" TYPE="STUDY">Taha 1999</LINK>; <LINK REF="STD-Pollak-2002" TYPE="STUDY">Pollak 2002</LINK>), one study because it reported long-term follow-up for an included trial but did not use controls (<LINK REF="STD-Aschengrau-1994" TYPE="STUDY">Aschengrau 1994</LINK>), one study because it compared two groups from different study bases (<LINK REF="STD-Omidpanah-1998" TYPE="STUDY">Omidpanah 1998</LINK>), and three studies because they did not measure any outcomes relevant for this Cochrane review: <LINK REF="STD-Boreland-2006" TYPE="STUDY">Boreland 2006</LINK> measured environmental measures, <LINK REF="STD-Dugbatey-2005" TYPE="STUDY">Dugbatey 2005</LINK> measured maternal blood levels, and <LINK REF="STD-Marlowe-2001" TYPE="STUDY">Marlowe 2001</LINK> measured hair lead levels.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2016-10-06 13:05:24 +0100" MODIFIED_BY="[Empty name]">
<P>This review includes 13 RCTs and one quasi-RCT in which alternate clinic numbers determined allocation to groups (<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>). We received responses from all 14 corresponding authors of the included studies when we contacted them to provide missing information on methodology or results, but in many instances, some of the requested information was not available.</P>
<P>
<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK> show the risk of bias of each domain for all included studies.</P>
<ALLOCATION MODIFIED="2016-10-03 13:57:28 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Sequence generation</HEADING>
<P>Of the 13 RCTs, the method of randomisation was adequate for 12 studies with available information. Eight studies used random number generators, tables or lists (<LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>; <LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>; <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>; <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>), two studies used coin toss (<LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK>; <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>), one study used numbered slips of paper (<LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>), and one study used permutated blocks of varying length (<LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>). Methods of randomisation were unclear in one study (<LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>). We rated the quasi-RCT, in which alternate clinic numbers determined allocation to groups, at high risk of bias (<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>). </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Allocation concealment</HEADING>
<P>Of the 13 RCTs, 7 used adequate methods of allocation concealment with either sealed envelopes or a central office (<LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>; <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>; <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>). Allocation concealment remained unclear in four studies (<LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK>; <LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>; <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>; <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>). Two of the RCTs did not report adequate concealment (<LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>; <LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>).</P>
<P>We assessed the quasi-RCT as being at high risk of bias because it had no allocation concealment (<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>).</P>
</SUBSECTION>
</ALLOCATION>
<BLINDING MODIFIED="2016-09-14 15:24:47 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Blinding participants and personnel (performance bias)</HEADING>
<P>Although not every study blinded participants and personnel, we rated the risk for performance bias as low because the participants' knowledge on treatment allocation probably had no influence on outcomes like blood lead level and household dust levels.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Blinding outcome assessment (detection bias)</HEADING>
<P>All but one study blinded outcome assessors for dust and blood samples; the personnel collecting dust samples in <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK> knew the household assignment. It is unclear whether this knowledge could have biased the result, so we rated the risk of detection bias accordingly.</P>
</SUBSECTION>
</BLINDING>
<EXCLUSIONS MODIFIED="2016-09-16 10:59:49 +0100" MODIFIED_BY="[Empty name]">
<P>We rated risk for attrition bias separately for the outcomes of blood lead levels and household dust measures of lead exposure.</P>
<P>For blood lead levels, we rated the risk of attrition bias as low in eight studies because the attrition rate was acceptable and similar in both the intervention and control groups (<LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>; <LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>; <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>; <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>). In one study we rated the risk of attrition as unclear, because the overall attrition rate was quite high, but it was the same in both groups (<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>). In the other studies we rated the risk of attrition bias as high. In <LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK> the overall attrition rate was 41%; it was 18% points higher in the intervention group than in the control group. In <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK> the attrition rate was 38%, with no information on the attrition rate in the treatment arms. In <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK> the attrition rate was acceptable (21%); however, it was much higher in the control group (30%) than in the intervention group (12%). In <LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK> the attrition rate was 55%, and in <LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK> it was 61%.</P>
<P>Of the nine studies that reported on household dust measures of lead exposure, we rated five as being at low risk of attrition bias because the attrition rate was acceptable and similar in both the intervention and control groups (<LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>; <LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>). We assessed one study as being at unclear risk because numbers and reasons for missing data were not available (<LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>). In <LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>, <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK> and <LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>, we rated the risk of attrition bias for household dust measures of lead exposure as high, because overall attrition rates were 46%, 64% and 66%, respectively.</P>
<P>The most common reasons reported for withdrawal were that families had moved out of the area or were no longer reachable.</P>
<P>We contacted authors to determine if they had analysed participants in the groups to which they were randomised (intention-to-treat). None of the studies performed complete measures of all participants' outcomes (full intention-to-treat analysis). Seven studies analysed data based on available participants' outcomes (available case analysis; <LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>; <LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>; <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>; <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>). We were unable to determine if five studies used data from all available participants (<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>; <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>; <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>; <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>; <LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>). In two studies, participants were excluded from analyses if non-study interventions (such as any lead hazard reduction measures performed independently of study intervention) occurred during the study (<LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>; <LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK>).</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2016-09-14 15:40:47 +0100" MODIFIED_BY="[Empty name]">
<P>Information from authors suggest that published reports of seven studies included all expected outcomes, including those they had pre-specified (<LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>; <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>; <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>). For six studies there was insufficient information, so we rated the risk of bias for this domain as unclear (<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>; <LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>; <LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>; <LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK>; <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>; <LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>). One study described measuring household dust lead outcomes but did not report these data in the article. We could not obtain any information on these outcomes from the author (<LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003)</LINK>.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2016-10-06 13:05:24 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Funding</HEADING>
<P>Of the 14 included studies, two studies did not mention their funding source, so we judged them to be at unclear risk of bias (<LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>; <LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Other potential sources of bias in cluster-randomised trials</HEADING>
<P>Two of the 14 included studies were cluster-randomised trials, a design that can be affected by additional sources of bias. Risk of recruitment bias and risk of bias due to baseline imbalance was low in <LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK> and <LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>, since baseline characteristics were comparable and randomisation was achieved by coin toss. Risk of bias due to unit of analysis was unclear in <LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK>, who used neighbourhood clusters, but it was unclear how they performed the analysis, as data were not available; and high in <LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>, since <LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK> randomised clusters of households but used individuals as the unit of analysis. </P>
</SUBSECTION>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2016-10-10 17:06:09 +0100" MODIFIED_BY="[Empty name]">
<P>We present results sequentially by intervention type, by outcome measure and by type of data (continuous and dichotomous). Cost data are presented at the end of this section for all intervention types combined.</P>
<P>We classified the 14 studies into subgroups based on type of intervention, as combining these significantly different types of intervention would not be clinically appropriate.</P>
<OL>
<LI>Education (<LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>; <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>).</LI>
<LI>Environmental.</LI>
<OL>
<LI>Dust control (<LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>; <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>).</LI>
<LI>Soil abatement (<LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>; <LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK>).</LI>
</OL>
<LI>Combination - education and dust control (<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>; <LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>; <LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>; <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>).</LI>
</OL>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 1. Education interventions versus no intervention or standard education</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Cognitive and neurobehavioural outcomes in children</HEADING>
<P>None of the included studies measured cognitive or neurobehavioural outcomes.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Adverse events of the intervention in children</HEADING>
<P>None of the included studies measured adverse events in children in a standardised way.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Blood lead levels in children</HEADING>
<P>Five studies of educational interventions were available for meta-analysis (<LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>; <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>). Geometric means were readily available from all authors, except <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>, who provided raw data.</P>
<P>See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="6">Continuous data</HEADING>
<P>Meta-analysis of log transformed summary data showed no evidence of a treatment effect (MD 0.02, 95% CI &#8722;0.09 to 0.12; I² = 0%, Tau² = 0.00; 5 studies, N = 815; high quality evidence; <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). Exponentiation of the result produced a treatment effect of 1.0 µg/dL (95% CI 0.9 to 1.1; analysis not shown). The mean age for participants in these studies was less than two years, and baseline blood level was less than 10.0 µg/dL (0.48 µmol/L) in all studies except for <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>. As the baseline blood lead level for <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK> was 15.0 µg/dL to 19.0 µg/dL (0.72 µmol/L to 0.92 µmol/L), we performed a sensitivity analysis to assess the effect of clinical heterogeneity. When we excluded <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>, there was still no evidence of a treatment effect (MD &#8722;0.01, 95% CI &#8722;0.13 to 0.11; I² = 0%; analysis not shown). Exponentiation of the result produced a treatment effect of 1.0 µg/dL (95% CI 0.9 to 1.1; analysis not shown).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Dichotomous data</HEADING>
<P>We performed meta-analysis of dichotomous data for four studies, as dichotomous outcomes were not available for <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>. Meta-analysis for numbers of children with blood lead level of 10.0 µg/dL (0.48 µmol/L) or more showed no evidence of a treatment effect (RR 1.02, 95% CI 0.79 to 1.30; I² = 0%, Tau² = 0.00; N = 520; moderate quality evidence; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). Meta-analysis of data reported as numbers of children with blood lead level of 15.0 µg/dL (0.72 µmol/L) or more also showed no evidence of a treatment effect (RR 0.60, 95% CI 0.33 to 1.09; I² = 0%, Tau² = 0.00; N = 520; moderate quality evidence; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Household dust measures of lead exposure</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Continuous data</HEADING>
<P>Two of the five studies had log transformed summary data available on hard floor dust lead levels for this intervention (<LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>). The mean hard floor dust level was below the 0.431 mg/m² (40.0 &#956;g/ft²) dust lead standard established by the US Department of Housing and Urban Development (HUD) and the US Environmental Protection Agency (EPA) for the home environment. The meta-analysis of the log transformed summary data showed no evidence of treatment effect (MD &#8722;0.07, 95% CI &#8722;0.37 to 0.24; I² = 0%, Tau² = 0.00; N = 318; moderate quality evidence; <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>). Exponentiation of the result produced a treatment effect of 0.010 mg/m², 95% CI 0.008 to 0.014; analysis not shown (0.9 µg/ft², 95% CI 0.7 to 1.3). <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK> reported postintervention floor dust lead levels as geometric means, but type of floor was not specified (hard floor or carpet), so we did not include the data in the meta-analysis. After one year, the dust lead level was 0.095 mg/m² (8.8 µg/ft²) in the control group and 0.059 mg/m² (5.5 µg/ft²) in the intervention group, and the difference was statistically significant (P &lt; 0.05, not presented more precisely in the study). One study had data on carpet floor (<LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>), showing 0.038 mg/m², 95% CI 0.017 to 0.081 (3.5 µg/ft², 95% CI 1.6 to 7.6) in the intervention group and 0.044 mg/m², 95% CI 0.014 to 0.138 (4.1 µg/ft², 95% CI 1.3 to 12.8) in the control group after seven months (P value = 0.72).</P>
<P>Three of the five studies reported outcomes on window dust lead levels. We did not pool these studies in a meta-analysis because investigators used different surfaces to collect the dust lead samples (window sill, window troughs, window wells or sills in general). <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK> reported dust lead levels in "other sills", not specifying where they were. One year after the intervention the level was 0.273 mg/m² (25.4 µg/ft²) in the intervention group compared to 0.563 mg/m² (52.3 µg/ft²) in the control group; the difference was statistically significant (P &lt; 0.05, not presented more precisely in the study). <LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK> measured dust lead levels in interior window sills and window wells. At the end of the study the level was 0.961 mg/m², 95% CI 0.260 to 3.539 (89.3 µg/ft², 95% CI 24.2 to 328.8) in the intervention group compared to 0.972 mg/m², 95% CI 0.203 to 4.648 (90.3 µg/ft², 95% CI 18.9 to 431.9) in the control group, and 32.421 mg/m², 95% CI 2.723 to 379.212 (3012.0 µg/ft², 95% CI 253.0 to 35,230.0) in the intervention group compared to 40.989 mg/m², 95% CI 4.434 to 379.212 (3808.0 µg/ft², 95% CI 412.0 to 35,230.0) in the control group, respectively. The difference was not statistically significant for either types of outcome. Also, <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK> did not report any statistically significant difference between control and intervention group at the end of the study in lead in window sills (intervention: 1.153 mg/m² (107.1 µg/ft²), control: 1.547 mg/m² (143.7 µg/ft²); P value = 0.19) and window troughs (intervention: 23.397 mg/m² (2173.7 µg/ft²), control 28.516 mg/m² (2649.2 µg/ft²); P value = 0.54).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 2. Environmental interventions versus no intervention or another intervention not aiming to influence domestic lead exposure</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Cognitive and neurobehavioural outcomes in children</HEADING>
<P>None of the included studies measured cognitive or neurobehavioural outcomes.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Adverse events of the intervention in children</HEADING>
<P>None of the included studies measured adverse events in children in a standardised way.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Blood lead levels in children</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Dust control</HEADING>
<P>
<U>Continuous data</U>
</P>
<P>Three studies used dust control interventions (<LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>; <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>). <LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK> and <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK> reported log transformed summary data while <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK> reported arithmetic means and SDs. The meta-analysis of log transformed summary data showed no evidence of a treatment effect (MD &#8722;0.15, 95% CI &#8722;0.42 to 0.11; I² = 90%, Tau² = 0.05; N = 298; low quality evidence; <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>). An I² of 90% is very high, indicating high heterogeneity between studies that cannot be explained by sampling error. One possible explanation for such a high I² could be that the interventions were too different in these studies. While <LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK> and <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK> used high-efficiency particulate air (HEPA) vacuum cleaning as an intervention, <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK> used a more intensive intervention: house remediation work (e.g. ceiling dust removal, sealing of ceilings, paint stabilisation, replacement of floor coverings/windows, and cleaning). However, excluding <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK> from the meta-analysis increased the I² value. Other possible explanations include the difference in the age of the children and the limitations of using the I² statistic when only a few studies are included in a meta-analysis. Exponentiation of the result produced a treatment effect of 0.9 µg/dL (95% CI 0.7 to 1.1; analysis not shown).</P>
<P>
<U>Dichotomous data</U>
</P>
<P>We performed a meta-analysis of dichotomous data for two studies (<LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>). The meta-analysis for numbers of children with blood lead level of 10.0 µg/dL (0.48 µmol/L) or more showed no evidence of a treatment effect (RR 0.93, 95% CI 0.73 to 1.18; I² = 0%, Tau² = 0.00; N = 210; moderate quality evidence; <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>), and this was also the case for children with blood lead levels at or above 15.0 µg/dL (0.72 µmol/L; RR 0.86, 95% CI 0.35 to 2.07; I² = 56%, Tau² = 0.23; N = 210; low quality evidence; <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>).</P>
<P>
<U>Impact of clustering and unit of analysis errors</U>
</P>
<P>We calculated effective sample sizes for the cluster-randomised trial for a range of ICCs before incorporating this study into the meta-analysis (<LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>). For blood lead levels of 10.0 µg/L (0.48 µmol/L) or more, there was no statistically significant treatment benefit when we adjusted the meta-analysis for clustering: ICC 0.01 (RR 0.93, 95% CI 0.73 to 1.18; I² = 0%, Tau² = 0.00; 2 studies; N = 204; <LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>); ICC of 0.1 (RR 0.95, 95% CI 0.72 to 1.24; I² = 0%, Tau² = 0.00; 2 studies; N = 173; <LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>); or ICC of 0.2 (RR 0.97, 95% CI 0.72 to 1.29; I² = 0%, Tau² 0.00; 2 studies; N = 155; <LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>). For blood lead levels of 15.0 µg/dL (0.72 µmol/L) or more, there was no statistically significant treatment benefit when the meta-analysis was adjusted for clustering: ICC 0.01 (RR 0.82, 95% CI 0.37 to 1.81; I² = 45%, Tau² = 0.15; 2 studies; N = 204; <LINK REF="CMP-002.07" TYPE="ANALYSIS">Analysis 2.7</LINK>); ICC 0.1 (RR 0.83, 95% CI 0.34 to 2.03; I² = 48%, Tau² = 0.20; 2 studies; N = 173; <LINK REF="CMP-002.08" TYPE="ANALYSIS">Analysis 2.8</LINK>); or ICC 0.2 (RR 0.75, 95% CI 0.34 to 1.66; I² = 25%, Tau² = 0.08; 2 studies; N = 155; <LINK REF="CMP-002.09" TYPE="ANALYSIS">Analysis 2.9</LINK>). Thus, correcting for unit of analysis errors did not alter the overall outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Soil abatement</HEADING>
<P>Two studies performed soil abatement interventions (<LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>; <LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK>). As no blood lead level data were available in a usable form from <LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK> and follow-up was less than 60%, comparison was not possible. <LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK> reported results as 'total effect' showing no statistical significance, and no data were available for our analysis. <LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK> reported a statistically significant effect in favour of the intervention. The difference in mean change scores between the intervention group and control group A (loose interior dust abatement and paint removal) was &#8722;1.5 µg/dL (SD 4.9), and between the intervention group and control group B (loose interior paint removal only), it was &#8722;1.9 µg/dL (SD 5.0). No measure of variance was available for post-treatment means or mean change scores, so further analysis was not possible in this review.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Household dust measures of lead exposure</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Dust control</HEADING>
<P>One study provided household carpet lead measures for dust control interventions (<LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>), reporting no clinically significant treatment effect with geometric means for post-treatment dust lead level, which was 0.360 mg/m² (33.5 µg/ft²) in the intervention group and 0.230 mg/m² (21.4 µg/ft²) in the control group. <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK> provided geometric means of lead loading from floor wipes, sill wipes and vacuum after one year. Investigators reported no significant difference for floor wipes (intervention: 0.163 mg/m² (15.1 µg/ft²), control: 0.207 mg/m² (19.2 µg/ft²)) or vacuum (intervention: 1.618 mg/m² (150.3 µg/ft²), control: 2.307 mg/m² (214.3 µg/ft²)). For sill wipes, the difference was statistically significant (P &lt; 0.05, not presented more precisely in the study), and lead levels were 0.263 mg/m² (24.4 µg/ft²) in the intervention group and 0.522 mg/m² (48.5 µg/ft²) in the control group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Soil abatement</HEADING>
<P>No studies reported household dust lead levels for this intervention.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 3. Combination interventions versus standard education</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Cognitive and neurobehavioural outcomes in children</HEADING>
<P>None of the included studies measured cognitive or neurobehavioural outcomes.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Adverse events of the intervention in children</HEADING>
<P>None of the included studies measured adverse events in children in a standardised way.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Blood lead levels in children</HEADING>
<P>Of the four studies that used a combination of interventions, two reported continuous data (<LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>; <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>), one arithmetic means (<LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>), and one geometric means (<LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>). One study reported dichotomous data (<LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>), and the fourth was clinically very different because it was a quasi-RCT (<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>), with high mean baseline blood lead levels (&gt; 30.0 µg/dL, or 1.44 µmol/L) and older participants (mean age 3.5 years). It was therefore not possible or appropriate to combine any of these studies in a meta-analysis.</P>
<P>
<LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK> reported arithmetic means for post-treatment blood lead levels as 11.5 µg/dL (SD 3.2) in the intervention group and 10.4 µg/dL (SD 3.1) in the control group. An analysis of these post-treatment scores performed in our review failed to reach statistical significance: MD 1.1 µg/dL (95% CI &#8722;1.5 to 3.7; analysis not shown). <LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK> reported dichotomous data with 4/10 (40%) in intervention group 1; 6/14 (43%) in intervention group 2, and 6/15 (40%) in the control group having blood lead levels less than 10.0 µg/dL (0.48 µmol/L) post-treatment, but this study had small numbers and less than 40% follow-up. An analysis of this data performed in our review, reported as numbers of children with blood lead levels at or above 10.0 µg/dL (0.48 µmol/L), showed no evidence of treatment effect (intervention group 1 &#8211; newsletters and education: RR 1.00, 95% CI 0.52 to 1.92; intervention group 2 &#8211; newsletters, education and specialised cleaning: RR 0.95, 95% CI 0.52 to 1.76; analyses not shown). <LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK> reported a significant effect favouring treatment with arithmetic means for post-treatment blood lead levels of 31.7 µg/dL (SD 2.6) in the intervention group and 37.8 µg/dL (SD 7.9) in the control group. <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK> reported similar geometric means for blood lead levels after 12 months for the intervention group (2.6 µg/dL) and control group (2.7 µg/dL) (P value = 0.68). Likewise, blood lead levels for the intervention group (3.5 µg/dL) and the control group (3.9 µg/dL) were not significantly different after two years (P value = 0.20).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Household dust measures in children</HEADING>
<P>One study provided continuous data of hard floor and window dust lead levels for this intervention subgroup (<LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>). We found no treatment effect, with median changes for floor dust lead level being -0.002 mg/m² (&#8722;0.2 µg/ft², SD 0.8) in the intervention group and 0.001 mg/m² (0.0 µg/ft², SD 0.2) in the control group. For window sills, the mean change in the intervention group was -0.006 mg/m² (&#8722;0.5 µg/ft², SD 1.3) in the intervention group and -0.005 mg/m² (&#8722;0.5 µg/ft², SD 1.0) in the control group; for window wells, it was -0.007 mg/m² (&#8722;0.7 µg/ft², SD 0.9) in the intervention group and 0.000 mg/m² (0.0 µg/ft², SD 1.6) in the control group. A second study provided dichotomous data with no significant difference observed in the number of households with positive dust lead levels (floor &gt; 0.431 mg/m² (40.0 µg/ft²); window &gt; 2.691 mg/m² (250.0 µg/ft²)) between the intervention (17/59) and control (11/51) groups at 12 months post-treatment (<LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>) .</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Cost of intervention</HEADING>
<P>Six studies provided cost data for their intervention or study, reporting large variations in costs depending on the types of interventions and types of cost data collected. The calculations often omitted the costs of researchers and educators. With regard to educational interventions, <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK> noted that, on average, comparison families spent USD 108.78 and intervention families spent USD 43.01 on cleaning supplies. <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK> reported that Medicaid paid for medical check-ups, and researchers spent USD 11 per blood test. With dust control interventions, <LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK> reported that the entire study cost approximately USD 200,000, but no detailed costs for the intervention were available. <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK> reported that the average cost per household was AUD 5000 (in 1994), but ranged from AUD 1000 to AUD 20,000. For soil abatement, <LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK> estimated that the average cost per household was USD 1700, with the entire study costing USD 5 million. For a combination of interventions, <LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK> reported an average cost per quarterly cleaning of USD 500 per household, and <LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK> reported median costs of lead hazard control or remediation work over a 12-month period of USD 4656 for 42 control households and USD 5512 for 36 intervention households. No cost data were available for seven studies (<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>; <LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>; <LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>; <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>).</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2016-10-10 17:06:43 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2016-10-06 13:25:56 +0100" MODIFIED_BY="[Empty name]">
<P>Of 2225 identified studies, 14 met our eligibility criteria for inclusion in this review. We identified no evidence on cognitive or neurobehavioural outcomes and adverse events. The results of this systematic review suggest that educational interventions and dust control interventions are not effective in reducing children's blood lead levels. Furthermore, when we adjusted the meta-analysis for the dust control subgroup for clustering, we again found no evidence of an effect.</P>
<P>We could not pool the studies that used soil abatement (removal and replacement) or combination intervention groups in a meta-analysis due to substantial differences between studies. For both soil abatement and combination interventions, two of the included studies reported reductions in blood lead level for treatment groups. We could not pool these results in a meta-analysis because studies used clinically distinct intervention types (soil abatement and a combination of interventions). One study showed a treatment effect with a combined (education and dust control) intervention (<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>). As this was a quasi-RCT and had participants with high baseline blood lead levels (more than 30.0 µg/dL), it was clinically distinct from other included studies. The significant blood lead level reduction after intervention is consistent with previous findings that interventions are likely to be more beneficial in children who have higher baseline blood lead levels (<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>; <LINK REF="REF-Haynes-2002" TYPE="REFERENCE">Haynes 2002</LINK>). This finding requires further research to assess whether or not preventive interventions are better aimed at particular populations of children. <LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK> estimated intervention effects on blood lead levels of 1.5 µg/dL to 1.9 µg/dL (0.07 µmol/L to 0.09 µmol/L). The clinical significance of this at an individual level is likely to be minimal, but at a population level may be important. However, the generalisability or reproducibility of the results from these studies is not known. Therefore, there is currently insufficient evidence to clarify whether soil abatement or a combination of interventions reduce blood lead levels.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2016-09-16 11:28:05 +0100" MODIFIED_BY="[Empty name]">
<P>None of the included studies used a standardised cognitive or neurobehavioural outcome measure despite this being one of the main adverse outcomes of lead exposure. However, in view of the magnitude of blood lead level reductions reported in the studies with significant treatment effect and the known correlation between blood lead level and cognition, we do not expect that we would have found any significant improvement in cognitive outcomes even if investigators had measured them.</P>
<P>No studies measured adverse events in children in a standardised way. Future trials need to better examine and report adverse effects and ensure that sample sizes are sufficiently large to allow this.</P>
<P>Some experts point out that blood lead levels are not suitable across all levels or durations of exposure. A recent review described blood lead levels as the most suitable biomarkers when assessing recent or current exposures to lead (weeks or months) at low or moderate levels (<LINK REF="REF-Barbosa-2005" TYPE="REFERENCE">Barbosa 2005</LINK>), but at high levels of exposure, a curvilinear relationship between blood lead levels and exposure makes its use as a biomarker more difficult (<LINK REF="REF-Bergdahl-2008" TYPE="REFERENCE">Bergdahl 2008</LINK>). Alternative measures have not shown to be superior to blood lead level when monitoring lead exposure (<LINK REF="REF-Barbosa-2005" TYPE="REFERENCE">Barbosa 2005</LINK>; <LINK REF="REF-Bergdahl-2008" TYPE="REFERENCE">Bergdahl 2008</LINK>). Lead is, moreover, a bone-seeking element, a characteristic that is especially relevant for constant lead exposure (<LINK REF="REF-Rust-1999" TYPE="REFERENCE">Rust 1999</LINK>). From the bone, it can be released into the blood (<LINK REF="REF-Rabinowitz-1991" TYPE="REFERENCE">Rabinowitz 1991</LINK>; <LINK REF="REF-Gulson-2003" TYPE="REFERENCE">Gulson 2003</LINK>), which is especially relevant for pregnant women and children (<LINK REF="REF-Manton-2000" TYPE="REFERENCE">Manton 2000</LINK>; <LINK REF="REF-Gulson-2003" TYPE="REFERENCE">Gulson 2003</LINK>). This release of lead from bone into blood adversely affects the reduction of blood lead levels (<LINK REF="REF-Rust-1999" TYPE="REFERENCE">Rust 1999</LINK>; <LINK REF="REF-Gwiazda-2005" TYPE="REFERENCE">Gwiazda 2005</LINK>). It is therefore necessary to assess remediation efforts over prolonged periods of time (i.e. at least 6 months to 12 months).</P>
<P>The participants in the included studies were all children younger than six years of age. Although we looked for studies in children from birth to 18 years of age, we did not identify any study on older children or adolescents. Future studies need to focus also on preventing lead exposure in these groups. All but one of the studies were conducted in North America (<LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>), and we cannot rule out that the treatment effects would be different if the interventions were transferred to other contexts.</P>
<P>Meta-analysis was not possible for all interventions or outcomes due to the clinical diversity of trials, use of different outcome measures and different forms of data reported. No more than five studies used a similar intervention and even within these intervention subgroups, the reported intervention varied significantly; for example, type of education, duration of intervention, study setting and whether or not supplies were provided. In addition, there were variations in baseline lead levels and mean age. However, due to the limited number of studies within each intervention type, there were insufficient data for subgroup analyses according to baseline age.</P>
<P>These issues of clinical diversity, inconsistent participant compliance with household cleaning practices, variability in interventions, suboptimal recruitment numbers and losses to follow-up that reduce study power may all contribute to the lack of clear effect demonstrated in a meta-analysis of study results. The effectiveness of other more intensive interventions, or interventions performed over a longer duration than those available to date, is not yet known. Also, the trials in this review largely focus on participants with low socioeconomic status in the USA, in rental housing and, as such, results may not be generalisable to different populations.</P>
<P>We lack studies of full remediation, as interventions evaluated were not able to eliminate all ongoing environmental lead sources and were limited to household interventions. Therefore, it is possible that recontamination occurred during the trial period. Thus, while reduction in lead-contaminated house dust may be needed to reduce or prevent childhood lead exposure, it is not sufficient. It may be necessary to eliminate the ongoing source of lead exposure by removing or eliminating ongoing contamination from lead-based paint and other residential lead hazards. Furthermore, other sources of lead contamination, like passive smoking, water, diet or sources outside the home, may have limited the possible benefit of interventions. Another reason for lack of treatment effect may be that most included studies had a follow-up period of 12 months or less, and the long half-life of lead in children may contaminate short-term outcomes.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2016-10-06 13:26:43 +0100" MODIFIED_BY="[Empty name]">
<P>For educational interventions, we assessed the quality of evidence from continuous blood lead level outcomes as high, so it is unlikely that further research will change our confidence in the effect estimate. We assessed the quality of evidence for dichotomous blood lead level outcomes as moderate because the 95% CIs around the pooled estimate included no effect and appreciable harm or benefit, and because the total number of events was less than 300. We assessed the quality of evidence for household dust measures of lead exposure to be moderate; we downgraded one level for imprecision because the total number of participants was less than 400. This means that for the latter two outcomes, further research is likely to have an important impact in our confidence in the estimate of effect and may change it.</P>
<P>For environmental interventions, we rated the quality of evidence from continuous and dichotomous blood lead level outcomes as moderate to low. We downgraded the evidence quality by one level because of imprecision and one level for inconsistency because I² was high (blood lead level, continuous: 90%; blood lead level, dichotomous &#8805; 15.0 µg/dL: 56%).</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2016-09-15 09:50:46 +0100" MODIFIED_BY="[Empty name]">
<P>We judge the risk of potential biases in the review process to be low. Most of the authors of this update were new. To avoid any biases caused by changing authors, the first author of the original review remained on the team, and we set a high value on intense communication and exchange of information with the original team. To minimise the risk of bias caused by a revised search strategy during the course of this update, we searched all newly added databases without time limits, and not just from the date of the last search to 2016. Publication bias and selective outcome reporting are potential limitations of any systematic review. Although we searched for grey and unpublished literature, the extent and impact of reporting biases of this body of evidence is impossible to determine.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2016-10-10 17:06:43 +0100" MODIFIED_BY="[Empty name]">
<P>A previous review limited to low-cost, lead hazard control interventions, which included only four trials, reported no substantial effect on mean blood lead concentration but noted treatment effect with dichotomous data for reducing the number of participants with blood lead levels of 15.0 µg/dL or more (<LINK REF="REF-Haynes-2002" TYPE="REFERENCE">Haynes 2002</LINK>). <LINK REF="REF-Haynes-2002" TYPE="REFERENCE">Haynes 2002</LINK> differed from our review in that it combined the results of different types of interventions in a meta-analysis. Our review did not find a statistically significant effect for participants with blood lead levels of 15.0 µg/dL or more.</P>
<P>Another systematic review assessed the effectiveness of interventions to reduce lead exposure through consumer products and drinking water (<LINK REF="REF-Pfadenhauer-2016" TYPE="REFERENCE">Pfadenhauer 2016</LINK>). This review reported on blood lead levels and could also not confirm the effectiveness of educational interventions.</P>
<P>On the surface, these results may appear to contradict observational studies that report a reduction in dust lead loadings and, on average, a decrease in children's blood lead levels (<LINK REF="REF-Clark-2004" TYPE="REFERENCE">Clark 2004</LINK>). However, the key question is whether the interim lead hazard controls or partial abatement led to a significant reduction or increase among at-risk (i.e. younger) children who exhibit mouthing behaviours. The observational data actually show that household interventions lead to a significant increase in blood lead concentration for young children, especially six-month old infants. Compared with children over 40 months of age, the odds of having an increase in blood lead levels of 5.0 &#956;g/dL or higher following abatement were high: OR 11.18 (95% CI 2.80 to 44.16) for six-month old infants; OR 3.69 (95% CI 1.68 to 8.09) for 12-month old children; OR 1.79 (95% CI 1.07 to 2.99) for 18-month old children; and OR 1.18 (95% CI 0.79 to 1.76) for 24-month old children. These results indicate that the floor clearance levels used by the HUD grantees (less than 1.076 or 2.153 mg/m² (100.0 or 200.0 &#956;g/ft²)) are insufficient to protect children. This is not surprising; there is considerable evidence that dust lead levels under 0.108 mg/m² (10.0 &#956;g/ft²) are associated with a large increase in the risk of children having a blood lead level of more than 10.0 µg/dL (<LINK REF="REF-Lanphear-1996b" TYPE="REFERENCE">Lanphear 1996b</LINK>; <LINK REF="REF-Lanphear-1998" TYPE="REFERENCE">Lanphear 1998</LINK>; <LINK REF="REF-Lanphear-2005b" TYPE="REFERENCE">Lanphear 2005b</LINK>; <LINK REF="REF-Dixon-2009" TYPE="REFERENCE">Dixon 2009</LINK>). Thus, even if lead hazard controls or renovation activities can be safely implemented, if we rely on empirically derived but obsolete dust clearance standards, the measures may actually increase young children's blood lead concentrations.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2016-09-26 08:34:37 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2016-08-30 14:43:55 +0100" MODIFIED_BY="[Empty name]">
<P>Based on a review of the current research, there is evidence that educational interventions are not effective in reducing blood lead levels in children. Dust control interventions may lead to little or no difference in blood lead levels (the quality of evidence was moderate to low, meaning that future research is likely to change these results). There is currently insufficient evidence that soil abatement or combination interventions reduce blood lead levels. No study reported on cognitive/neurobehavioural outcomes and adverse events. These patient-relevant outcomes would have been of great interest to draw conclusions for practice.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2016-09-26 08:34:37 +0100" MODIFIED_BY="[Empty name]">
<P>Further trials are required to establish the most effective intervention for the prevention or reduction of lead exposure in children. Key elements for these trials should include more intensive interventions that simultaneously reduce multiple sources of lead exposure using neurodevelopmental outcomes, incorporation of placebo interventions as control, different populations, stratification of participants based on baseline blood lead levels, measures of intervention compliance, data collection over longer time periods (36 months to 48 months), and measures to reduce loss to follow-up.</P>
<P>Trials that look at suitable interventions in low- and middle-income countries are also urgently required, as are studies in children in more affluent areas where lead exposure is often due to renovation rather than poor maintenance and hence may be more short-term and amenable to preventive interventions.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2016-09-15 10:06:36 +0100" MODIFIED_BY="[Empty name]">
<P>The authors would like to thank the trial authors who provided us with information. We thank Dr Katrina Williams for her advice and assistance with methods and meta-analysis. We commend and appreciate the continued efforts of CDPLPG for their help with literature searching, review and editing, in particular the support of Jane Dennis, former Managing Editor, and Joanne Wilson, current Managing Editor. We would also like to thank Danielle Wheeler for her contribution to the original review. The authors of this updated version of the Cochrane review want to thank the authors of the original review, who did not remain authors of this update, but supported us as external experts: Susan Woolfenden (SW), Bruce Lanphear (BL), Greta F Ridley (GR), Nuala Livingstone (NL), Emile Jorgensen (EJ). We would also like to thank Evelyn Auer for her organisational support throughout the update. We highly appreciate the financial support of the World Health Organization (WHO).</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2016-09-15 10:09:20 +0100" MODIFIED_BY="[Empty name]">
<P>WHO financially supported the update of this review as part of its guideline development process.</P>
<P>Barbara Nussbaumer-Streit - none known.<BR/>Berlinda Yeoh - none known.<BR/>Ursula Griebler - none known.<BR/>Lisa M Pfadenhauer and Laura K Busert - attended the Cochrane Colloquium in 2015. Their participation fees were covered by WHO and paid via Danube University Krems.<BR/>Stefan K Lhachimi - none known.<BR/>Szimonetta Lohner - none known.<BR/>Gerald Gartlehner - none known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2016-09-15 10:08:56 +0100" MODIFIED_BY="[Empty name]">
<P>BNS, BY, UG, LMP, LKB, SKL, SL, GG wrote the updated text of the review. Margaret Anderson updated and performed the search. LKB, LMP, SL, SKL, BNS and GG screened titles, abstracts and full-text articles. UG resolved conflicts regarding inclusion/exclusion of an article. SL and BNS extracted data from original studies into data extraction forms. BNS and UG assessed the blinding domain in accordance with the updated methodological criteria in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011a" TYPE="REFERENCE">Higgins 2011a</LINK>), as 'blinding of participants and personnel' and 'blinding of outcome assessment'. BNS and GG also reassessed the domain 'attrition bias'. BNS took over first authorship and is the guarantor for the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2016-10-06 13:50:04 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="2">Search methods for identification of studies</HEADING>
<P>We revised the search strategies used for the original review for the 2012 update (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>) by introducing additional search strings in which 'lead' is found in proximity to other terms (rather than searching for 'lead' as a single term). We re-ran the revised strategies for this 2016 update, and searched two additional databases (Cochrane Database of Systematic Reviews (CDSR) and Database of Abstracts of Reviews of Effects (DARE). We also searched Conference Proceedings Citation Index - Science (CPCI-S) as a substitute for searching for conference papers in ZETOC, because of its more advanced search interface.</P>
<SUBSECTION>
<HEADING LEVEL="3">Searching other resources</HEADING>
<P>We did not search the internet for unpublished studies, because we examined the reference list of relevant studies, and contacted experts to determine whether any unpublished or ongoing trials existed.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Data collection and analysis</HEADING>
<SUBSECTION>
<HEADING LEVEL="3">Data extraction and management</HEADING>
<P>We used the most up-to-date version of RevMan (version 5.3) for this update (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Measures of treatment effect</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Binary data</HEADING>
<P>We did not calculate risk differences because they strongly depend on the baseline risk and are not as stable as risk ratios (<LINK REF="REF-Higgins-2011b" TYPE="REFERENCE">Higgins 2011b</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Continuous data</HEADING>
<P>For continuous data, we compared post-treatment means between intervention and control groups, and calculated mean differences (MDs) instead of comparing mean changes (from baseline to post-treatment) between intervention and control groups, because baseline data were comparable in the included studies.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Confidence in cumulative evidence</HEADING>
<P>We used the GRADE method to assess the quality of the evidence from meta-analyses per outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessment of heterogeneity</HEADING>
<P>We reported Tau², an estimate of the between-study variance in a random-effects meta-analysis.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Changes in author team</HEADING>
<P>Berlinda Yeoh (BY), Susan Woolfenden (SW), Danielle M Wheeler (DMW), Garth Aperstein (GA), and Bruce Lanphear (BL) developed and wrote the text of the original review (<LINK REF="REF-Yeoh-2006" TYPE="REFERENCE">Yeoh 2006</LINK>). In 2012 BY, SW, BL, Greta F Ridley (GFR), and Nuala Livingstone (NL) updated the original review. In 2014 BY, SW, BL, GFR, NL, and Emile Jorgensen (EJ) updated the review again. In 2016 the authors' team changed. BNS took over first authorship, BY stayed in the authors' team, and UG, LMP, LKB, SKL, SL, GG joined the new author team.</P>
</SUBSECTION>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2016-10-11 11:42:23 +0100" MODIFIED_BY="Joanne Wilson">
<STUDIES MODIFIED="2016-09-15 15:17:11 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2016-09-15 15:07:05 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="MIX" ID="STD-Aschengrau-1998" MODIFIED="2016-09-15 14:54:14 +0100" MODIFIED_BY="[Empty name]" NAME="Aschengrau 1998" YEAR="1998">
<REFERENCE MODIFIED="2016-04-07 10:22:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Aschengrau A, Hardy S, Mackey P, Pultinas D</AU>
<TI>The impact of low technology lead hazard reduction activities among children with mildly elevated blood lead levels</TI>
<SO>Environmental Research</SO>
<YR>1998</YR>
<VL>79</VL>
<NO>1</NO>
<PG>41-50</PG>
<IDENTIFIERS MODIFIED="2016-04-07 10:22:02 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359434"/><IDENTIFIER MODIFIED="2016-04-07 10:22:01 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1006/enrs.1998.3858"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 14:53:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Aschengrau A</AU>
<TI>Blinding (participants, personnel, outcome assessors) in the trial [personal communication]</TI>
<SO>Email to: B Nussbaumer</SO>
<YR>2 September 2015</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359432"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 14:54:14 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Aschengrau A</AU>
<TI>Detailled information on study conduct and results [personal communication]</TI>
<SO>Email to: B Yeoh</SO>
<YR>27 February 2007</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359433"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359431"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Boreland-2009" MODIFIED="2016-09-15 14:58:34 +0100" MODIFIED_BY="[Empty name]" NAME="Boreland 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-04-07 10:23:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Boreland F, Lesjak M, Lyle D</AU>
<TI>Evaluation of home and lead remediation in an Australian mining community</TI>
<SO>Science of the Total Environment</SO>
<YR>2009</YR>
<VL>408</VL>
<NO>2</NO>
<PG>202-8</PG>
<IDENTIFIERS MODIFIED="2016-04-07 10:23:13 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359437"/><IDENTIFIER MODIFIED="2016-04-07 10:23:13 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/j.scitotenv.2009.10.013"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 14:58:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Boreland F</AU>
<TI>Detailed information on study conduct and results [personal communication]</TI>
<SO>Email to: B Yeoh</SO>
<YR>30 July 2010</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359436"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2010-08-12 11:08:16 +0100" MODIFIED_BY="Berlinda Yeoh"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359435"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Brown-2006" MODIFIED="2016-09-15 14:58:51 +0100" MODIFIED_BY="[Empty name]" NAME="Brown 2006" YEAR="2006">
<REFERENCE MODIFIED="2016-04-07 10:24:05 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Brown MJ, McLaine P, Dixon S, Simon P</AU>
<TI>A randomized, community-based trial of home visiting to reduce blood lead levels in children</TI>
<SO>Pediatrics</SO>
<YR>2006</YR>
<VL>117</VL>
<NO>1</NO>
<PG>147-53</PG>
<IDENTIFIERS MODIFIED="2016-04-07 10:24:05 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359440"/><IDENTIFIER MODIFIED="2016-04-07 10:24:05 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16396872"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 14:58:51 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Brown MJ</AU>
<TI>Detailed information on study conduct and results [personal communication]</TI>
<SO>Email to: B Yeoh</SO>
<YR>23 February 2007</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359439"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359438"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Campbell-2011" MODIFIED="2016-09-15 14:59:44 +0100" MODIFIED_BY="[Empty name]" NAME="Campbell 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-09-15 14:59:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Campbell 2011</AU>
<TI>Additional information on study conduct and results [personal communication]</TI>
<SO>Email to: B Nussbaumer</SO>
<YR>31 July 2015</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359442"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-22 10:39:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Campbell C, Gracely E, Tran M, Starkey N, Kersten H, Palermo P, et al</AU>
<TI>Primary prevention of lead exposure - blood lead results at age two years</TI>
<SO>International Journal of Environmental Research in Public Health</SO>
<YR>2012</YR>
<VL>9</VL>
<NO>4</NO>
<PG>1216-26</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359443"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 14:59:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Campbell C, Tran M, Gracely E, Starkey N, Kersten H, Palermo P, et al</AU>
<TI>Primary prevention of lead exposure: the Philadelphia Lead Safety Homes Study</TI>
<SO>Public Health Reports</SO>
<YR>2011</YR>
<VL>126</VL>
<NO>Suppl 1</NO>
<PG>76-88</PG>
<IDENTIFIERS MODIFIED="2016-04-07 10:26:19 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359444"/><IDENTIFIER MODIFIED="2016-04-07 10:26:19 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="21563715"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-07-08 12:57:36 +0100" MODIFIED_BY="Barbara Nussbaumer"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359441"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Charney-1983" MODIFIED="2016-09-15 15:00:10 +0100" MODIFIED_BY="[Empty name]" NAME="Charney 1983" YEAR="1983">
<REFERENCE MODIFIED="2016-04-07 10:26:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Charney E, Kessler B, Farfel M, Jackson D</AU>
<TI>Childhood lead poisoning. A controlled trial of the effect of dust-control measures on blood lead levels</TI>
<SO>New England Journal of Medicine</SO>
<YR>1983</YR>
<VL>309</VL>
<NO>18</NO>
<PG>1089-93</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359447"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 15:00:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Charney E</AU>
<TI>Additional information on study conduct and results [personal communication]</TI>
<SO>Email to: B Nussbaumer</SO>
<YR>30 July 2015</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359446"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359445"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Farrell-1998" MODIFIED="2016-09-15 15:00:29 +0100" MODIFIED_BY="[Empty name]" NAME="Farrell 1998" YEAR="1998">
<REFERENCE MODIFIED="2015-12-14 11:26:26 +0000" MODIFIED_BY="Barbara Nussbaumer" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Farrell KP, Brophy MC, Chisolm JJ, Rohde CA, Strauss WJ</AU>
<TI>Soil lead abatement and children's blood lead levels in an urban setting</TI>
<SO>American Journal of Public Health</SO>
<YR>1998</YR>
<VL>88</VL>
<NO>12</NO>
<PG>1837-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359450"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 15:00:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Farrell KP</AU>
<TI>Detailled information on study conduct and results [personal communication]</TI>
<SO>Email to: B Yeoh</SO>
<YR>28 November 2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359449"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359448"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Hilts-1995" MODIFIED="2016-09-15 15:01:05 +0100" MODIFIED_BY="[Empty name]" NAME="Hilts 1995" YEAR="1995">
<REFERENCE MODIFIED="2016-04-07 10:29:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hilts SR, Hertzman C, Marion SA</AU>
<TI>A controlled trial of the effect of HEPA vacuuming on childhood lead exposure</TI>
<SO>Canadian Journal of Public Health</SO>
<YR>1995</YR>
<VL>86</VL>
<NO>5</NO>
<PG>345-50</PG>
<IDENTIFIERS MODIFIED="2016-04-07 10:29:23 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359454"/><IDENTIFIER MODIFIED="2016-04-07 10:29:23 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="8556684"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 15:00:52 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Hilts SR</AU>
<TI>Blinding (participants, personnel, outcome assessors) in the trial [personal communication]</TI>
<SO>Email to: B Nussbaumer</SO>
<YR>30 July 2015</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359452"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 15:01:05 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Hilts SR</AU>
<TI>Detailled information on study conduct and results [personal communication]</TI>
<SO>Email to: B Yeoh</SO>
<YR>16 November 2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359453"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359451"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Jordan-2003" MODIFIED="2016-09-15 15:01:26 +0100" MODIFIED_BY="[Empty name]" NAME="Jordan 2003" YEAR="2003">
<REFERENCE MODIFIED="2015-12-14 11:33:44 +0000" MODIFIED_BY="Barbara Nussbaumer" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Jordan CM, Yust BL, Robison LL, Hannan P, Deinard AS</AU>
<TI>A randomized trial of education to prevent lead burden in children at high risk for lead exposure: efficacy as measured by blood lead monitoring</TI>
<SO>Environmental Health Perspectives</SO>
<YR>2003</YR>
<VL>111</VL>
<NO>16</NO>
<PG>1947-51</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359458"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 15:01:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Jordan CM</AU>
<TI>Blinding (participants, personnel, outcome assessors) in the trial [personal communication]</TI>
<SO>Email to: B Nussbaumer</SO>
<YR>30 July 2015</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359456"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 15:01:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Jordan CM</AU>
<TI>Detailed information on study conduct and results [personal communication]</TI>
<SO>Email to: B Yeoh</SO>
<YR>18 February 2007</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359457"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359455"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Lanphear-1996a" MODIFIED="2016-09-15 15:02:05 +0100" MODIFIED_BY="[Empty name]" NAME="Lanphear 1996a" YEAR="1996">
<REFERENCE MODIFIED="2015-12-14 11:43:44 +0000" MODIFIED_BY="Barbara Nussbaumer" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lanphear BP, Winter NL, Apetz L, Eberly S, Weitzman M</AU>
<TI>A randomized trial of the effect of dust control on children's blood lead levels</TI>
<SO>Pediatrics</SO>
<YR>1996</YR>
<VL>98</VL>
<NO>1</NO>
<PG>35-40</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359462"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 15:01:50 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Lanphear BP</AU>
<TI>Additonal information on study conduct and results [personal communication]</TI>
<SO>Conversations with: B Yeoh (as coauthor of the original review)</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359460"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 15:02:05 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Lanphear BP</AU>
<TI>Blinding (participants, personnel, outcome assessors) in the trial [personal communication]</TI>
<SO>Email to: B Nussbaumer</SO>
<YR>30 July 2015</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359461"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359459"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Lanphear-1999" MODIFIED="2016-09-15 15:03:12 +0100" MODIFIED_BY="[Empty name]" NAME="Lanphear 1999" YEAR="1999">
<REFERENCE MODIFIED="2016-04-07 10:32:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lanphear BP, Eberly S, Howard CR</AU>
<TI>Long-term effect of dust control on blood lead concentrations</TI>
<SO>Pediatrics</SO>
<YR>2000</YR>
<VL>106</VL>
<NO>4</NO>
<PG>E48</PG>
<IDENTIFIERS MODIFIED="2016-04-07 10:32:58 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359466"/><IDENTIFIER MODIFIED="2016-04-07 10:32:58 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11015543"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-04-07 10:33:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lanphear BP, Howard C, Eberly S, Auinger P, Kolassa J, Weitzman M, et al</AU>
<TI>Primary prevention of childhood lead exposure: a randomized trial of dust control</TI>
<SO>Pediatrics</SO>
<YR>1999</YR>
<VL>103</VL>
<NO>4 Pt 1</NO>
<PG>772-7</PG>
<IDENTIFIERS MODIFIED="2016-04-07 10:33:44 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359467"/><IDENTIFIER MODIFIED="2016-04-07 10:33:44 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10103301"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 15:02:50 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Lanphear BP</AU>
<TI>Additonal information on study conduct and results [personal communication]</TI>
<SO>Conversations with: B Yeoh (as co-author of the original review)</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359464"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 15:03:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Lanphear BP</AU>
<TI>Blinding (participants, personnel, outcome assessors) in the trial [personal communication]</TI>
<SO>Email to: B Nussbaumer</SO>
<YR>30 July 2015</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359465"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359463"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Rhoads-1999" MODIFIED="2016-09-15 15:03:39 +0100" MODIFIED_BY="[Empty name]" NAME="Rhoads 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lioy PJ, Yiin LM, Adgate J, Weisel C, Rhoads GG</AU>
<TI>The effectiveness of a home cleaning intervention strategy in reducing potential dust and lead exposures</TI>
<SO>Journal of Exposure Analysis and Environmental Epidemiology</SO>
<YR>1998</YR>
<VL>8</VL>
<NO>1</NO>
<PG>17-35</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359469"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-04-07 10:35:39 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Rhoads GG, Ettinger AS, Weisel CP, Buckley TJ, Goldman KD, Adgate J, et al</AU>
<TI>The effect of dust lead control on blood lead in toddlers: a randomized trial</TI>
<SO>Pediatrics</SO>
<YR>1999</YR>
<VL>103</VL>
<NO>3</NO>
<PG>551-5</PG>
<IDENTIFIERS MODIFIED="2016-04-07 10:35:39 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359472"/><IDENTIFIER MODIFIED="2016-04-07 10:35:39 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10049955"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 15:03:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Rhoads GG</AU>
<TI>Blinding (participants, personnel, outcome assessors) in the trial [personal communication]</TI>
<SO>Email to: B Nussbaumer</SO>
<YR>3 August 2015</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359470"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 15:03:39 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Rhoads GG</AU>
<TI>Detailled information about study conduct and results [personal communication]</TI>
<SO>Email to: B Yeoh</SO>
<YR>8 November 2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359471"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-04-07 10:36:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yiin LM, Lioy PJ, Rhoads GG</AU>
<TI>Impact of home carpets on childhood lead intervention study</TI>
<SO>Environmental Research</SO>
<YR>2003</YR>
<VL>92</VL>
<NO>2</NO>
<PG>161-5</PG>
<IDENTIFIERS MODIFIED="2016-04-07 10:36:55 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359473"/><IDENTIFIER MODIFIED="2016-04-07 10:36:55 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="12854696"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359468"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Sterling-2004" MODIFIED="2016-09-15 15:04:04 +0100" MODIFIED_BY="[Empty name]" NAME="Sterling 2004" YEAR="2004">
<REFERENCE MODIFIED="2016-04-07 10:37:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sterling DA, Evans RG, Shadel BN, Serrano F, Arndt B, Chen JJ, et al</AU>
<TI>Effectiveness of cleaning and health education in reducing childhood lead poisoning among children residing near superfund sites in Missouri</TI>
<SO>Archives of Environmental Health</SO>
<YR>2004</YR>
<VL>59</VL>
<NO>3</NO>
<PG>121-31</PG>
<IDENTIFIERS MODIFIED="2016-04-07 10:37:34 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359476"/><IDENTIFIER MODIFIED="2016-04-07 10:37:34 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16121901"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 15:04:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Sterling DA</AU>
<TI>Additional information on study conduct and results [personal communication]</TI>
<SO>Email to: B Nussbaumer</SO>
<YR>3 August 2015</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359475"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359474"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Wasserman-2002" MODIFIED="2016-09-15 15:06:17 +0100" MODIFIED_BY="[Empty name]" NAME="Wasserman 2002" YEAR="2002">
<REFERENCE MODIFIED="2016-09-15 15:04:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Bliss LR</AU>
<TI>Blinding (participants, personnel, outcome assessors) in trial [personal communication]</TI>
<SO>Email to: B Nussbaumer</SO>
<YR>30 July 2015</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359478"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 15:04:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Wasserman LR</AU>
<TI>Detailed information on study conduct and results [personal communication]</TI>
<SO>Email to: B Yeoh</SO>
<YR>19 February 2007</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359479"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 15:06:17 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="BOOK">
<AU>Wasserman LR</AU>
<SO>The Effects of a Family-based Educational Intervention on the Prevention of Lead Poisoning in Children [thesis]</SO>
<YR>2002</YR>
<PB>Florida International University</PB>
<CY>Miami, FL</CY>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359480"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359477"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Weitzman-1993" MODIFIED="2016-09-15 15:07:05 +0100" MODIFIED_BY="[Empty name]" NAME="Weitzman 1993" YEAR="1993">
<REFERENCE MODIFIED="2016-04-07 10:40:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aschengrau A, Beiser A, Bellinger D, Copenhafer D, Weitzman M</AU>
<TI>Residential lead-based-paint hazard remediation and soil lead abatement: their impact among children with mildly elevated blood lead levels</TI>
<SO>American Journal of Public Health</SO>
<YR>1997</YR>
<VL>87</VL>
<NO>10</NO>
<PG>1698-702</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359483"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 15:06:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Aschengrau A</AU>
<TI>Additional information on study conduct and results [personal communication]</TI>
<SO>Email to: B Yeoh</SO>
<YR>26 February 2007</YR>
<IDENTIFIERS MODIFIED="2015-12-14 11:59:59 +0000" MODIFIED_BY="Barbara Nussbaumer"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359482"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Glotzer DE, Weitzman M, Aschengrau A, Freedberg KA</AU>
<TI>Economic evaluation of environmental interventions for low-level childhood lead poisoning</TI>
<SO>Ambulatory Child Health</SO>
<YR>1997</YR>
<VL>3</VL>
<NO>3</NO>
<PG>255-67</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359484"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-04-07 11:06:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Weitzman M, Aschengrau A, Bellinger D, Jones R, Hamlin JS, Beiser A</AU>
<TI>Lead-contaminated soil abatement and urban children's blood lead levels</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1993</YR>
<VL>269</VL>
<NO>13</NO>
<PG>1647-54</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:06:37 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359486"/><IDENTIFIER MODIFIED="2016-04-07 11:06:37 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1001/jama.1993.03500130061033"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-15 15:07:05 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Weitzman M</AU>
<TI>Blinding (participants, personnel, outcome assessors) in the trial [personal communication]</TI>
<SO>Email to: B Nussbaumer</SO>
<YR>30 July 2015</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359485"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359481"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2016-09-15 15:12:12 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="MIX" ID="STD-Aschengrau-1994" MODIFIED="2016-04-07 11:07:36 +0100" MODIFIED_BY="[Empty name]" NAME="Aschengrau 1994" YEAR="1994">
<REFERENCE MODIFIED="2016-04-07 11:07:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aschengrau A, Beiser A, Bellinger D, Copenhafer D, Weitzman M</AU>
<TI>The impact of soil lead abatement on urban children's blood lead levels: phase II results from the Boston Lead-In-Soil Demonstration Project</TI>
<SO>Environmental Research</SO>
<YR>1994</YR>
<VL>67</VL>
<NO>2</NO>
<PG>125-48</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:07:36 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359488"/><IDENTIFIER MODIFIED="2016-04-07 11:07:36 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="7982389"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359487"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Boreland-2006" MODIFIED="2016-04-07 11:08:05 +0100" MODIFIED_BY="[Empty name]" NAME="Boreland 2006" YEAR="2006">
<REFERENCE MODIFIED="2016-04-07 11:08:05 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boreland F, Lyle DM</AU>
<TI>Lead dust in Broken Hill homes: effect of remediation on indoor lead levels</TI>
<SO>Environmental Research</SO>
<YR>2006</YR>
<VL>100</VL>
<NO>2</NO>
<PG>276-83</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:08:05 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359490"/><IDENTIFIER MODIFIED="2016-04-07 11:08:05 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/j.envres.2005.06.007"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359489"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Butterfield-2011" MODIFIED="2016-04-07 11:10:42 +0100" MODIFIED_BY="[Empty name]" NAME="Butterfield 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-04-07 11:10:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Butterfield PG, Hill W, Postma J, Butterfield PW, Odom-Maryon T</AU>
<TI>Effectiveness of a household environmental health intervention delivered by rural public health nurses</TI>
<SO>American Journal of Public Health</SO>
<YR>2011</YR>
<VL>101</VL>
<NO>S1</NO>
<PG>S262-70</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359492"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359491"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dixon-2012" MODIFIED="2016-04-07 11:13:53 +0100" MODIFIED_BY="[Empty name]" NAME="Dixon 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-04-07 11:13:53 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dixon SL, Jacobs D, Wilson JW, Akoto JY, Nevin R, Clark CS</AU>
<TI>Window replacement and residential lead paint hazard control 12 years later</TI>
<SO>Environmental Research</SO>
<YR>2012</YR>
<VL>113</VL>
<PG>14-20</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:13:53 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359494"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359493"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dugbatey-2005" MODIFIED="2016-09-15 15:08:00 +0100" MODIFIED_BY="[Empty name]" NAME="Dugbatey 2005" YEAR="2005">
<REFERENCE MODIFIED="2016-09-15 15:08:00 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dugbatey K, Croskey V, Evans RG, Narayan G, Osamudiamen OE</AU>
<TI>Lessons from a primary-prevention program for lead poisoning among inner-city children</TI>
<SO>Journal of Environmental Health</SO>
<YR>2005</YR>
<VL>68</VL>
<NO>5</NO>
<PG>15-20</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:13:50 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359496"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359495"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-EPA-1996" MODIFIED="2016-09-15 15:08:49 +0100" MODIFIED_BY="[Empty name]" NAME="EPA 1996" YEAR="1996">
<REFERENCE MODIFIED="2016-09-15 15:08:49 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>US Environmental Protection Agency</AU>
<TI>Effect of in-home educational intervention on children's blood lead levels in Milwaukee: technical report</TI>
<SO>www.epa.gov/sites/production/files/documents/r95-009.pdf</SO>
<YR>(accessed 30 April 2016)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359498"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359497"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-EPA-1997" MODIFIED="2016-09-15 15:09:15 +0100" MODIFIED_BY="[Empty name]" NAME="EPA 1997" YEAR="1997">
<REFERENCE MODIFIED="2016-09-15 15:09:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>US Environmental Protection Agency</AU>
<TI>Lead-based paint abatement and repair and maintenance study in Baltimore: findings based on two years of follow-up</TI>
<SO>www.epa.gov/sites/production/files/documents/24folup.pdf</SO>
<YR>(accessed 30 April 2016)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359500"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2016-05-18 16:08:18 +0100" MODIFIED_BY="Margaret J Anderson"><IDENTIFIER MODIFIED="2016-05-18 16:08:18 +0100" MODIFIED_BY="Margaret J Anderson" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359499"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Farfel-1990" MODIFIED="2016-04-07 11:17:11 +0100" MODIFIED_BY="[Empty name]" NAME="Farfel 1990" YEAR="1990">
<REFERENCE MODIFIED="2016-04-07 11:17:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Farfel MR, Chisolm JJ</AU>
<TI>Health and environmental outcomes of traditional and modified practices for abatement of residential lead-based paint</TI>
<SO>American Journal of Public Health</SO>
<YR>1990</YR>
<VL>80</VL>
<NO>10</NO>
<PG>1240-5</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:17:11 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359502"/><IDENTIFIER MODIFIED="2016-04-07 11:17:11 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="2136329"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359501"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Feit-2014" MODIFIED="2016-04-07 11:17:38 +0100" MODIFIED_BY="[Empty name]" NAME="Feit 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-04-07 11:17:38 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Feit MN, Mathee A, Harpham T, Barnes BR</AU>
<TI>Using behavior change to reduce child lead exposure in resource-poor settings: a formative study</TI>
<SO>Health Education Research</SO>
<YR>2014</YR>
<VL>29</VL>
<NO>6</NO>
<PG>933-40</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:17:38 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359504"/><IDENTIFIER MODIFIED="2016-04-07 11:17:38 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="25214512"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359503"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maharaj-2007" MODIFIED="2016-04-07 11:17:43 +0100" MODIFIED_BY="[Empty name]" NAME="Maharaj 2007" YEAR="2007">
<REFERENCE MODIFIED="2016-04-07 11:17:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maharaj V</AU>
<TI>Link between childhood lead poisoning and asthma development and intervention</TI>
<SO>Epidemiology</SO>
<YR>2007</YR>
<VL>18</VL>
<NO>5</NO>
<PG>S194</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359506"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359505"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Malcoe-2004" MODIFIED="2016-04-13 14:35:17 +0100" MODIFIED_BY="[Empty name]" NAME="Malcoe 2004" YEAR="2004">
<REFERENCE MODIFIED="2016-04-13 14:35:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Malcoe LH, Gekler MC, Whitecrow-Ollis S</AU>
<TI>A community-level intervention to prevent lead poisoning in native American children: findings from a university-tribal partnership</TI>
<SO>American Journal of Epidemiology</SO>
<YR>2004</YR>
<VL>159</VL>
<NO>11 Suppl.</NO>
<PG>S28, E1</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359508"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359507"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marlowe-2001" MODIFIED="2016-04-07 11:21:13 +0100" MODIFIED_BY="[Empty name]" NAME="Marlowe 2001" YEAR="2001">
<REFERENCE MODIFIED="2016-04-07 11:21:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marlowe M, Trathen W</AU>
<TI>The Adventures of Lead Commander: an environmental education program to prevent lead poisoning in young children</TI>
<SO>Journal of Environmental Education</SO>
<YR>2001</YR>
<VL>28</VL>
<NO>1</NO>
<PG>19-23</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:21:13 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359510"/><IDENTIFIER MODIFIED="2016-04-07 11:21:13 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1080/00958964.1996.9942811"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359509"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT00000104" MODIFIED="2016-09-15 15:11:17 +0100" MODIFIED_BY="[Empty name]" NAME="NCT00000104" YEAR="0104">
<REFERENCE MODIFIED="2016-09-15 15:11:17 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00000104</AU>
<TI>Does lead burden alter neuropsychological development?</TI>
<SO>clinicaltrials.gov/ct2/show/NCT00000104</SO>
<YR>(first received 3 November 1999)</YR>
<IDENTIFIERS MODIFIED="2016-02-03 13:37:17 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359512"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359511"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT00011674" MODIFIED="2016-09-15 15:12:12 +0100" MODIFIED_BY="[Empty name]" NAME="NCT00011674" YEAR="1674">
<REFERENCE MODIFIED="2016-09-15 15:12:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00011674</AU>
<TI>Early exposure to lead and adolescent development</TI>
<SO>clinicaltrials.gov/ct2/show/NCT00011674</SO>
<YR>(first received 26 February 2001)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359514"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359513"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Omidpanah-1998" MODIFIED="2016-04-07 11:25:02 +0100" MODIFIED_BY="[Empty name]" NAME="Omidpanah 1998" YEAR="1998">
<REFERENCE MODIFIED="2016-04-07 11:25:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="BOOK">
<AU>Omidpanah P</AU>
<SO>The Effects of Parental Education on Preventing Childhood Lead Poisoning in Inner City Cleveland, Ohio</SO>
<YR>1998</YR>
<PB>Walden University</PB>
<CY>Online university</CY>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359516"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359515"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Phoenix-2013" MODIFIED="2016-04-07 11:25:46 +0100" MODIFIED_BY="[Empty name]" NAME="Phoenix 2013" YEAR="2013">
<REFERENCE MODIFIED="2016-04-07 11:25:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Phoenix JA, Green RD, Thompson AM</AU>
<TI>Can realtor education reduce lead exposures for vulnerable populations?</TI>
<SO>Journal of Environmental Health</SO>
<YR>2013</YR>
<VL>76</VL>
<NO>1</NO>
<PG>28-36</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:25:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359518"/><IDENTIFIER MODIFIED="2016-04-07 11:25:46 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="23947286"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359517"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pollak-2002" MODIFIED="2016-05-18 16:07:20 +0100" MODIFIED_BY="Margaret J Anderson" NAME="Pollak 2002" YEAR="2002">
<REFERENCE MODIFIED="2016-04-07 11:26:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pollak J</AU>
<TI>The lead-based paint abatement repair and maintenance study in Baltimore: historic framework and study design</TI>
<SO>Journal of Health Care Law and Policy</SO>
<YR>2002</YR>
<VL>6</VL>
<NO>1</NO>
<PG>89-108</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359520"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2016-05-18 16:07:20 +0100" MODIFIED_BY="Margaret J Anderson"><IDENTIFIER MODIFIED="2016-05-18 16:07:20 +0100" MODIFIED_BY="Margaret J Anderson" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359519"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Taha-1999" MODIFIED="2016-04-07 11:27:39 +0100" MODIFIED_BY="[Empty name]" NAME="Taha 1999" YEAR="1999">
<REFERENCE MODIFIED="2016-04-07 11:27:39 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Taha T, Kanarek MS, Schultz BD, Murphy A</AU>
<TI>Low-cost household paint abatement to reduce children's blood lead levels</TI>
<SO>Environmental Research</SO>
<YR>1999</YR>
<VL>81</VL>
<NO>4</NO>
<PG>334-8</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:27:39 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359522"/><IDENTIFIER MODIFIED="2016-04-07 11:27:39 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1006/enrs.1999.3998"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359521"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thomas-2013" MODIFIED="2016-04-07 11:28:18 +0100" MODIFIED_BY="[Empty name]" NAME="Thomas 2013" YEAR="2013">
<REFERENCE MODIFIED="2016-04-07 11:28:18 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thomas, SL, Boreland F, Lyle DM</AU>
<TI>Improving participation by Aboriginal children in blood lead screening services in Broken Hill, NSW</TI>
<SO>New South Wales Public Health Bulletin</SO>
<YR>2012</YR>
<VL>23</VL>
<NO>11-12</NO>
<PG>234-8</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:28:18 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359524"/><IDENTIFIER MODIFIED="2016-04-07 11:28:18 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="23490095"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359523"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Untimanon-2012" MODIFIED="2016-04-07 11:28:46 +0100" MODIFIED_BY="[Empty name]" NAME="Untimanon 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-04-07 11:28:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Untimanon O, Geater A, Chongsuvivatwong V, Saetia W, Verkasalo P</AU>
<TI>Relative contribution of potential modes of surface dust lead contamination in the homes of boatyard caulkers</TI>
<SO>Journal of Occupational Health</SO>
<YR>2012</YR>
<VL>54</VL>
<NO>3</NO>
<PG>165-75</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:28:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359526"/><IDENTIFIER MODIFIED="2016-04-07 11:28:46 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="22790518"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359525"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Whitehead-2014" MODIFIED="2016-04-07 11:29:45 +0100" MODIFIED_BY="[Empty name]" NAME="Whitehead 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-04-07 11:29:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Whitehead TP, Metayer C, Ward MH, Colt JS, Gunier RB, Deziel NC, et al</AU>
<TI>Persistent organic pollutants in dust from older homes: learning from lead</TI>
<SO>American Journal of Public Health</SO>
<YR>2014</YR>
<VL>104</VL>
<NO>7</NO>
<PG>1320-6</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:29:45 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359528"/><IDENTIFIER MODIFIED="2016-04-07 11:29:45 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="24832145"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359527"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilson-2015" MODIFIED="2016-04-07 11:30:11 +0100" MODIFIED_BY="[Empty name]" NAME="Wilson 2015" YEAR="2015">
<REFERENCE MODIFIED="2016-04-07 11:30:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilson J, Dixon SL, Jacobs DE, Akoto J, Kormacher KS, Breysse J</AU>
<TI>An investigation into porch dust lead levels</TI>
<SO>Environmental Research</SO>
<YR>2015</YR>
<VL>137</VL>
<PG>129-35</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:30:11 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359530"/><IDENTIFIER MODIFIED="2016-04-07 11:30:11 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="25531817"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359529"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yeoh-2014" MODIFIED="2016-04-07 11:30:15 +0100" MODIFIED_BY="[Empty name]" NAME="Yeoh 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-04-07 11:30:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="COCHRANE_REVIEW">
<AU>Yeoh B, Woolfenden S, Lanphear B, Ridley GF, Livingstone N, Jorgensen E</AU>
<TI>Household interventions for preventing domestic lead exposure in children</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2014</YR>
<NO>12</NO>
<IDENTIFIERS MODIFIED="2016-04-07 11:30:15 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359532"/><IDENTIFIER MODIFIED="2016-02-03 14:54:13 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006047.pub4"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359531"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zimmermann-2006" MODIFIED="2016-04-07 11:34:11 +0100" MODIFIED_BY="[Empty name]" NAME="Zimmermann 2006" YEAR="2006">
<REFERENCE MODIFIED="2016-04-07 11:34:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zimmermann, MB, Muthayya S, Moretti D, Kurpad A, Hurrell R</AU>
<TI>Iron fortification reduces blood lead levels in children: a randomized, double-blind, controlled trial in Bangalore, India</TI>
<SO>FASEB Journal</SO>
<YR>2006</YR>
<VL>20</VL>
<NO>4</NO>
<PG>A131</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359534"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359533"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES MODIFIED="2016-09-15 15:17:11 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="UNPUB" ID="STD-NCT00129324" MODIFIED="2016-09-15 15:17:11 +0100" MODIFIED_BY="[Empty name]" NAME="NCT00129324" YEAR="2017">
<REFERENCE MODIFIED="2016-09-15 15:17:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00129324</AU>
<TI>HOME Study (Health Outcomes and Measures of the Environment Study)</TI>
<TO>Neurobehavioral effects of prevalent neurotoxicants in children: a cohort study of the Cincinnati Center for Children's Environmental Health</TO>
<SO>clinicaltrials.gov/ct2/show/NCT00129324</SO>
<YR>(first received: 10 August 2005)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3359536"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-11-05 10:03:11 +0000" MODIFIED_BY="Barbara Nussbaumer"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3359535"/><IDENTIFIER MODIFIED="2015-11-05 10:03:11 +0000" MODIFIED_BY="Barbara Nussbaumer" TYPE="CTG" VALUE="NCT00129324"/></IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2016-09-27 10:27:22 +0100" MODIFIED_BY="Margaret J Anderson">
<ADDITIONAL_REFERENCES MODIFIED="2016-09-27 10:27:22 +0100" MODIFIED_BY="Margaret J Anderson">
<REFERENCE ID="REF-AAP-1998" MODIFIED="2011-04-20 12:36:31 +0100" MODIFIED_BY="Dawn Brown" NAME="AAP 1998" TYPE="JOURNAL_ARTICLE">
<AU>American Academy of Pediatrics</AU>
<TI>Screening for elevated blood lead levels</TI>
<SO>Pediatrics</SO>
<YR>1998</YR>
<VL>101</VL>
<NO>6</NO>
<PG>1072-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-AbstrackR-2015" MODIFIED="2015-10-22 11:43:14 +0100" MODIFIED_BY="[Empty name]" NAME="AbstrackR 2015" TYPE="COMPUTER_PROGRAM">
<TI>AbstrackR</TI>
<YR>2015</YR>
<PB>Brown University</PB>
<CY>Providence RI</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Achenbach-1991" MODIFIED="2011-04-20 12:37:04 +0100" MODIFIED_BY="Dawn Brown" NAME="Achenbach 1991" TYPE="BOOK">
<AU>Achenbach TM</AU>
<SO>Manual for the Child Behavior Checklist</SO>
<YR>1991</YR>
<PB>University of Vermont</PB>
<CY>Burlington, VT</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Adebanowo-2007" MODIFIED="2016-04-07 11:40:02 +0100" MODIFIED_BY="[Empty name]" NAME="Adebanowo 2007" TYPE="JOURNAL_ARTICLE">
<AU>Adebamowo EB, Clark CS, Roda S, Agbede OA, Sridhar MKC, Adebamowo CA</AU>
<TI>Lead content of dried films of domestic paint currently sold in Nigeria</TI>
<SO>Science of the Total Environment</SO>
<YR>2007</YR>
<VL>388</VL>
<NO>1-3</NO>
<PG>116-20</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:40:02 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 11:40:02 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17854862"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Attina-2013" MODIFIED="2016-04-07 11:40:39 +0100" MODIFIED_BY="[Empty name]" NAME="Attina 2013" TYPE="JOURNAL_ARTICLE">
<AU>Attina TM, Trasande L</AU>
<TI>Economic costs of childhood lead exposure in low- and middle-income countries</TI>
<SO>Environmental Health Perspective</SO>
<YR>2013</YR>
<VL>121</VL>
<NO>9</NO>
<PG>1097-102</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:40:39 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 11:40:39 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="23797342"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Balshem-2011" MODIFIED="2016-04-07 11:41:17 +0100" MODIFIED_BY="[Empty name]" NAME="Balshem 2011" TYPE="JOURNAL_ARTICLE">
<AU>Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al</AU>
<TI>GRADE guidelines: 3. Rating the quality of evidence</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2011</YR>
<VL>64</VL>
<NO>4</NO>
<PG>401-6</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:41:17 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 11:41:17 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="21208779"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Barbosa-2005" MODIFIED="2016-07-07 12:35:03 +0100" MODIFIED_BY="[Empty name]" NAME="Barbosa 2005" TYPE="JOURNAL_ARTICLE">
<AU>Barbosa F, Tanus-Santos JE, Gerlach RF, Parsons PJ</AU>
<TI>A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs</TI>
<SO>Environmental Health Perspectives</SO>
<YR>2005</YR>
<VL>113</VL>
<NO>12</NO>
<PG>1669-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bellinger-2008" MODIFIED="2016-04-07 11:42:23 +0100" MODIFIED_BY="[Empty name]" NAME="Bellinger 2008" TYPE="JOURNAL_ARTICLE">
<AU>Bellinger DC</AU>
<TI>Very low lead exposures and children's neurodevelopment</TI>
<SO>Current Opinion in Pediatrics</SO>
<YR>2008</YR>
<VL>20</VL>
<NO>2</NO>
<PG>172-7</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:42:23 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 11:42:23 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="18332714"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bergdahl-2008" MODIFIED="2016-07-14 12:20:33 +0100" MODIFIED_BY="[Empty name]" NAME="Bergdahl 2008" TYPE="JOURNAL_ARTICLE">
<AU>Bergdahl IA, Skerfving S</AU>
<TI>Biomonitoring of lead exposure-alternatives to blood</TI>
<SO>Journal of Toxicology and Environmental Health. Part A</SO>
<YR>2008</YR>
<VL>71</VL>
<NO>18</NO>
<PG>1235&#8211;43</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:43:02 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 11:43:02 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="18654894"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Braubach-2011" MODIFIED="2016-09-16 11:36:59 +0100" MODIFIED_BY="[Empty name]" NAME="Braubach 2011" TYPE="OTHER">
<AU>Braubach M, Jacobs DE, Ormandy D (editors)</AU>
<TI>Environmental burden of disease associated with inadequate housing: a method guide to the quantification of health effects of selected housing risks in the WHO European region</TI>
<SO>www.euro.who.int/__data/assets/pdf_file/0003/142077/e95004.pdf</SO>
<YR>(accessed 30 April 2016)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Campbell-2000" MODIFIED="2016-04-07 11:45:53 +0100" MODIFIED_BY="[Empty name]" NAME="Campbell 2000" TYPE="JOURNAL_ARTICLE">
<AU>Campbell C, Osterhoudt K</AU>
<TI>Prevention of childhood lead poisoning</TI>
<SO>Current Opinion in Pediatrics</SO>
<YR>2000</YR>
<VL>12</VL>
<NO>5</NO>
<PG>428-37</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:45:53 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 11:45:53 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11021406"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Canfield-2003" MODIFIED="2016-09-16 13:12:17 +0100" MODIFIED_BY="[Empty name]" NAME="Canfield 2003" TYPE="JOURNAL_ARTICLE">
<AU>Canfield RL, Henserson CR, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP</AU>
<TI>Intellectual impairment in children with blood lead concentrations below 10 &#956;g per decilitre</TI>
<SO>New England Journal of Medicine</SO>
<YR>2003</YR>
<VL>348</VL>
<NO>16</NO>
<PG>1517-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-CDC-1991" MODIFIED="2016-04-07 11:47:50 +0100" MODIFIED_BY="[Empty name]" NAME="CDC 1991" TYPE="BOOK">
<AU>Centers for Disease Control and Prevention</AU>
<SO>Preventing Lead Poisoning in Young Children</SO>
<YR>1991</YR>
<PB>US Department of Health and Human Services, Centers for Disease Control and Prevention</PB>
<CY>Atlanta, GA, US</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-CDC-2005" MODIFIED="2016-04-07 11:47:52 +0100" MODIFIED_BY="[Empty name]" NAME="CDC 2005" TYPE="BOOK">
<AU>Centers for Disease Control and Prevention</AU>
<SO>Preventing Lead Poisoning in Young Children</SO>
<YR>2005</YR>
<PB>US Department of Health and Human Services, Centers for Disease Control and Prevention</PB>
<CY>Atlanta, GA, US</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-CDC-2012" MODIFIED="2016-04-07 11:47:56 +0100" MODIFIED_BY="[Empty name]" NAME="CDC 2012" TYPE="BOOK">
<AU>Centers for Disease Control and Prevention</AU>
<SO>Low Level Lead Exposure Harms Children: A Renewed Call for Primary Prevention</SO>
<YR>2012</YR>
<PB>US Department of Health and Human Services, Centers for Disease Control and Prevention</PB>
<CY>Atlanta, GA, US</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chisolm-2001" MODIFIED="2016-04-07 11:48:30 +0100" MODIFIED_BY="[Empty name]" NAME="Chisolm 2001" TYPE="JOURNAL_ARTICLE">
<AU>Chisolm J</AU>
<TI>The road to primary prevention of lead toxicity in children</TI>
<SO>Pediatrics</SO>
<YR>2001</YR>
<VL>107</VL>
<NO>3</NO>
<PG>581-3</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:48:30 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 11:48:30 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11230602"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Clark-2004" MODIFIED="2016-04-07 11:49:04 +0100" MODIFIED_BY="[Empty name]" NAME="Clark 2004" TYPE="JOURNAL_ARTICLE">
<AU>Clark S, Grote J, Wilson J, Succop P, Chen M, Glake W, et al</AU>
<TI>Occurrence and determinants of increases in blood lead levels in children shortly after lead hazard control activities</TI>
<SO>Environmental Research</SO>
<YR>2004</YR>
<VL>96</VL>
<NO>2</NO>
<PG>196-205</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:49:04 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 11:49:04 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15325880"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Clark-2005" MODIFIED="2016-04-07 11:49:37 +0100" MODIFIED_BY="[Empty name]" NAME="Clark 2005" TYPE="JOURNAL_ARTICLE">
<AU>Clark CS, Rampal KG, Thuppil V, Chen CK, Clark R, Roda S</AU>
<TI>The lead content of currently available new residential paint in several Asian countries</TI>
<SO>Environmental Research</SO>
<YR>2005</YR>
<VL>102</VL>
<NO>1</NO>
<PG>9-12</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:49:37 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 11:49:37 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16782088"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Dietrich-2004" MODIFIED="2016-04-07 11:50:22 +0100" MODIFIED_BY="[Empty name]" NAME="Dietrich 2004" TYPE="JOURNAL_ARTICLE">
<AU>Dietrich KN, Ware JH, Salganik M, Radcliffe J, Rogan WJ, Rhoads GG, et al</AU>
<TI>Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry</TI>
<SO>Pediatrics</SO>
<YR>2004</YR>
<VL>114</VL>
<NO>1</NO>
<PG>19-26</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:50:22 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 11:50:22 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15231903"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Dixon-2009" MODIFIED="2016-04-07 11:51:08 +0100" MODIFIED_BY="[Empty name]" NAME="Dixon 2009" TYPE="JOURNAL_ARTICLE">
<AU>Dixon SL, Gaitens JM, Jacobs DE, Strauss W, Nagaraja J, Pivetz T et al</AU>
<TI>Exposure of U.S. children to residential dust lead, 1999-2004: II The contribution of lead-contaminated house dust to children's blood lead levels</TI>
<SO>Environmental Health Perspectives</SO>
<YR>2009</YR>
<VL>117</VL>
<NO>3</NO>
<PG>468-74</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:51:08 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 11:51:08 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19337524"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2016-04-13 14:13:04 +0100" MODIFIED_BY="[Empty name]" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey Smith G, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7109</NO>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-EHU-2002" MODIFIED="2011-04-20 13:40:16 +0100" MODIFIED_BY="Dawn Brown" NAME="EHU 2002" TYPE="BOOK">
<AU>Environmental Health Unit</AU>
<SO>Excessive Lead Exposure - Public Health Guidelines Notice</SO>
<YR>2002</YR>
<PB>Public Health Services, Queensland Health</PB>
<CY>QLD, Australia</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-EndNote-2012" MODIFIED="2016-09-27 10:27:22 +0100" MODIFIED_BY="Margaret J Anderson" NAME="EndNote 2012" TYPE="COMPUTER_PROGRAM">
<TI>EndNote X6</TI>
<YR>2012</YR>
<PB>Thomson Reuters</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Evens-2015" MODIFIED="2016-04-07 11:52:50 +0100" MODIFIED_BY="[Empty name]" NAME="Evens 2015" TYPE="JOURNAL_ARTICLE">
<AU>Evens A, Hryhorczuk D, Lanphear BP, Rankin KM, Lewis DA, Forst L, et al</AU>
<TI>The impact of low-level lead toxicity on school performance among children in the Chicago public schools: a population-based retrospective cohort study</TI>
<SO>Environmental Health</SO>
<YR>2015</YR>
<VL>14</VL>
<NO>1</NO>
<PG>21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Grandjean-2010" MODIFIED="2016-04-07 11:54:40 +0100" MODIFIED_BY="[Empty name]" NAME="Grandjean 2010" TYPE="JOURNAL_ARTICLE">
<AU>Grandjean P</AU>
<TI>Even low-dose lead exposure is hazardous</TI>
<SO>Lancet</SO>
<YR>2010</YR>
<VL>376</VL>
<NO>9744</NO>
<PG>855-6</PG>
<IDENTIFIERS MODIFIED="2016-04-07 11:54:40 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 11:54:40 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/S0140-6736(10)60745-3"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Griffiths-1954" MODIFIED="2016-04-07 11:54:48 +0100" MODIFIED_BY="[Empty name]" NAME="Griffiths 1954" TYPE="BOOK">
<AU>Griffiths R</AU>
<SO>The Abilities of Babies</SO>
<YR>1954</YR>
<PB>The Association for Research in Infant and Child Development</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Griffiths-1970" NAME="Griffiths 1970" TYPE="BOOK">
<AU>Griffiths R</AU>
<SO>The Abilities of Young Children</SO>
<YR>1970</YR>
<PB>Child Development and Research Centre</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gulson-2003" MODIFIED="2016-07-07 12:38:53 +0100" MODIFIED_BY="[Empty name]" NAME="Gulson 2003" TYPE="JOURNAL_ARTICLE">
<AU>Gulson B, Mizon K, Korsch M, Palmer J, Donnelly J</AU>
<TI>Mobilization of lead from human bone tissue during pregnancy and lactation--a summary of long-term research</TI>
<SO>Science of the Total Environment</SO>
<YR>2003</YR>
<VL>302</VL>
<NO>1-2</NO>
<PG>79-104</PG>
<IDENTIFIERS MODIFIED="2016-04-07 12:01:02 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 12:01:02 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/S0048-9697(02)00355-8"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2011" MODIFIED="2016-04-07 12:01:50 +0100" MODIFIED_BY="[Empty name]" NAME="Guyatt 2011" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al</AU>
<TI>GRADE guidelines: 1. Introduction&#8212;GRADE evidence profiles and summary of findings tables</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2011</YR>
<VL>64</VL>
<NO>4</NO>
<PG>383-94</PG>
<IDENTIFIERS MODIFIED="2016-04-07 12:01:50 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 12:01:50 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="21195583"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Gwiazda-2005" MODIFIED="2016-07-07 12:38:46 +0100" MODIFIED_BY="[Empty name]" NAME="Gwiazda 2005" TYPE="JOURNAL_ARTICLE">
<AU>Gwiazda R, Campbell C, Smith D</AU>
<TI>A noninvasive isotopic approach to estimate the bone lead contribution to blood in children: implications for assessing the efficacy of lead abatement</TI>
<SO>Environmental Health Perspectives</SO>
<YR>2005</YR>
<VL>113</VL>
<NO>1</NO>
<PG>104-10</PG>
<IDENTIFIERS MODIFIED="2016-07-07 12:38:22 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-07-07 12:38:22 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15626656"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Haynes-2002" MODIFIED="2016-04-07 12:03:06 +0100" MODIFIED_BY="[Empty name]" NAME="Haynes 2002" TYPE="JOURNAL_ARTICLE">
<AU>Haynes E, Lanphear B, Tohn E, Farr N, Rhoads G</AU>
<TI>The effect of interior lead hazard controls on children's blood concentrations: a systematic evaluation</TI>
<SO>Environmental Health Perspectives</SO>
<YR>2002</YR>
<VL>110</VL>
<NO>1</NO>
<PG>103-7</PG>
<IDENTIFIERS MODIFIED="2016-04-07 12:03:06 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 12:03:06 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11781171"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2002" MODIFIED="2016-04-07 12:03:35 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2002" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG</AU>
<TI>Quantifying heterogeneity in a meta-analysis</TI>
<SO>Statistics in Medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<NO>11</NO>
<PG>1539-58</PG>
<IDENTIFIERS MODIFIED="2016-04-07 12:03:35 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 12:03:35 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="12111919"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2016-04-07 12:04:07 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2008" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, White IR, Anzures-Cabrera J</AU>
<TI>Meta-analysis of skewed data: combining results reported on log-transformed or raw scales</TI>
<SO>Statistics in Medicine</SO>
<YR>2008</YR>
<VL>27</VL>
<NO>29</NO>
<PG>6072-92</PG>
<IDENTIFIERS MODIFIED="2016-04-07 12:04:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 12:04:07 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="18800342"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011a" MODIFIED="2016-09-15 15:24:52 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011a" TYPE="OTHER">
<AU>Higgins JPT, Altman DG, Sterne JAC (editors)</AU>
<TI>Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</TI>
<SO>Available from www.handbook.cochrane.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011b" MODIFIED="2016-09-15 15:25:31 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011b" TYPE="OTHER">
<AU>Deeks JJ, Higgins JPT, Altman DG (editors)</AU>
<TI>Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</TI>
<SO>Available from www.handbook.cochrane.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011c" MODIFIED="2016-09-15 15:26:09 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011c" TYPE="OTHER">
<AU>Higgins JPT, Deeks JJ (editors)</AU>
<TI>Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</TI>
<SO>Available from www.handbook.cochrane.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011d" MODIFIED="2016-09-15 15:26:43 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011d" TYPE="OTHER">
<AU>Higgins JPT, Deeks JJ, Altman DG (editors)</AU>
<TI>Chapter 16: Special topics in statistics. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2001). The Cochrane Collaboration, 2011</TI>
<SO>Available from www.handbook.cochrane.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jacobs-2006" MODIFIED="2016-04-07 12:05:01 +0100" MODIFIED_BY="[Empty name]" NAME="Jacobs 2006" TYPE="JOURNAL_ARTICLE">
<AU>Jacobs DE, Nevin R</AU>
<TI>Validation of a twenty-year forecast of US childhood lead poisoning: updated prospects for 2010</TI>
<SO>Environmental Research</SO>
<YR>2006</YR>
<VL>102</VL>
<NO>3</NO>
<PG>352-64</PG>
<IDENTIFIERS MODIFIED="2016-04-07 12:05:01 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 12:05:01 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/j.envres.2005.12.015"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kordas-2006" MODIFIED="2016-04-07 12:06:19 +0100" MODIFIED_BY="[Empty name]" NAME="Kordas 2006" TYPE="JOURNAL_ARTICLE">
<AU>Kordas K, Canfield RL, López P, Rosado JL, Vargas GG, Cebrián ME, et al</AU>
<TI>Deficits in cognitive function and achievement in Mexican first-graders with low blood lead concentrations</TI>
<SO>Environmental Research</SO>
<YR>2006</YR>
<VL>100</VL>
<NO>3</NO>
<PG>371-86</PG>
<IDENTIFIERS MODIFIED="2016-04-07 12:06:19 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 12:06:19 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16169549"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lanphear-1996b" MODIFIED="2016-09-15 15:27:11 +0100" MODIFIED_BY="[Empty name]" NAME="Lanphear 1996b" TYPE="JOURNAL_ARTICLE">
<AU>Lanphear BP, Weitzman M, Winter NL, Eberly S, Yakir B, Tanner M, et al</AU>
<TI>Lead-contaminated house dust and urban children's blood lead levels</TI>
<SO>American Journal of Public Health</SO>
<YR>1996</YR>
<VL>86</VL>
<NO>10</NO>
<PG>1416-21</PG>
<IDENTIFIERS MODIFIED="2011-12-19 08:27:17 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Lanphear-1998" MODIFIED="2016-09-15 15:27:26 +0100" MODIFIED_BY="[Empty name]" NAME="Lanphear 1998" TYPE="JOURNAL_ARTICLE">
<AU>Lanphear BP, Matte TD, Rogers J, Clickner RP, Dietz B, Bornschein RL, et al</AU>
<TI>The contribution of lead-contaminated house dust and residential soil to children's blood lead levels: a pooled analysis of 12 epidemiologic studies</TI>
<SO>Environmental Research</SO>
<YR>1998</YR>
<VL>79</VL>
<NO>1</NO>
<PG>51-68</PG>
<IDENTIFIERS MODIFIED="2016-04-07 12:07:56 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 12:07:56 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1006/enrs.1998.3859"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lanphear-2000" MODIFIED="2016-04-07 12:08:25 +0100" MODIFIED_BY="[Empty name]" NAME="Lanphear 2000" TYPE="JOURNAL_ARTICLE">
<AU>Lanphear BP, Eberly S, Howard CR</AU>
<TI>Long-term effect of dust control on blood lead concentrations</TI>
<SO>Pediatrics</SO>
<YR>2000</YR>
<VL>106</VL>
<NO>4</NO>
<PG>E48</PG>
<IDENTIFIERS MODIFIED="2016-04-07 12:08:25 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 12:08:25 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11015543"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lanphear-2005a" MODIFIED="2016-04-07 12:08:59 +0100" MODIFIED_BY="[Empty name]" NAME="Lanphear 2005a" TYPE="JOURNAL_ARTICLE">
<AU>Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC, et al</AU>
<TI>Low-level environmental lead exposure and children's intellectual function: an international pooled analysis</TI>
<SO>Environmental Health Perspective</SO>
<YR>2005</YR>
<VL>113</VL>
<NO>7</NO>
<PG>894-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lanphear-2005b" MODIFIED="2016-09-16 13:13:01 +0100" MODIFIED_BY="[Empty name]" NAME="Lanphear 2005b" TYPE="JOURNAL_ARTICLE">
<AU>Lanphear BP, Hornung R, Ho M</AU>
<TI>Screening housing to prevent lead toxicity in children</TI>
<SO>Public Health Reports</SO>
<YR>2005</YR>
<VL>120</VL>
<NO>3</NO>
<PG>305-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lefebvre-2008" MODIFIED="2016-09-15 15:29:01 +0100" MODIFIED_BY="[Empty name]" NAME="Lefebvre 2008" TYPE="OTHER">
<AU>Lefebvre C, Manheimer E, Glanville J</AU>
<TI>Chapter 6: Searching for studies. In: Higgins, JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane.handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lim-2012" MODIFIED="2016-04-07 12:11:41 +0100" MODIFIED_BY="[Empty name]" NAME="Lim 2012" TYPE="JOURNAL_ARTICLE">
<AU>Lim SS, Vos T, Flaxman D, Danaei G, Shibuya H, Adair-Rohani H, et al</AU>
<TI>A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010</TI>
<SO>Lancet</SO>
<YR>2012</YR>
<VL>380</VL>
<NO>9859</NO>
<PG>2224-60</PG>
<IDENTIFIERS MODIFIED="2016-04-07 12:11:41 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 12:11:41 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="23245609"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Manton-2000" MODIFIED="2016-04-07 12:12:07 +0100" MODIFIED_BY="[Empty name]" NAME="Manton 2000" TYPE="JOURNAL_ARTICLE">
<AU>Manton WL, Angle CR, Stanek KL, Reese YR, Kuehnemann TJ</AU>
<TI>Acquisition and retention of lead by young children</TI>
<SO>Environmental Research</SO>
<YR>2000</YR>
<VL>82</VL>
<NO>1</NO>
<PG>60-80</PG>
<IDENTIFIERS MODIFIED="2016-04-07 12:12:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 12:12:07 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10677147"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mason-2014" MODIFIED="2016-09-16 13:20:24 +0100" MODIFIED_BY="[Empty name]" NAME="Mason 2014" TYPE="JOURNAL_ARTICLE">
<AU>Mason LH, Harp JP, Han DY</AU>
<TI>Pb neurotoxicity: neuropsychological effects of lead toxicity</TI>
<SO>BioMed Research International</SO>
<YR>2014</YR>
<VL>2014</VL>
<NO>Article ID 840547</NO>
<PG>1-8</PG>
<IDENTIFIERS MODIFIED="2016-09-16 13:20:24 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 12:13:20 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1155/2014/840547"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Miranda-2011" MODIFIED="2016-04-07 12:13:25 +0100" MODIFIED_BY="[Empty name]" NAME="Miranda 2011" TYPE="JOURNAL_ARTICLE">
<AU>Miranda ML, Anthopolos R, Hastings D</AU>
<TI>A geospatial analysis of the effects of aviation gasoline on childhood blood lead levels</TI>
<SO>Environmental Health Perspectives</SO>
<YR>2011</YR>
<VL>119</VL>
<NO>10</NO>
<PG>1513-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-O_x0027_Flaherty-1995" MODIFIED="2016-07-07 12:40:30 +0100" MODIFIED_BY="[Empty name]" NAME="O'Flaherty 1995" TYPE="JOURNAL_ARTICLE">
<AU>O'Flaherty EJ</AU>
<TI>Physiologically based models for bone-seeking elements. V. Lead absorption and disposition in childhood</TI>
<SO>Toxicology and Applied Pharmacology</SO>
<YR>1995</YR>
<VL>131</VL>
<NO>2</NO>
<PG>297-308</PG>
<IDENTIFIERS MODIFIED="2016-07-07 12:40:18 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-07-07 12:40:18 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="7716770"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Pfadenhauer-2016" MODIFIED="2016-09-16 13:19:32 +0100" MODIFIED_BY="[Empty name]" NAME="Pfadenhauer 2016" TYPE="JOURNAL_ARTICLE">
<AU>Pfadenhauer LM, Burns J, Rohwer A, Rehfuess EA</AU>
<TI>Effectiveness of interventions to reduce exposure to lead through consumer products and drinking water: a systematic review</TI>
<SO>Environmental Research</SO>
<YR>2016</YR>
<VL>147</VL>
<PG>525-36</PG>
<IDENTIFIERS MODIFIED="2016-04-07 12:14:29 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 12:14:29 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/j.envres.2016.03.004"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rabinowitz-1991" MODIFIED="2016-09-16 13:14:46 +0100" MODIFIED_BY="[Empty name]" NAME="Rabinowitz 1991" TYPE="JOURNAL_ARTICLE">
<AU>Rabinowitz MB</AU>
<TI>Toxicokinetics of bone lead</TI>
<SO>Environmental Health Perspectives</SO>
<YR>1991</YR>
<VL>91</VL>
<NO>Feb</NO>
<PG>33-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2016-04-07 12:14:54 +0100" MODIFIED_BY="[Empty name]" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>Cochrane Collaboration, The Nordic Cochrane Centre</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rogan-2001" MODIFIED="2016-09-16 13:04:23 +0100" MODIFIED_BY="[Empty name]" NAME="Rogan 2001" TYPE="JOURNAL_ARTICLE">
<AU>Rogan WJ, Dietrich KN, Ware JH, Dockery DW, Salganik M, Radcliffe J, et al</AU>
<TI>The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead</TI>
<SO>New England Journal of Medicine</SO>
<YR>2001</YR>
<VL>344</VL>
<NO>19</NO>
<PG>1421-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rust-1999" MODIFIED="2016-08-24 11:04:42 +0100" MODIFIED_BY="[Empty name]" NAME="Rust 1999" TYPE="JOURNAL_ARTICLE">
<AU>Rust SW, Kumar P, Burgoon DA, Niemuth NA, Schultz BD</AU>
<TI>Influence of bone-lead stores on the observed effectiveness of lead hazard intervention</TI>
<SO>Environmental Research</SO>
<YR>1999</YR>
<VL>81</VL>
<NO>3</NO>
<PG>175-84</PG>
<IDENTIFIERS MODIFIED="2016-04-07 12:16:12 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 12:16:12 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1006/enrs.1999.3972"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Smith-1989" MODIFIED="2016-04-07 12:17:10 +0100" MODIFIED_BY="[Empty name]" NAME="Smith 1989" TYPE="JOURNAL_ARTICLE">
<AU>Smith DK, St Martin ME, Lyon MA</AU>
<TI>A validity study of the Stanford-Binet: fourth edition with students with learning disabilities</TI>
<SO>Journal of Learning Disabilities</SO>
<YR>1989</YR>
<VL>22</VL>
<NO>4</NO>
<PG>260-1</PG>
<IDENTIFIERS MODIFIED="2016-04-07 12:17:10 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 12:17:10 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1177/002221948902200412"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Tong-2000" MODIFIED="2016-09-15 15:31:36 +0100" MODIFIED_BY="[Empty name]" NAME="Tong 2000" TYPE="JOURNAL_ARTICLE">
<AU>Tong S, Von Schirnding YE, Prapamontol T</AU>
<TI>Environmental lead exposure: a public health problem of global dimensions</TI>
<SO>Bulletin of the World Health Organization</SO>
<YR>2000</YR>
<VL>78</VL>
<NO>9</NO>
<PG>1068-77</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ukoumunne-1999" MODIFIED="2016-04-07 12:19:48 +0100" MODIFIED_BY="[Empty name]" NAME="Ukoumunne 1999" TYPE="JOURNAL_ARTICLE">
<AU>Ukoumunne OC, Gulliford MC, Chinn S, Sterne JA, Burney PG</AU>
<TI>Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review</TI>
<SO>Health Technology Assessment</SO>
<YR>1999</YR>
<VL>3</VL>
<NO>5</NO>
<PG>1-110</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-UNEP-2013" MODIFIED="2016-09-15 15:31:59 +0100" MODIFIED_BY="[Empty name]" NAME="UNEP 2013" TYPE="OTHER">
<AU>United Nations Environment Programme</AU>
<TI>Lead in enamel decorative paints: national paint testing results: a nine country study</TI>
<SO>www.unep.org/chemicalsandwaste/Portals/9/Mercury/Documents/publications/Lead_in_Enamel_decorative_paints.pdf</SO>
<YR>(accessed 30 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-UNEP_x002d_UNICEF-1997" MODIFIED="2016-09-15 15:33:02 +0100" MODIFIED_BY="[Empty name]" NAME="UNEP-UNICEF 1997" TYPE="OTHER">
<AU>United Nations Environment Programme, United Nations Children's Fund</AU>
<TI>Childhood lead poisoning - information for advocacy and action. UNEP-UNICEF information series booklet. 1997</TI>
<SO>www.who.int/ceh/publications/leadpoison/en</SO>
<YR>(accessed 30 January 2006)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wechsler-1989" NAME="Wechsler 1989" TYPE="BOOK">
<AU>Wechsler D</AU>
<SO>Wechsler Preschool and Primary Scale of Intelligence-Revised</SO>
<YR>1989</YR>
<PB>Psychological Corporation</PB>
<CY>San Antonio, Texas</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wechsler-1991" MODIFIED="2011-04-20 14:18:50 +0100" MODIFIED_BY="Dawn Brown" NAME="Wechsler 1991" TYPE="BOOK">
<AU>Wechsler D</AU>
<SO>Wechsler Intelligence Scale for Children</SO>
<YR>1991</YR>
<EN>3rd</EN>
<PB>Psychological Corporation</PB>
<CY>San Antonio, Texas</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wheeler-2013" MODIFIED="2016-04-07 12:23:09 +0100" MODIFIED_BY="[Empty name]" NAME="Wheeler 2013" TYPE="JOURNAL_ARTICLE">
<AU>Wheeler W, Brown MJ</AU>
<TI>Blood lead levels in children aged 1&#8211;5 years &#8212; United States, 1999&#8211;2010</TI>
<SO>Morbidity and Mortality Weekly Report</SO>
<YR>2013</YR>
<VL>62</VL>
<NO>13</NO>
<PG>245-8</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2016-04-13 14:25:50 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Yeoh-2006" MODIFIED="2016-04-07 12:27:44 +0100" MODIFIED_BY="[Empty name]" NAME="Yeoh 2006" TYPE="COCHRANE_PROTOCOL">
<AU>Yeoh B, Woolfenden S, Wheeler D, Alperstein G, Lanphear B</AU>
<TI>Household interventions for prevention of domestic lead exposure in children</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2016-04-07 12:27:44 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 12:27:44 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006047"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Yeoh-2008" MODIFIED="2012-02-11 13:23:15 +0000" MODIFIED_BY="Dawn Brown" NAME="Yeoh 2008" TYPE="COCHRANE_REVIEW">
<AU>Yeoh B, Woolfenden S, Wheeler DM, Alperstein G, Lanphear B</AU>
<TI>Household interventions for prevention of domestic lead exposure in children</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2011-12-20 23:46:45 +0000" MODIFIED_BY="Berlinda Yeoh"><IDENTIFIER MODIFIED="2011-12-20 23:46:45 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006047.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Yeoh-2012" MODIFIED="2016-04-07 12:29:35 +0100" MODIFIED_BY="[Empty name]" NAME="Yeoh 2012" TYPE="COCHRANE_REVIEW">
<AU>Yeoh B, Woolfenden S, Lanphear B, Ridley GF, Livingstone N</AU>
<TI>Household interventions for preventing domestic lead exposure in children</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2016-04-07 12:29:35 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-04-07 12:29:35 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006047.pub3"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Yeoh-2014" MODIFIED="2015-10-22 11:25:33 +0100" MODIFIED_BY="[Empty name]" NAME="Yeoh 2014" TYPE="COCHRANE_REVIEW">
<AU>Yeoh B, Woolfenden S, Lanphear B, Ridley GF, Livingstone N, Jorgensen E</AU>
<TI>Household interventions for preventing domestic lead exposure in children</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2014</YR>
<NO>12</NO>
<IDENTIFIERS MODIFIED="2015-07-08 12:43:40 +0100" MODIFIED_BY="Barbara Nussbaumer"><IDENTIFIER MODIFIED="2015-07-08 12:43:40 +0100" MODIFIED_BY="Barbara Nussbaumer" TYPE="DOI" VALUE="10.1002/14651858.CD006047.pub4"/></IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2016-10-06 15:22:31 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2016-10-06 15:22:31 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2016-10-06 15:16:48 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Aschengrau-1998">
<CHAR_METHODS MODIFIED="2016-09-15 10:27:30 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Study design</B>: RCT</P>
<P>
<B>Study location/setting</B>: Boston, USA. Urban area</P>
<P>
<B>Recruitment</B>: children were screened for lead from May 1993 to April 1995</P>
<P>
<B>Follow-up</B>: 6 months from baseline</P>
<P>
<B>Intention-to-treat</B>: available case analysis<BR/>
</P>
<P>
<B>Power calculation</B>: performed to determine number of participants (required number not recruited)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-10-06 15:16:48 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Eligibility criteria</B>
</P>
<OL>
<LI>Resided in the city of Boston</LI>
<LI>Less than 4 years of age</LI>
<LI>Had venous blood lead level from 11.0 to 24.0 &#956;g/dL</LI>
<LI>No history of lead poisoning or chelation therapy</LI>
<LI>Not expected to undergo chelation treatment</LI>
<LI>Lived on the premises for at least 3 months with no definite plans to move within the next 3 months</LI>
<LI>Lived in home with lead-based paint on at least 2 window sills and/or window wells, as determined by sodium sulphide tests</LI>
<LI>The home had not been previously de-leaded or received lead hazard reduction activities</LI>
<LI>The parents spoke English, Spanish, or Cape Verdean Creole</LI>
<LI>No other child in the home was already a study participant</LI>
</OL>
<P>
<B>Participation rate</B>: 63/402 (16%) enrolled, of which 41 were randomised (22 intervention, 19 control); 22 other participants at high risk were automatically assigned to the intervention and therefore were not considered in this Cochrane review</P>
<P>
<B>Reason for non-participation</B>: 163 unreachable; 64 unable to communicate due to language barriers; 112 refused to participate (demographic characteristics similar between participants and non-participants)</P>
<P>
<B>Analysis</B>: 24/41 (59%) for blood lead levels, 22/41 (54%) for household dust</P>
<P>
<B>Number of dropouts/withdrawals</B>: 17 blood lead levels, 19 household dust lead levels</P>
<P>
<B>Reasons for dropout/withdrawal</B>: children were excluded because no 6-month follow-up blood samples were taken, their homes received non-study environmental interventions, or they received chelation therapy (no specific numbers per reason were reported for the randomised children that dropped out)</P>
<P>I<B>ntervention baseline characteristics</B> (available for n = 11)</P>
<UL>
<LI>36.4% boys, 63.6% girls</LI>
<LI>Mean age 28.3 months</LI>
<LI>Blood lead level 17.6 µg/dL</LI>
</UL>
<P>
<B>Control baseline characteristics</B> (available for n = 13)</P>
<UL>
<LI>53.9% boys, 46.1% girls</LI>
<LI>23 months</LI>
<LI>Blood lead level 16.3 µg/dL</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-15 11:08:37 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Intervention (low technology lead hazard reduction)</B>
</P>
<OL>
<LI>Remove lead dust</LI>
<LI>Loose paint chips</LI>
<LI>HEPA (high efficiency particulate air) vacuum</LI>
<LI>Parental education: demonstrating effective housekeeping techniques and sending monthly reminders with instructions to wash hard surface floors, window sills, and wells</LI>
<LI>Usual outreach and educational activities (1 home visit by an outreach worker to visually assess the home for lead hazards and to educate the caregiver about the causes and prevention of lead poisoning)</LI>
</OL>
<P>
<B>Control</B>: usual outreach and educational activities provided to both groups (1 home visit by an outreach worker to visually assess the home for lead hazards and to educate the caregiver about the causes and prevention of lead poisoning)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-07-14 12:29:12 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Blood lead level 6 months from baseline (venous blood sample)</LI>
<LI>Household dust lead levels</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-09-16 12:56:44 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Funding</B>: this research was supported by a co-operative agreement (Grant H64/CCH108235-03) with the Centers for Disease Control and Prevention (CDC), Atlanta, GA</P>
<P>
<B>Conflicts of interest</B>: none declared</P>
<P>
<B>Other comments</B>
</P>
<OL>
<LI>Different baseline characteristics and small sample size</LI>
<LI>Inconsistent parental compliance with housekeeping</LI>
<LI>Several participants had non-study interventions and were excluded from analysis in the report</LI>
</OL>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-10-06 15:17:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Boreland-2009">
<CHAR_METHODS MODIFIED="2016-09-15 10:59:28 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Study design</B>: RCT</P>
<P>
<B>Study location/setting</B>: Australia. Mining community</P>
<P>
<B>Recruitment</B>: October 1994 to August 1996</P>
<P>
<B>Follow-up</B>: 12 months from baseline</P>
<P>
<B>Intention-to-treat</B>: available case analysis</P>
<P>
<B>Power calculation</B>: performed to determine number of participants (required number not recruited)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-10-06 15:17:38 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Eligibility criteria</B>
</P>
<OL>
<LI>Children from a surveillance programme, aged 12 to 60 months</LI>
<LI>Blood lead level &#8805; 15.0 &#956;g/dL and &#8804; 30.0 &#956;g/dL</LI>
</OL>
<P>
<B>Participation rate</B>: 103/365 (28%). 365 were eligible for remediation, 117 enrolled in remediation program and 103 were eligible for randomisation (all children with a blood lead level &#8805; 30.0 &#956;g/dL were offered immediate home remediation, and therefore were not part of the randomisation). Of the 103 children, 90 were matched by age and blood lead level range and were randomised (45 intervention, 45 control)</P>
<P>
<B>Reason for non-participation</B>: 13 were unable to be adequately matched<BR/>
</P>
<P>
<B>Analysis</B>: 88/90 (98%) blood levels analysed</P>
<P>
<B>Number of dropouts/withdrawals</B>: 2</P>
<P>
<B>Reasons for withdrawal</B>: no blood samples for either participant</P>
<P>
<B>Baseline data</B> available for all children randomised</P>
<UL>
<LI>Overall 42% males, 58% females</LI>
<LI>Mean age 3.5 years</LI>
<LI>Mean blood lead level 19.4 µg/dL</LI>
</UL>
<P>Baseline characteristics not reported separately for intervention and control group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-15 11:08:11 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Intervention (home remediation work)</B>
</P>
<OL>
<LI>Performed on intervention households and varied depending on assessment of need to provide each house with a "similar level of lead safety"</LI>
<LI>Work may have included: ceiling dust removal, sealing of ceilings, paint stabilisation, replacement of floor coverings/windows and cleaning</LI>
<LI>Visiting families at home and providing them with information about minimising lead hazards</LI>
</OL>
<P>
<B>Control</B>: visiting families at home and providing them with information about minimising lead hazards</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-09-15 11:02:00 +0100" MODIFIED_BY="[Empty name]">
<P>Blood lead level six months from baseline (venous blood sample)</P>
<P>(Internal floor dust quintile only used to examine dose response effects)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-09-16 12:56:30 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Funding</B>: Australian Government Department of Health and Ageing</P>
<P>
<B>Conflicts of interest</B>: none declared</P>
<P>
<B>Other comments</B>
</P>
<UL>
<LI>Control group received remediation after completion of study</LI>
<LI>To examine dose response effect, indoor dust levels were measured to examine the extent in which indoor lead levels were associated with changes in blood lead level</LI>
</UL>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-10-06 15:21:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Brown-2006">
<CHAR_METHODS MODIFIED="2016-10-06 15:19:42 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Study design</B>: RCT<BR/>
<B>Study location/setting</B>: Rhode Island, USA. Urban area</P>
<P>
<B>Recruitment</B>: all children who were identified through routine blood lead testing as having venous blood lead levels 15.0 to 19.0 µg/dL, and reported to Rhode Island Department of Health between July 1999 and June 2002, were referred to the study</P>
<P>
<B>Follow-up</B>: 12 months from baseline</P>
<P>
<B>Intention-to-treat analysis</B>: available case analysis<BR/>
<B>Power calculation</B>: performed to determine number of participants (required number recruited)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-10-06 15:21:07 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Eligibility criteria</B>
</P>
<UL>
<LI>Venous blood lead level 15.0 to 19.0 &#956;g/dL</LI>
<LI>28 months of age or younger</LI>
<LI>Family spoke English or Spanish</LI>
</UL>
<P>
<B>Participation rate</B>: 175/241 (73%) consented to participate and were randomised (92 intervention, 83 control)</P>
<P>
<B>Reason for non-participation</B>: 66 refused due to work and school responsibilities (no breakdown in figures per reason reported)</P>
<P>
<B>Analysis</B>: 145/175 (83%) analysed blood lead level, 153/175 floor dust lead levels</P>
<P>
<B>Number of dropouts/withdrawals</B>: 30 blood lead level, 22 floor dust lead levels</P>
<P>
<B>Reasons for dropout/withdrawal</B>: 9 children moved away, 2 were lost to follow-up, 9 parents refused participation of their child during the study, 2 refused first and all subsequent visits. No reason for dropout/withdrawal was reported for 8 children</P>
<P>
<B>Intervention baseline characteristics</B> (available for n = 90)</P>
<UL>
<LI>% boys/girls not reported</LI>
<LI>Mean age 19.1 months</LI>
<LI>Mean blood lead level 16.5 µg/dL</LI>
</UL>
<P>
<B>Control baseline characteristics</B> (n = 83)</P>
<UL>
<LI>boys/girls not reported</LI>
<LI>Mean age 18.8 months</LI>
<LI>Mean blood lead level 16.3 µg/dL</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-15 11:06:38 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Intervention</B>: parental education (with nursing care plan) via 5 home visits during 1-year period. Nurses collected interior dust and soil samples, evaluated parent-child interaction, identified occupational or recreational exposure to lead sources and other factors thought to influence lead exposure. The nursing care plan directed parent teaching and other services</P>
<P>
<B>Control</B>: children received customary care: one to two educational visits by outreach workers. These visits focused on standard health education about lead poisoning and its prevention but did not include environmental sampling, education tailored to individual circumstances, or assessment or parent-child interaction</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-07-14 12:29:23 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Blood lead level 12 months from baseline (venous blood sample)</LI>
<LI>Household floor and window dust lead</LI>
</OL>
<P>(Questionnaires on lead exposures)<BR/>(Parental-infant interaction scale)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-09-16 12:57:02 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Funding</B>: sponsored in part by CDC (grant TS 275 14/14) and Maternal and Child Health Bureau (grant 5T76 MC 00001; formerly MCJ201)</P>
<P>
<B>Conflicts of interest</B>: none declared</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-09-16 12:57:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Campbell-2011">
<CHAR_METHODS MODIFIED="2016-09-15 11:23:13 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Study design</B>: RCT<BR/>
<B>Study location/setting</B>: Philadelphia, USA. Urban area</P>
<P>
<B>Recruitment</B>: children were recruited from urban outpatient practices located in low-income neighbourhoods of Philadelphia</P>
<P>
<B>Follow-up</B>: 24 months from baseline</P>
<P>
<B>Intention-to-treat analysis</B>: available case analysis</P>
<P>
<B>Power calculation</B>: performed to determine number of participants (required number recruited)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-09-15 11:28:27 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Eligibility criteria</B>
</P>
<OL>
<LI>Residing in Philadelphia County</LI>
<LI>Children speak English or Spanish</LI>
<LI>Home that was judged to be in a condition enabling remediation</LI>
<LI>No history of elevated blood lead levels</LI>
<LI>No former participation in the Lead Safe Babies program</LI>
<LI>No child of the family has ever received services from the Childhood Lead Poisoning Prevention Program of the Philadelphia Department of Public Health</LI>
</OL>
<P>
<B>Participation rate</B>: 314/314 (100%) newborn children enrolled and randomised (154 intervention, 160 control); 310/310 (100%) households enrolled</P>
<P>
<B>Reasons for non-participation</B>: NA</P>
<P>
<B>Analysis</B>: 279/314 (89%) blood lead levels analysed at 12 months of age; 110/306 (36%) household dust analysed at 12 months. No information on number of children for whom blood lead levels were analysed at 24 months</P>
<P>
<B>Number of dropout/withdrawal</B>: 35 (blood lead levels), 196 (household dust lead)</P>
<P>
<B>Reasons for dropout/withdrawal</B>: for 35 children no venous specimen was taken (nor reasons specified); for 196 no household dust lead level was measured because of problems finding participants who changed address or phone numbers, non-compliance with study visits, lack of approval by family members (no breakdown in specific numbers per reasons reported)</P>
<P>
<B>Intervention baseline characteristics</B> (n = 154): 53.2% boys, 46.8% girls</P>
<P>
<B>Control baseline characteristics</B> (n = 160): 51.2% boys, 48.8% girls</P>
<P>Mean age and mean blood lead level only reported for both groups combined: 11 months and 2.7 µg/dL, respectively</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-15 11:58:16 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Intervention</B>
</P>
<OL>
<LI>Standard lead poisoning prevention education plus additional extensive education regarding maintaining home in lead-safe condition and home visits from outreach workers at baseline, 6 and 12 months. The additional education was compiled in a 22-page handbook.</LI>
<LI>Cleaning materials provided (MEG: maintenance education group)</LI>
</OL>
<P>
<B>Control</B>: standard lead poisoning prevention education, not described in more detail (SEG: standard education group)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-09-15 11:29:43 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Blood lead levels at 12 and 24 months (venous blood sample)</LI>
<LI>Housing lead dust levels at 12 months</LI>
</OL>
<P>(Parental Knowledge Assessment)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-09-16 12:57:18 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Funding</B>: Housing and Urban Development (HUD) Lead Technical Studies Grant</P>
<P>
<B>Conflicts of interest</B>: none declared</P>
<P>
<B>Other comments</B>: a matched comparison group was included in results of the paper, receiving community standard for prevention of elevated blood lead levels. This group was not part of the randomisation process and therefore was not integrated in this Cochrane review</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-10-06 15:21:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Charney-1983">
<CHAR_METHODS MODIFIED="2016-09-15 11:36:19 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Study design</B>: quasi-RCT (even/odd clinic number assignment)<BR/>
<B>Study location/setting</B>: Baltimore, USA. Recruited from a lead poisoning clinic</P>
<P>
<B>Recruitment</B>: children were recruited in July-October 1981 as they appeared for regular blood lead monitoring in a lead poisoning clinic</P>
<P>
<B>Follow-up</B>: 12 months from baseline</P>
<P>
<B>Intention-to-treat</B>: unclear<BR/>
<B>Power calculation</B>: performed to determine number of participants (unclear if required number recruited)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-10-06 15:21:19 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Eligibility criteria</B>
</P>
<OL>
<LI>Blood lead level 30.0 µg/dL to 49.0 µg/dL</LI>
<LI>Children from lead poisoning clinic in Baltimore</LI>
<LI>Between the age of 15 to 72 months</LI>
<LI>Lived at present address for at least 6 months</LI>
</OL>
<P>
<B>Participation rate</B>: 78/78 (100%) children enrolled and randomised (22 intervention, 56 control)</P>
<P>
<B>Reasons for non-participation</B>: NA</P>
<P>
<B>Analysis</B>: 49/78 (63%) analysed</P>
<P>
<B>Number of dropouts/withdrawals</B>: 29</P>
<P>
<B>Reasons for dropout/withdrawal</B>: children moved, spent considerable time with relatives in another household, not home for visits (no specific numbers per reason reported)</P>
<P>
<B>Intervention baseline characteristics</B> (available for n = 14)</P>
<UL>
<LI>36% boys, 64% girls</LI>
<LI>Mean age 45 months</LI>
<LI>Mean blood lead level 38.0 µg/dL</LI>
</UL>
<P>
<B>Control baseline characteristics</B> (available for n = 35)</P>
<UL>
<LI>51% boys, 49% girls</LI>
<LI>Mean age 43 months</LI>
<LI>Mean blood lead level 38.0 µg/dL</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-15 11:58:04 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Intervention</B>
</P>
<OL>
<LI>Dust control team to wet mop all rooms twice per month</LI>
<LI>Parental education to clean more frequently over 12-month period</LI>
<LI>Paint stabilisation</LI>
</OL>
<P>
<B>Control</B>: routine advice dust control by mopping given at clinic plus paint stabilisation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-09-15 11:38:21 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Blood lead level 12 months from baseline (venous blood sample)</LI>
<LI>Household floor dust (only reported in intervention group)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-09-16 12:57:30 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Funding</B>: supported from Department of Housing and Urban Development (HUD) Grant</P>
<P>
<B>Conflicts of interest</B>: none declared</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-10-06 15:18:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Farrell-1998">
<CHAR_METHODS MODIFIED="2016-09-15 11:41:51 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Study design</B>: cluster-RCT, by neighbourhood<BR/>
<B>Study location/setting</B>: Baltimore, USA. Urban neighbourhoods</P>
<P>
<B>Recruitment</B>: children from 2 neighbourhoods were recruited beginning in 1988</P>
<P>
<B>Follow-up</B>: 1 year</P>
<P>
<B>Intention-to-treat analysis</B>: no, due to exclusion of those not adhering to the study protocol (n = 226)<BR/>
<B>Power calculation</B>: performed to determine number of participants (required number recruited)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-10-06 15:18:09 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Eligibility criteria for neighbourhoods</B>
</P>
<OL>
<LI>Sufficient children to test hypothesis</LI>
<LI>Areas of exposed soil around homes</LI>
<LI>Pre-1950 urban housing away from major industries or highways</LI>
<LI>Comparable demographics</LI>
<LI>Moderate risk for lead exposure</LI>
</OL>
<P>
<B>Eligibility criteria for children</B>
</P>
<OL>
<LI>6 months to 6 years of age</LI>
<LI>Living in the same house (in selected neighbourhood) for at least 3 months and family was not planning to move</LI>
</OL>
<P>
<B>Participation rate</B>: NA as community recruitment; 408 children (212 intervention, 196 control) in 263 houses randomised</P>
<P>
<B>Reasons for non-participation</B>: NA</P>
<P>
<B>Analysis</B>: 182/408 (121/263 households) (45%) analysed</P>
<P>
<B>Number of dropouts/withdrawals</B>: 226</P>
<P>
<B>Reasons for dropouts/withdrawals</B>: children did not complete the study protocol (no specific reasons reported)</P>
<P>
<B>Intervention baseline characteristics</B> (n = 212): mean blood lead level 11.0 µg/dL</P>
<P>
<B>Control baseline characteristics</B> (n = 196): mean blood lead level 10.9 µg/dL</P>
<P>No information on sex or age of included children</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-15 11:57:56 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Intervention</B>
</P>
<OL>
<LI>Soil abatement consisting of removing the top 6 inches (15 cm) of soil, replacing it with lead-free soil, then sodding or seeding, all within 1 week of exterior paint stabilisation</LI>
<LI>External paint stabilisation as means of preventing soil recontamination</LI>
</OL>
<P>
<B>Control</B>: external paint stabilisation as means of preventing soil recontamination</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-09-15 11:44:44 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Blood lead level at 2 years from baseline (venous blood sample)</LI>
<LI>(Soil lead levels)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-09-16 12:57:35 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Funding</B>: US Environmental Protection Agency (EPA)</P>
<P>
<B>Conflicts of interest</B>: none declared</P>
<P>
<B>Other comments</B>:</P>
<OL>
<LI>Baseline soil lead levels lower than hypothesised with 54% &gt; 1000 parts per million</LI>
<LI>No internal household interventions</LI>
<LI>Adjacent properties not abated</LI>
</OL>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-09-16 12:57:41 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hilts-1995">
<CHAR_METHODS MODIFIED="2016-09-15 11:23:15 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Study design</B>: cluster-RCT, by household (in blocks of 6 stratified by area and blood lead level)<BR/>
<B>Study location/setting</B>: British Columbia, Canada. Higher lead risk area (active smelter)</P>
<P>
<B>Recruitment</B>: blood screen in 1992</P>
<P>
<B>Follow-up</B>: 10 months from baseline</P>
<P>
<B>Intention-to-treat</B> available case analysis<BR/>
<B>Power calculation</B>: performed to determine number of participants (required number recruited)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-09-15 11:47:35 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Eligibility criteria</B>
</P>
<OL>
<LI>Households in the study area with children under 72 months of age</LI>
<LI>No plans of moving</LI>
<LI>Living at the present address for &gt; 1 month</LI>
</OL>
<P>
<B>Participation rate</B>: 122/176 eligible households (69%) enrolled and randomised (122 children; 61 intervention, 61 control)</P>
<P>
<B>Reasons for non-participation</B>: 54 households were not interested in participating</P>
<P>
<B>Analysis</B>: 111/122 (99%) analysed</P>
<P>
<B>Number of dropouts/withdrawals</B>: 11</P>
<P>
<B>Reasons for dropouts/withdrawals</B>: moved house or did not provide a final blood sample (no specific numbers per reasons reported)</P>
<P>
<B>Intervention baseline characteristics</B> (available for n = 55)</P>
<UL>
<LI>Mean age 32.9 months</LI>
<LI>Mean blood lead level 11.9 µg/dL</LI>
</UL>
<P>
<B>Control baseline characteristics</B> (available for n = 56)</P>
<UL>
<LI>Mean age 31.9 months</LI>
<LI>Mean blood lead level 11.3 µg/dL</LI>
<LI>No information on sex of children</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-15 11:48:06 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Intervention</B>:</P>
<OL>
<LI>HEPA vacuuming (7 times in a 10-month period)</LI>
<LI>Routine advice regarding maintenance and general lead educational materials provided</LI>
</OL>
<P>
<B>Control</B>: routine advice regarding maintenance and general lead educational materials provided</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-07-14 12:14:45 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Blood lead level 10 months from baseline (venous blood sample)</LI>
<LI>Floor dust and lead levels</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-09-16 12:57:41 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Funding</B>: grants to the Trail Community Lead Task Force by: BC Ministry of Health, BC, Ministry of Environment, Lands and Parks, Cominco Limited and City of Trail</P>
<P>
<B>Conflicts of interest</B>: none declared</P>
<P>
<B>Other comments</B>: potential for unit of analysis error</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-10-06 15:18:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jordan-2003">
<CHAR_METHODS MODIFIED="2016-09-15 11:50:26 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Study design</B>: RCT<BR/>
<B>Study location/setting</B>: Minneapolis, USA. Urban area</P>
<P>
<B>Recruitment</B>: recruited by door knocking and community information</P>
<P>
<B>Follow-up</B>: 3 years from baseline<BR/>
</P>
<P>
<B>Intention-to-treat</B>: unclear<BR/>
<B>Power calculation</B>: performed to determine number of participants (unclear if required number recruited)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-10-06 15:18:19 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Eligibility criteria</B>: pregnant women and mothers of young infants from the Phillips Neighborhood (economically disadvantaged, ethnically diverse neighbourhood)</P>
<P>
<B>Participation rate</B>: NA as community recruitment</P>
<P>
<B>Reasons for non-participation</B>: NA</P>
<P>
<B>Analysis</B>: 607 children (299 intervention, 308 control) randomised, 378 (62%) analysed</P>
<P>
<B>Number of dropouts/withdrawals</B>: 229</P>
<P>
<B>Reasons for dropouts/withdrawal</B>: no reasons stated</P>
<P>No information if baseline data were available for all randomised children</P>
<OL>
<LI>According to the authors, there was no difference in baseline characteristics between treatment groups (no table presented, no detailed information on sex or age)</LI>
<LI>Mean blood lead level less than 10.0 µg/dL</LI>
</OL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-15 11:52:26 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Intervention</B>:</P>
<OL>
<LI>Intensive educational intervention: 20 bi-weekly, culturally specific educational session by peer leaders provided individually and 3-monthly boosters until child was 3 years of age</LI>
<LI>Routine state health brochures about lead, home assessment for lead contamination, and feedback about home inspections</LI>
</OL>
<P>
<B>Control</B>: routine state health brochures about lead, home assessment for lead contamination, and feedback about home inspections</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-09-15 11:52:33 +0100" MODIFIED_BY="[Empty name]">
<P>Blood lead level (capillary until 12 months, venous &gt; 12 months) 3 years from baseline</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-09-16 12:57:45 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Funding</B>: supported by Grant MCJ 270801 from the Maternal and Child Health Bureau and Grant U67/CCU510771 from the CDC</P>
<P>
<B>Conflicts of interest</B>: authors declare they have no competing financial interests</P>
<P>
<B>Other comments</B>
</P>
<OL>
<LI>Dichotomous data</LI>
<LI>All participants given financial incentive</LI>
</OL>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-09-16 12:57:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lanphear-1996a">
<CHAR_METHODS MODIFIED="2016-09-15 11:54:38 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Study design</B>: RCT<BR/>
<B>Study location/setting</B>: Rochester, NY, USA. Community-based trial in urban area</P>
<P>
<B>Recruitment</B>: baseline data collected between August 1993 and November 1993; follow-up samples collected between April 1994 and June 1994</P>
<P>
<B>Follow-up</B>: 7 months from baseline</P>
<P>
<B>Intention-to-treat</B> available case analysis<BR/>
<B>Power calculation</B>: not performed to determine number of participants<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-09-15 11:56:09 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Eligibility criteria</B>: families with children who participated in the Lead-in Dust study (a cross-sectional study to assess relationship of lead-contaminated house dust and urban children's blood lead levels)</P>
<P>
<B>Participation rate</B>: 104/205 (50%) enrolled (no significant difference in those refused) and randomised (57 intervention, 47 control)</P>
<P>
<B>Reasons for non-participation</B>: 101 not interested in participating<BR/>
<B>Analysis</B>: blood lead level 96/104 (91%), non-carpet floor dust lead level 70/104 (67%), carpet floor dust lead level 60/104 (57%)</P>
<P>
<B>Number of dropouts/withdrawals</B>: 8 (blood lead level), 34 (non-carpet floor lead dust level), 44 (carpet floor lead dust level)</P>
<P>
<B>Reasons for dropout/withdrawal</B>: 2 refused second blood tests, 3 had moved outside of the area, 2 had no time, and 1 was lost to follow-up; for others of whom floor dust lead levels were not available and no reasons were specified</P>
<P>
<B>Intervention baseline characteristics</B> (n = 57)</P>
<UL>
<LI>Mean age 19.8 months</LI>
<LI>Mean blood lead level 6.6 µg/dL</LI>
</UL>
<P>
<B>Control baseline characteristics</B> (n = 47)</P>
<UL>
<LI>Mean age 20.4 months</LI>
<LI>Mean blood lead level 6.8 µg/dL</LI>
</UL>
<P>No information on sex of participants</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-15 11:57:06 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Intervention</B>
</P>
<OL>
<LI>Trained interviewer emphasised the importance of dust control for reducing children's exposure to lead, provided them with cleaning supplies, gave a demonstration of how to clean and instructed families how and when to clean</LI>
<LI>Families were given a colouring book that described lead poisoning and its prevention</LI>
<LI>Families were given a brochure on lead poisoning and its prevention</LI>
</OL>
<P>
<B>Control</B>: families with children who participated in the Lead-in Dust study (a cross-sectional study to assess relationship of lead-contaminated house dust and urban children's blood lead levels)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-09-15 11:57:20 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Blood lead level at 7 months from baseline (venous blood sample)</LI>
<LI>Household floor and window dust lead</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-09-16 12:57:52 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Funding</B>: grant NYLPR002-94 from the US Department of Housing and Urban Development (HUD), the National Center for Lead-Safe Housing, and Institutional National Research Service Award 2T-32 PE-12002 from the Bureau of Health Professions, Health Resources and Services Administration, US Public Health Service, Department of Health and Human Services</P>
<P>
<B>Conflicts of interest</B>: none declared</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-09-16 12:57:59 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lanphear-1999">
<CHAR_METHODS MODIFIED="2016-09-15 11:23:17 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Study design</B>: RCT (also non-study control to rule out Hawthorne effect)<BR/>
<B>Study location/setting</B>: Rochester, NY, USA. Urban area</P>
<P>
<B>Recruitment</B>: identified by birth data from hospitals, inner-city clinics and the Department of Social Services and Health - families were called to determine eligibility via interviews</P>
<P>
<B>Follow-up</B>: 42 months from baseline</P>
<P>
<B>Intention-to-treat</B>: available case analysis<BR/>
<B>Power calculation</B>: performed to determine number of participants (required number recruited)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-09-15 12:00:38 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Eligibility criteria</B>
</P>
<OL>
<LI>Living in Rochester, NY</LI>
<LI>No plans to relocate in the next 3 months</LI>
<LI>Children older than 5 months but less than 7 months of age at baseline visit</LI>
</OL>
<P>
<B>Participation rate</B>: 275/429 (64%) enrolled and randomised (140 intervention, 135 control)</P>
<P>
<B>Reasons for non-participation</B>: not interested in participating<BR/>
<B>Analysis</B>: 245/275 (89%) and 189/275 (69%) analysed at 24 and 48 months, respectively</P>
<P>
<B>Number of dropouts/withdrawals</B>: 30 at 24 months, 86 at 48 months</P>
<P>
<B>Reasons for dropout/withdrawal</B>: lost to follow-up</P>
<P>
<B>Intervention baseline data</B> (n = 140)</P>
<UL>
<LI>Mean age 6.68 months</LI>
<LI>Mean blood lead levels 2.8 µg/dL</LI>
</UL>
<P>
<B>Control baseline data</B> (n = 135)</P>
<UL>
<LI>Mean age 6.65 months</LI>
<LI>Mean blood lead level 2.9 µg/dL</LI>
</UL>
<P>No information on sex of participants</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-15 12:01:10 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Intervention</B>
</P>
<OL>
<LI>Up to 8 visits by dust control advisors, cleaning equipment and supplies in 24-month period. Dust control advisors were trained to use educational model developed specifically for home visitation</LI>
<LI>Baseline 4 home visits by trained interviewer to collect data</LI>
</OL>
<P>
<B>Control</B>
</P>
<OL>
<LI>Baseline 4 home visits by trained interviewer to collect data</LI>
<LI>Families in the control group did not receive any lead exposure prevention education or intervention</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-09-15 12:01:23 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Blood lead level measured at 6 months (baseline), 12-, 18-, 24-, 36- and 48-months (venous blood sample)</LI>
<LI>Household floor and window dust lead</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-09-16 12:57:59 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Funding</B>: CDC Grant (U67/CCU210773) and an Institutional National Research Service Award (#2T-32 PE-12002) from the Bureau of Health Professions, Human Resources and Services Administration, Public Health Service, Department of Health and Human Services</P>
<P>
<B>Conflicts of interest</B>: none declared</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-09-16 12:58:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rhoads-1999">
<CHAR_METHODS MODIFIED="2016-09-15 12:04:33 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Study design</B>: RCT<BR/>
<B>Study location/setting</B>: Jersey City, NY, USA</P>
<P>
<B>Recruitment</B>: families that responded to posters and door hangers or were referred to the study by the municipal lead poisoning prevention programme, local health care providers, or word of mouth.</P>
<P>
<B>Follow-up</B>: 12 months from baseline</P>
<P>
<B>Intention-to-treat</B>: unclear<BR/>
<B>Power calculation</B>: performed to determine number of participants (required number not recruited)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-09-15 12:05:42 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Eligibility criteria</B>
</P>
<OL>
<LI>Children aged 6 months to 3 years</LI>
<LI>Responsible adult had to speak English or Spanish</LI>
<LI>Presence of lead paint in the home</LI>
<LI>Home had to be in a state that could be cleaned effectively (not structural disrepaired)</LI>
<LI>no evidence of illicit drug use, firearms, or other major staff safety concerns</LI>
<LI>index child was not in regular day care</LI>
</OL>
<P>
<B>Participation rate</B>: 113/147(77%) enrolled and randomised (56 intervention, 57 control)</P>
<P>
<B>Reasons for non-participation</B>: 7 could not be re-contacted or refused to allow a baseline blood lead sample to be drawn, 27 were not interested in participating.<BR/>
<B>Analysis</B>: 99/113 (87%) analysed for blood lead levels, 95/113 (84%) analysed for floor wipes, 76/113 (67%) analysed for sill wipes, 49/113 (43%) analysed for vacuum</P>
<P>
<B>Number of dropouts/withdrawals</B>: 14 blood lead level, 18 to 64 household dust lead levels</P>
<P>
<B>Reasons for dropout/withdrawal</B>: because of frequent moves and changing circumstances of the enrolled families, it was not possible to draw final blood samples from 14 children. No explanation for missing data on household dust lead levels stated</P>
<P>
<B>Intervention baseline characteristics</B> (available for n = 46)</P>
<UL>
<LI>Mean age 1.7 years</LI>
<LI>Mean blood lead level 12.4 µg/dL</LI>
</UL>
<P>
<B>Control baseline characteristics </B>(available for n = 53)</P>
<UL>
<LI>Mean age 1.6 years</LI>
<LI>Mean blood lead level 11.6 µg/dL</LI>
</UL>
<P>No information on sex of children</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-15 12:06:19 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Intervention</B>
</P>
<OL>
<LI>Bi-weekly assistance with household cleaning (HEPA vacuum and wet mopping) by community staff members for 1 year. Visits usually lasted 2 hours.</LI>
<LI>Offer to attend 4-5 educational sessions a year about lead prevention</LI>
</OL>
<P>
<B>Control</B>
</P>
<OL>
<LI>Accident prevention group given household safety items, but no assistance with household cleaning and no special education on lead prevention during visits</LI>
<LI>Offer to attend 4-5 educational sessions a year about lead prevention</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-09-15 12:06:39 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Blood lead level 12 months from baseline</LI>
<LI>Household dust lead levels</LI>
<LI>Maternal lead knowledge</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-09-16 12:58:07 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Funding</B>: work was supported by Co-operative Agreement CR820235 from the Environmental Protection Agency, by an Interagency Agreement from the National Institute for Child Health and Human Development, National Institutes of Health, to US Environmental Protection Agency, by Grant 18152 from the Robert Wood Johnson Foundation, and by Grant ES-05022 from the National Institute of Environmental Health Sciences.</P>
<P>
<B>Conflicts of interest</B>: none declared</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-10-06 15:20:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sterling-2004">
<CHAR_METHODS MODIFIED="2016-09-15 11:24:20 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Study design</B>: RCT<BR/>
<B>Study location</B>: Missouri, USA. Former lead mining areas with large amounts of lead mining waste</P>
<P>
<B>Recruitment</B>: screenings in health department lead clinics; women, infants, and children's clinics; daycare centres; door-to-door screening;and health fairs</P>
<P>
<B>Follow-up</B>: 9 months</P>
<P>
<B>Intention-to-treat</B>: only cases with all quarterly measurements were included in analysis<BR/>
<B>Power calculation</B>: performed to determine number of participants (unclear if required number recruited)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-10-06 15:20:26 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Eligibility criteria</B>
</P>
<OL>
<LI>Children 6-72 months of age</LI>
<LI>Blood lead level 10.0 to 20.0 µg/dL</LI>
<LI>For 1 of the 2 counties, the households were required to be below the medium income level for the area</LI>
</OL>
<P>
<B>Participation rate</B>: 101/134 (75%) randomised (34 intervention one, 35 intervention two, 32 control)</P>
<P>
<B>Reasons for non-participation</B>: no reasons for non-participation provided<BR/>
<B>Analysis</B>: blood lead level 39/101 (39%), household lead dust 34/101 (34%) analysed</P>
<P>
<B>Number of dropouts/withdrawals</B>: 62 blood lead level, 67 household lead dust level<BR/>
<B>Reasons for dropout/withdrawal</B>: no reasons for dropouts provided</P>
<P>
<B>Intervention one baseline characteristics</B> (n = 34)</P>
<UL>
<LI>59% boys, 41% girls</LI>
<LI>Mean age 2.8 years</LI>
<LI>Mean blood lead level 12.8 µg/dL</LI>
</UL>
<P>
<B>Intervention two baseline characteristics</B> (n = 35)</P>
<UL>
<LI>49% boys, 51% girls</LI>
<LI>Mean age 3.6 years</LI>
<LI>Mean blood lead level 12.7 µg/dL</LI>
</UL>
<P>
<B>Control baseline characteristics</B> (n = 32)</P>
<UL>
<LI>47% boys, 53% girls</LI>
<LI>Mean age 2.8 years</LI>
<LI>Mean blood lead level 12.7 µg/dL</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-15 12:13:41 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Intervention 1</B>:</P>
<OL>
<LI>A standard health education session on lead exposure reduction activities, given by a nurse educator, a letter reporting the results of the environmental lead assessment of the home, generic educational information in the form of pamphlets produced by state and federal agencies</LI>
<LI>Three times quarterly educational home visit by nurse (providing education on hygiene, nutrition, blood-lead screening, house cleaning and providing cleaning supplies) and 6 personalised newsletters over 9-month period</LI>
</OL>
<P>
<B>Intervention 2</B>: as intervention 1, plus three x quarterly professional cleans with wet mopping, HEPA (high efficiency particulate air) and carpet shampooing</P>
<P>
<B>Control</B>: standard health education session on lead exposure reduction activities, given by a nurse educator, a letter reporting the results of the environmental lead assessment of the home, generic educational information in the form of pamphlets produced by state and federal agencies</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-09-15 12:14:27 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Blood lead level at 3, 6 and 9 months from baseline (not stated if venous or capillary sample)</LI>
<LI>Household lead dust levels until 9 months from baseline (only presented graphically</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-09-16 12:58:14 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Funding</B>: not stated</P>
<P>
<B>Conflict of interests</B>: none declared</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-10-06 15:19:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wasserman-2002">
<CHAR_METHODS MODIFIED="2016-09-15 12:15:19 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Study design</B>: RCT<BR/>
<B>Study location/setting</B>: Florida, USA</P>
<P>
<B>Recruitment</B>: caregivers selected from clients enrolled in Broward County MediPass (Medicaid) who selected Children's Diagnostic and Treatment Center as their health care provider</P>
<P>
<B>Follow-up</B>: 4 months from baseline</P>
<P>
<B>Intention-to-treat</B> : unclear<BR/>
<B>Power calculation</B>: not performed to determine number of participants</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-10-06 15:19:10 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Eligibility-criteria</B>
</P>
<OL>
<LI>Aged 1-3 years</LI>
<LI>MediPass (Medicaid) as their insurance</LI>
</OL>
<P>
<B>Participation rate</B>: 63/63 (100%) children randomised (32 intervention, 31 control)</P>
<P>
<B>Reasons for non-participation</B>: NA<BR/>
<B>Analysis</B>: 50/63 (79%) analysed</P>
<P>
<B>Number of dropouts/withdrawals</B>: 13</P>
<P>
<B>Reasons for dropout/withdrawal</B>: reasons not specified</P>
<P>
<B>Intervention baseline characteristics</B> (available for n = 28)</P>
<UL>
<LI>Mean age 23.5 months</LI>
<LI>Mean blood lead level 4.5 µg/dL</LI>
</UL>
<P>
<B>Control baseline characteristics </B>(available for n = 22)</P>
<UL>
<LI>Mean age 21.5 months</LI>
<LI>Mean blood lead level 2.6 µg/dL</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-15 12:18:10 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Intervention</B>: education session at clinic consisting of print-based module written by the researcher and used as the basis of parental lead education, a video used to show methods parents could use in the home to prevent lead poisoning, and brochure highlighting the risks of childhood lead exposure including factors that affect the home environment, behaviours that mitigate risk, and the need for proper nutrition at first clinic</P>
<P>
<B>Control</B>: education session as described above at second clinic (wait-list control)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-09-15 12:18:43 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Blood lead level at 3-4 months from baseline (venous blood sample)</LI>
<LI>Parental knowledge - Chicago Lead Knowledge Test</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-09-16 12:58:20 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Funding</B>: not stated</P>
<P>
<B>Conflicts of Interest</B>: none declared</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-10-06 15:21:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Weitzman-1993">
<CHAR_METHODS MODIFIED="2016-09-15 12:19:24 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Study design</B>: RCT<BR/>
<B>Study location/setting</B>: Boston, USA. Urban neighbourhoods with a high incidence of childhood lead poisoning and high soil lead levels</P>
<P>
<B>Recruitment</B>: screening efforts between January and June 1989</P>
<P>
<B>Follow-up</B>: 11 months from baseline<BR/>
<B>Intention-to-treat</B>: available case analysis<BR/>
<B>Power calculation</B>: performed to determine number of participants (required number recruited)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-10-06 15:21:54 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Eligibility criteria</B>
</P>
<OL>
<LI>Up to 4 years of age</LI>
<LI>Finger-stick blood lead level of 0.48 to 0.96 µmol/L</LI>
<LI>Chipping or peeling paint did not exceed 30% of the total surface area on the exterior walls of the child's home or exceed 40% on the walls of abutting premises</LI>
<LI>Premise had a yard of at least 0.9 m<SUP>2</SUP> composed of dirt or grass, or both, that was accessible to the child and the mean or median surface soil lead level among samples taken near the house was at least 1500 parts per million</LI>
<LI>The child resided in a dwelling with &#8804; 8 residential units and was mobile</LI>
<LI>Child had never been lead poisoned</LI>
<LI>Family resided on the premises for at least 3 months and had no plans to move within the 3 months after enrolment</LI>
</OL>
<P>
<B>Participation rate</B>: 152/236 (64%) children randomised (54 intervention, 51 control group 1, 47 control group 2)</P>
<P>
<B>Reasons for non-participation</B>: children who had venous blood lead levels above 1.16 µmol/L were excluded because they met the former definition of lead poisoning and were likely to undergo medical and environmental interventions that could obscure changes associated with the study interventions (not specified whether all 84 children had high blood lead levels or if other reasons account for non-participation)<BR/>
<B>Analysis</B>: 149/152 (98%) analysed</P>
<P>
<B>Number of dropouts/withdrawals</B>: 3</P>
<P>
<B>Reasons for dropouts/withdrawals</B>: no specific reasons for dropouts stated</P>
<P>
<B>Intervention baseline characteristics</B> (available for n = 52)</P>
<UL>
<LI>60% boys, 40% girls</LI>
<LI>Mean age 30.5 months</LI>
<LI>Mean blood lead level 0.6 µg/dL</LI>
</UL>
<P>
<B>Control group 1 baseline characteristics</B> (n = 51):</P>
<UL>
<LI>49% boys, 51% girls</LI>
<LI>Mean age 31.4 months</LI>
<LI>Mean blood lead level 0.6 µg/dL</LI>
</UL>
<P>
<B>Control group 2 baseline characteristics</B> (n = 47):</P>
<UL>
<LI>51% boys, 49% girls</LI>
<LI>Mean age 33.1 months</LI>
<LI>Mean blood lead level 0.6 µg/dL</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-15 12:24:51 +0100" MODIFIED_BY="[Empty name]">
<P>Phase I only<BR/>
<B>Intervention</B>
</P>
<OL>
<LI>Soil abatement from yard (15 cm layer of topsoil was removed and replaced with 20 cm of clean soil)</LI>
<LI>Interior dust abatement (high-efficiency particulate air filter vacuuming and wiping surfaces with a wet cloth or an oil-treated rag for furniture, floors, walls, woodwork, windows, furniture surfaces were cleaned)</LI>
<LI>Loose interior paint removal (vacuuming the loose paint areas with HEPA, washing loose paint areas, painting window wells with primer)</LI>
</OL>
<P>
<B>Control A</B>
</P>
<OL>
<LI>Interior dust abatement (high-efficiency particulate air filter vacuuming and wiping surfaces with a wet cloth or an oil-treated rag for furniture, floors, walls, woodwork, windows, furniture surfaces were cleaned)</LI>
<LI>Loose interior paint removal (vacuuming the loose paint areas with HEPA, washing loose paint areas, painting window wells with primer)</LI>
</OL>
<P>
<B>Control B</B>
</P>
<OL>
<LI>Loose interior paint removal (vacuuming the loose paint areas with HEPA, washing loose paint areas, painting window wells with primer)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-07-14 12:30:24 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Blood lead levels 11 months from baseline (venous blood sample)</LI>
<LI>Household dust levels (only reported as percentage of households that remained at a lower dust level than at baseline after 4 to 5 weeks and after 33 weeks after the intervention)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-09-16 12:58:30 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Funding</B>: grant X001822-01-06 from Environmental Protection Agency, Washington, DC</P>
<P>
<B>Conflicts of interest</B>: none declared</P>
<P>
<B>Other comments</B>: phase I and phase II of Boston Lead-In-Soil trial performed but phase II excluded as no controls</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>
<B>BLL</B>: blood lead level; <B>CDC</B>: Centers for Disease Prevention and Control (USA); <B>HEPA</B>: high efficiency particulate air; <B>MEG</B>: maintenance education group; <B>NA</B>: not available; <B>SEG</B>: standard education group.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2016-09-15 14:09:59 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2016-09-15 14:08:35 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Aschengrau-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-09-15 14:08:35 +0100" MODIFIED_BY="[Empty name]">
<P>No control group used for phase II</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-09-15 14:08:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Boreland-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-09-15 14:08:44 +0100" MODIFIED_BY="[Empty name]">
<P>Only before-and-after intervention assessment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-09-15 14:08:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Butterfield-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-09-15 14:08:49 +0100" MODIFIED_BY="[Empty name]">
<P>Outcome was parents' self-efficacy and pre-caution adoption (not relevant for this review). Outcomes relevant for this Cochrane review not measured in this study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-11 07:40:25 +0000" MODIFIED_BY="Barbara Nussbaumer" STUDY_ID="STD-Dixon-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-11 07:40:25 +0000" MODIFIED_BY="Barbara Nussbaumer">
<P>Observational study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-09-15 14:09:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dugbatey-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-09-15 14:09:01 +0100" MODIFIED_BY="[Empty name]">
<P>Outcome (blood lead levels) only measured in mothers, not children. Outcomes relevant for this Cochrane review not measured in this study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-09-15 14:09:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-EPA-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-09-15 14:09:08 +0100" MODIFIED_BY="[Empty name]">
<P>Retrospective data collection on 2 groups not randomly assigned</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-07-29 14:18:49 +0100" MODIFIED_BY="Barbara Nussbaumer" STUDY_ID="STD-EPA-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-07-29 14:18:49 +0100" MODIFIED_BY="Barbara Nussbaumer">
<P>Historical control group with no randomisation used</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-07-29 14:19:58 +0100" MODIFIED_BY="Barbara Nussbaumer" STUDY_ID="STD-Farfel-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-07-29 14:19:58 +0100" MODIFIED_BY="Barbara Nussbaumer">
<P>Observational study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-07-29 14:46:11 +0100" MODIFIED_BY="Barbara Nussbaumer" STUDY_ID="STD-Feit-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-07-29 14:46:11 +0100" MODIFIED_BY="Barbara Nussbaumer">
<P>Qualitative study with semi-structured interviews</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-03 15:54:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Maharaj-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-03 15:54:57 +0000" MODIFIED_BY="[Empty name]">
<P>Conference abstract arguing the link between lead poisoning and asthma</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-07-29 14:47:41 +0100" MODIFIED_BY="Barbara Nussbaumer" STUDY_ID="STD-Malcoe-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-07-29 14:47:41 +0100" MODIFIED_BY="Barbara Nussbaumer">
<P>Observational study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-08 15:20:26 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Marlowe-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-08 15:20:26 +0000" MODIFIED_BY="[Empty name]">
<P>Outcome measured using hair lead levels. Outcomes relevant for this Cochrane review not measured in this study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-03 14:45:00 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT00000104">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-03 14:45:00 +0000" MODIFIED_BY="[Empty name]">
<P>Observational study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-11 08:02:44 +0000" MODIFIED_BY="Barbara Nussbaumer" STUDY_ID="STD-NCT00011674">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-11 08:02:44 +0000" MODIFIED_BY="Barbara Nussbaumer">
<P>Observational study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-09-15 14:09:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Omidpanah-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-09-15 14:09:28 +0100" MODIFIED_BY="[Empty name]">
<P>Control and Intervention groups from 2 different study bases</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-09-15 14:09:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Phoenix-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-09-15 14:09:42 +0100" MODIFIED_BY="[Empty name]">
<P>Before-and-after design without comparison group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pollak-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Historical control group with no randomisation used</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Taha-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Retrospective control with no randomisation used</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-07-29 14:48:18 +0100" MODIFIED_BY="Barbara Nussbaumer" STUDY_ID="STD-Thomas-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-07-29 14:48:18 +0100" MODIFIED_BY="Barbara Nussbaumer">
<P>Analysis of database records and qualitative research</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-08 15:20:44 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Untimanon-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-08 15:20:44 +0000" MODIFIED_BY="[Empty name]">
<P>Compared contamination modes, not prevention of lead exposure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-11 08:11:31 +0000" MODIFIED_BY="Barbara Nussbaumer" STUDY_ID="STD-Whitehead-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-11 08:11:31 +0000" MODIFIED_BY="Barbara Nussbaumer">
<P>Cross-sectional study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-09-15 14:09:59 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wilson-2015">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-09-15 14:09:59 +0100" MODIFIED_BY="[Empty name]">
<P>Before-and-after design without comparison group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-03 14:48:11 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yeoh-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-03 14:48:11 +0000" MODIFIED_BY="[Empty name]">
<P>Systematic review. Former version of this Cochrane review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-11 07:29:33 +0000" MODIFIED_BY="Barbara Nussbaumer" STUDY_ID="STD-Zimmermann-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-11 07:29:33 +0000" MODIFIED_BY="Barbara Nussbaumer">
<P>No intervention of interest reported (iron fortification)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2016-09-15 14:10:16 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2016-09-15 14:10:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT00129324">
<CHAR_STUDY_NAME MODIFIED="2015-11-30 14:11:07 +0000" MODIFIED_BY="[Empty name]">
<P>HOME Study (<B>H</B>ealth <B>O</B>utcomes and <B>M</B>easures of the <B>E</B>nvironment Study)</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2016-09-14 11:48:31 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised, double-blinded trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-09-15 14:10:16 +0100" MODIFIED_BY="[Empty name]">
<P>Pregnant women and their children</P>
<OL>
<LI>Group 1: 174 lead hazard control</LI>
<LI>Group 2: 181 injury control</LI>
<LI>Group 3: 53 no intervention</LI>
</OL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-15 11:23:22 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Group 1: participants received lead hazard reduction controls prior to their child's birth</LI>
<LI>Group 2: participants received injury hazard reduction controls prior to their child's birth</LI>
<LI>Group 3: no intervention</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-22 12:07:06 +0100" MODIFIED_BY="[Empty name]">
<P>Blood lead concentrations and neurobehavioral outcomes</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-09-15 10:13:23 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Started</B>: March 2003</P>
<P>
<B>Estimated completion date</B>: September 2017</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2016-09-15 10:13:23 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Principal investigator</B>: Bruce P Lanphear, MD, MPH</P>
<P>
<B>Address</B>: Children's Hospital Medical Center, Cincinnati</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2016-09-15 10:13:23 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Trials identifier</B>: NCT00129324</P>
<P>
<B>More information about the study</B>: <A HREF="http://www.cincinnatichildrens.org/research/divisions/e/environmental/study/summary/">cincinnatichildrens.org/research/divisions/e/environmental/study/summary</A>
</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2016-10-06 15:22:31 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2016-10-06 13:58:21 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 10:57:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aschengrau-1998">
<DESCRIPTION>
<P>Quote from correspondence with author: "an open list of random numbers"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 13:58:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Boreland-2009">
<DESCRIPTION>
<P>Quote from correspondence with author: "children were matched in pairs and then a coin tossed to see which would be the 'case' and have their home re-mediated first"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 11:38:55 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brown-2006">
<DESCRIPTION>
<P>Quote from report: "[r]andom numbers table was used to assign cases to either the intervention or the comparison group, sequentially"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 13:50:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Campbell-2011">
<DESCRIPTION>
<P>Quote from correspondence with author: "randomized blocks using computer-generated random numbers"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 11:14:21 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Charney-1983">
<DESCRIPTION>
<P>Quote from report allocation method alternate based on "even or odd clinic number"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 11:45:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Farrell-1998">
<DESCRIPTION>
<P>Quote from correspondence with author: "coin toss"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 11:48:40 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hilts-1995">
<DESCRIPTION>
<P>Quote from correspondence with author: "drew concealed slips of paper numbered 1-6 without replacement" and assigned blocks and then "coin toss" determined that "odds would be treatment blocks"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 11:33:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jordan-2003">
<DESCRIPTION>
<P>Quote from correspondence with author: "Random number generator"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 13:51:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lanphear-1996a">
<DESCRIPTION>
<P>Quote from correspondence with author: "computer random number generator"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 12:03:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lanphear-1999">
<DESCRIPTION>
<P>Quote from correspondence with author: "random number generator"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 13:52:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rhoads-1999">
<DESCRIPTION>
<P>Quote from correspondence with author: "permutated blocks of varying length"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 11:20:59 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sterling-2004">
<DESCRIPTION>
<P>Comment: method of randomisation unknown</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 13:53:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wasserman-2002">
<DESCRIPTION>
<P>Quote from correspondence with author: "random list of numbers"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 13:53:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weitzman-1993">
<DESCRIPTION>
<P>Quote from correspondence with author: "computer-based random number generator"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2016-10-06 13:53:05 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 10:57:33 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Aschengrau-1998">
<DESCRIPTION>
<P>Quote from correspondence with author: "open list"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 11:02:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Boreland-2009">
<DESCRIPTION>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 13:50:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brown-2006">
<DESCRIPTION>
<P>Quote from report: "group assignments were sealed into envelopes and unknown to either study personnel or the families until after parental consent was obtained"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 13:50:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Campbell-2011">
<DESCRIPTION>
<P>Quote from correspondence with author: "study coordinator selected next card in the random sequence to randomise that family"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 11:21:21 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Charney-1983">
<DESCRIPTION>
<P>Comment: not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 11:19:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Farrell-1998">
<DESCRIPTION>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 11:48:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hilts-1995">
<DESCRIPTION>
<P>Quote from correspondence with author: "done in central office"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 11:33:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jordan-2003">
<DESCRIPTION>
<P>Quote from correspondence with author: "Central office"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 13:51:47 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lanphear-1996a">
<DESCRIPTION>
<P>Quote from correspondence with author: "sealed opaque envelopes"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 12:03:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lanphear-1999">
<DESCRIPTION>
<P>Quote from correspondence with author: "sealed opaque envelopes"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 13:52:24 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rhoads-1999">
<DESCRIPTION>
<P>Quote from correspondence with author: "sealed envelopes"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 11:25:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sterling-2004">
<DESCRIPTION>
<P>Comment: unknown</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 13:53:05 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wasserman-2002">
<DESCRIPTION>
<P>Quote from report: "assigned by central office"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 12:25:36 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Weitzman-1993">
<DESCRIPTION>
<P>Comment: allocation performed by 1 staff member but not actively concealed from other investigators enrolling participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2016-10-06 14:06:54 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>Household dust measures</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-10-06 14:05:16 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aschengrau-1998">
<DESCRIPTION>
<P>Quote from correspondence with author: "the subjects and the investigators interacting with the subjects knew which group they were assigned to"</P>
<P>Comment: we rated this domain as low risk, because blood lead levels and household dust lead measures are unlikely to be influenced by participants' knowledge about treatment allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-10-06 14:05:28 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Boreland-2009">
<DESCRIPTION>
<P>Comment: no information provided on blinding. However, we rated this domain as low risk, because blood lead levels and household dust lead measures are unlikely to be influenced by participants' knowledge about treatment allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-10-06 14:05:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brown-2006">
<DESCRIPTION>
<P>Quote from report: "the nurses who provided follow up to comparison group children were blinded and nurses that provided care to intervention group were not blinded"</P>
<P>Comment: we rated this domain as low risk, because blood lead levels and household dust lead measures are unlikely to be influenced by participants' knowledge about treatment allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-10-06 14:05:48 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Campbell-2011">
<DESCRIPTION>
<P>Quote from correspondence with author: "once the randomization occurred they were told of their assignment. The outreach workers who performed the randomization were made aware of the assignment category, as well."</P>
<P>Comment: we rated this domain as low risk, because blood lead levels and household dust lead measures are unlikely to be influenced by participants' knowledge about treatment allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-10-06 14:06:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Charney-1983">
<DESCRIPTION>
<P>Quote from correspondence with author: "personnel was not blinded. Participants were not aware of the existence of another study group"</P>
<P>Comment: we rated this domain as low risk, because blood lead levels won't be influenced by the participants knowledge about treatment allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-10-06 14:06:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Farrell-1998">
<DESCRIPTION>
<P>Comment: no information provided on blinding. We rated this domain as low risk, because blood lead levels and household dust lead measures are unlikely to be influenced by participants' knowledge about treatment allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-10-06 14:06:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hilts-1995">
<DESCRIPTION>
<P>Quote from correspondence with author: "participants and personnel were not blinded as to treatment allocation"</P>
<P>Comment: we rated this domain as low risk, because blood lead levels and household dust lead measures are unlikely to be influenced by participants' knowledge about treatment allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-10-06 14:06:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jordan-2003">
<DESCRIPTION>
<P>Quote from correspondence with author: "no blinding of participants or personnel"</P>
<P>Comment: we rated this domain as being at low risk because blood lead levels are unlikely to be influenced by participants' knowledge about treatment allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-09-15 11:33:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lanphear-1996a">
<DESCRIPTION>
<P>Quote from correspondence with author: "personnel and participants were blinded"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-09-15 11:33:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lanphear-1999">
<DESCRIPTION>
<P>Quote from correspondence with author: "personnel and participants were blinded"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-10-06 14:04:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rhoads-1999">
<DESCRIPTION>
<P>Quote from correspondence with author: "it was not possible to blind participants or field personnel to the assignments since one group had cleaning teams come to their homes and the other group did not"</P>
<P>Comment: we rated this domain as low risk, because blood lead levels and household dust lead measures are unlikely to be influenced by participants' knowledge about treatment allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-10-06 14:04:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sterling-2004">
<DESCRIPTION>
<P>Quote from correspondence with author: "no blinding of participants or researchers occurred"</P>
<P>Comment: we rated this domain as low risk, because blood lead levels and household dust lead measures are unlikely to be influenced by participants' knowledge about treatment allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-10-06 14:03:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wasserman-2002">
<DESCRIPTION>
<P>Quote from correspondence with author: "Personnel was not blinded. Participants were unaware of the existence of the comparison group"</P>
<P>Comment: we rated this domain as low risk, because blood lead levels are unlikely to be influenced by participants' knowledge about treatment allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-10-06 14:02:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weitzman-1993">
<DESCRIPTION>
<P>Quote from correspondence with author: "impossible for participants or personnel to be blinded to treatment allocation"</P>
<P>Comment: we rated this domain as low risk, because blood lead levels and household dust lead measures are unlikely to be influenced by participants' knowledge about treatment allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2016-10-06 14:06:14 +0100" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-09-15 10:58:20 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aschengrau-1998">
<DESCRIPTION>
<P>Quote from correspondence with author: "lab analysers were blinded"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-09-15 11:02:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Boreland-2009">
<DESCRIPTION>
<P>Quote from correspondence with author: "lab analysers were blinded"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-09-15 11:10:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brown-2006">
<DESCRIPTION>
<P>Quote from report: "venous blood samples were collected by children's pediatric health care providers"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-10-06 14:05:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Campbell-2011">
<DESCRIPTION>
<P>Quote from correspondence with author: "the samples were sent to 2 different analytic labs during the course of the 3-year study period, and their job is to analyze BLLs. They were blinded to status". "The outreach workers collecting the dust wipe samples knew the household assignment" - this might have had an influence on household dust levels</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-09-15 11:16:48 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Charney-1983">
<DESCRIPTION>
<P>Comment: blinding of outcome assessors (laboratory)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-10-06 14:06:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Farrell-1998">
<DESCRIPTION>
<P>Quote from correspondence with author: "Specimen collectors and laboratory personnel were blinded to group allocation and analyses were done by the State laboratory which had no interest in the outcome of the study"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-10-06 13:55:05 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hilts-1995">
<DESCRIPTION>
<P>Quote from correspondence with author: "blood specimen collector and lab personnel did not know of group assignments", "lab personnel analysing the carpet dust samples were not aware of group assignment"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-09-15 11:33:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jordan-2003">
<DESCRIPTION>
<P>Quote from correspondence with author: outcome assessors "laboratory" blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-10-06 13:54:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lanphear-1996a">
<DESCRIPTION>
<P>Quote from correspondence with author: "yes, blood lead specimen collectors and analysers were blinded to group allocation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-10-06 13:54:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lanphear-1999">
<DESCRIPTION>
<P>Quote from correspondence with author: "yes, blood lead specimen collectors and analysers were blinded to group allocation", "environmental technicians and interviewers blind to group assignment"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-09-15 11:22:55 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rhoads-1999">
<DESCRIPTION>
<P>Comment: outcome assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-09-15 11:22:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sterling-2004">
<DESCRIPTION>
<P>Comment: outcome analysers (laboratory) blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-09-15 11:17:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wasserman-2002">
<DESCRIPTION>
<P>Comment: blinding of outcome assessors (laboratory)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-09-15 11:22:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weitzman-1993">
<DESCRIPTION>
<P>Comment: outcome assessors (laboratory analysers) were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2015-07-27 16:14:57 +0100" MODIFIED_BY="Barbara Nussbaumer" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>Blood lead level</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.02" NO="2">
<NAME>Household dust</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2016-10-06 15:22:31 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.02" NO="2" REF_IDS="CMP-001.04">
<NAME>Household dust lead level</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1" REF_IDS="CMP-001.01 CMP-001.02">
<NAME>Blood lead level</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-10-06 14:05:19 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Aschengrau-1998">
<DESCRIPTION>
<P>Comment: high attrition rate (41%) and high differential attrition. Attrition rate was 18% points higher in the intervention group than in the control group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2016-10-06 14:05:22 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Aschengrau-1998">
<DESCRIPTION>
<P>Comment: high attrition rate (46%) and high differential attrition. Attrition rate was 27% points higher in the intervention group than in the control group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-09-15 11:03:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Boreland-2009">
<DESCRIPTION>
<P>Comment: attrition rate was low (2%)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2015-12-09 11:21:15 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Boreland-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-10-06 14:05:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brown-2006">
<DESCRIPTION>
<P>Comment: the overall attrition rate (17%) was acceptable. The attrition rates in intervention (18%) and control group (15%) were similar</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2016-10-06 14:05:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brown-2006">
<DESCRIPTION>
<P>Comment: the overall attrition rate was acceptable (13%). The attrition rates in intervention (12%) and control group (13%) were similar</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-10-06 15:22:24 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Campbell-2011">
<DESCRIPTION>
<P>Comment: attrition rate for blood lead level was acceptable (11%). No information on dropout rates in either study arm</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2016-10-06 13:59:33 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Campbell-2011">
<DESCRIPTION>
<P>Comment: for the outcome, household dust, attrition rate was very high (64%). No information on dropout rates in either study arm</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-09-15 11:15:58 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Charney-1983">
<DESCRIPTION>
<P>Comment: attrition rate was quite high (37%), but there was no difference in attrition rates between study arms (37% in both groups)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2015-12-09 11:21:23 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Charney-1983">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-10-06 14:00:36 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Farrell-1998">
<DESCRIPTION>
<P>Comment: attrition rate was very high (55%). Attrition was similar in both groups (intervention group 53%, control group 58%)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2015-12-09 11:21:32 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Farrell-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-09-15 11:20:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hilts-1995">
<DESCRIPTION>
<P>Comment: low attrition rate (1%)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2016-09-15 11:20:34 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hilts-1995">
<DESCRIPTION>
<P>Comment: low attrition rate (1%)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-10-06 13:54:53 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jordan-2003">
<DESCRIPTION>
<P>Comment: attrition was quite high (38%), no information on attrition rates in both groups were given, so we rated it as being at high risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2015-12-09 11:21:37 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jordan-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-10-06 15:22:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lanphear-1996a">
<DESCRIPTION>
<P>Comment: attrition rate for blood lead level was low (9%)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2016-10-06 13:54:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lanphear-1996a">
<DESCRIPTION>
<P>Comment: attrition rate was acceptable (33%) and similar between groups (intervention group 32%, control group 36%)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-10-06 13:54:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lanphear-1999">
<DESCRIPTION>
<P>Comment: attrition rate at 12 months was 11%, at 24 months it was 31% - both acceptable. Attrition rate between groups was similar</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2016-09-15 11:16:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lanphear-1999">
<DESCRIPTION>
<P>Comment: attrition rate at 12 months was 11%, at 24 months it was 31% - both acceptable. Attrition rate between groups was similar</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-09-15 11:20:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rhoads-1999">
<DESCRIPTION>
<P>Comment: low attrition rate (12%)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2016-09-15 11:18:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rhoads-1999">
<DESCRIPTION>
<P>Comment: for the outcome household dust, attrition rate was higher and reasons for missing data were not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-09-15 11:19:33 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sterling-2004">
<DESCRIPTION>
<P>Comment: high attrition rate (61%). Reasons for missing data not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2016-09-15 11:19:34 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sterling-2004">
<DESCRIPTION>
<P>Comment: high attrition rate (66%). Reasons for missing data not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-10-06 14:03:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wasserman-2002">
<DESCRIPTION>
<P>Comment: attrition rate (21%) was acceptable. However, attrition rate was much higher in control group (30%) than in intervention group (12%). Reasons for dropouts not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2015-12-09 11:21:54 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wasserman-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-09-15 11:16:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weitzman-1993">
<DESCRIPTION>
<P>Comment: attrition rate was low (2%)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2016-09-15 11:16:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weitzman-1993">
<DESCRIPTION>
<P>Comment: attrition rate was low (2%)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2016-10-06 14:07:04 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 11:13:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aschengrau-1998">
<DESCRIPTION>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 14:05:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Boreland-2009">
<DESCRIPTION>
<P>Comment: the study protocol is not available, but it is clear that the published reports include all expected outcomes, including those that were pre-specified and confirmed by investigator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 14:05:40 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brown-2006">
<DESCRIPTION>
<P>Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified and confirmed by the investigator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 14:05:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Campbell-2011">
<DESCRIPTION>
<P>Comment: the study protocol is not available, but it is clear that the published reports include all expected outcomes, including those that were pre-specified and confirmed by the investigator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 11:19:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Charney-1983">
<DESCRIPTION>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 11:19:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Farrell-1998">
<DESCRIPTION>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 14:06:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hilts-1995">
<DESCRIPTION>
<P>Comment: the study protocol is not available, but it is clear that the published reports include all expected outcomes, including those that were pre-specified and confirmed by the investigator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 13:54:55 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jordan-2003">
<DESCRIPTION>
<P>Comment: results on household dust lead outcomes were not reported although they were measured. No information from the author on these outcomes could be obtained</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 14:07:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lanphear-1996a">
<DESCRIPTION>
<P>Comment: the study protocol is available and all of the study's pre-specified outcomes are reported in the pre-specified way</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 14:05:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lanphear-1999">
<DESCRIPTION>
<P>Comment: the study protocol is available and all of the study's pre-specified outcomes are reported in the pre-specified way</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 11:19:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rhoads-1999">
<DESCRIPTION>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 11:19:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sterling-2004">
<DESCRIPTION>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 14:03:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wasserman-2002">
<DESCRIPTION>
<P>Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified and confirmed by the investigator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 11:19:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weitzman-1993">
<DESCRIPTION>
<P>Comment: insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2016-10-06 14:07:04 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 14:05:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aschengrau-1998">
<DESCRIPTION>
<P>Comment: the study appears to be free from other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 14:05:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Boreland-2009">
<DESCRIPTION>
<P>Comment: the study appears to be free from other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 14:05:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brown-2006">
<DESCRIPTION>
<P>Comment: the study appears to be free from other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 14:05:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Campbell-2011">
<DESCRIPTION>
<P>Comment: the study appears to be free from other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 14:06:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Charney-1983">
<DESCRIPTION>
<P>Comment: the study appears to be free from other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 11:45:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Farrell-1998">
<DESCRIPTION>
<P>Comment: risk of bias due to cluster randomisation</P>
<P>Used neighbourhood clusters, and it was unclear how analysis was performed as data were not available - unclear if there is unit of analysis bias. We assessed risk of recruitment bias and bias risk due to baseline imbalance as low, since baseline characteristics were comparable and randomisation was achieved by coin toss.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 13:55:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hilts-1995">
<DESCRIPTION>
<P>Comment: risk of bias for cluster-randomised studies</P>
<P>Used clusters of 6 households but used individuals as unit for analysis and therefore introduced a unit of analysis error. We assessed risk of recruitment bias and bias risk due to baseline imbalance as low, since baseline characteristics were comparable and randomisation was achieved by coin toss.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 14:06:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jordan-2003">
<DESCRIPTION>
<P>Comment: the study appears to be free from other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 14:07:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lanphear-1996a">
<DESCRIPTION>
<P>Comment: the study appears to be free from other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 14:05:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lanphear-1999">
<DESCRIPTION>
<P>Comment: the study appears to be free of other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 14:05:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rhoads-1999">
<DESCRIPTION>
<P>Comment: the study appears to be free from other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 11:21:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sterling-2004">
<DESCRIPTION>
<P>Comment: no information on funding provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-15 11:21:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wasserman-2002">
<DESCRIPTION>
<P>Comment: no information on funding provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-06 14:03:00 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weitzman-1993">
<DESCRIPTION>
<P>Comment: the study appears to be free from other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2016-10-06 13:49:31 +0100" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2016-10-06 13:49:31 +0100" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2016-09-15 14:11:06 +0100" MODIFIED_BY="[Empty name]">Education strategies versus no intervention for preventing domestic lead exposure in children</TITLE>
<TABLE COLS="7" ROWS="15">
<TR>
<TD COLSPAN="7">
<P>
<B>Education strategies versus no intervention for preventing domestic lead exposure in children</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population</B>: children<BR/>
<B>Settings</B>: households in the USA<BR/>
<B>Intervention</B>: education strategies for prevention of domestic lead exposure<BR/>
<B>Comparison</B>: no intervention 
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Outcomes</P>
</TH>
<TH ALIGN="CENTER" COLSPAN="2" VALIGN="BOTTOM">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Number of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="CENTER" VALIGN="BOTTOM">
<P>Assumed risk</P>
</TH>
<TH ALIGN="CENTER" VALIGN="BOTTOM">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Regular environment</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Educational strategies </B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Cognitive and neurobehavioural outcomes</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>None of the included studies assessed effects on cognitive or neurobehavioural outcomes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Adverse events</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>None of the included studies assessed adverse event outcomes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Blood lead level (continuous)</B>
<BR/>Blood lead levels after intervention</P>
<P>
<B>Scale</B>: 0-30<BR/>
<B>Follow-up</B>: 6-18 months</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>The mean blood lead level (continuous) ranged across control groups from <B>1.24 to 2.13 </B>
<SUP>a,b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>The mean blood lead level (continuous) in the intervention groups was <B>0.02 higher</B>
<BR/>(0.09 lower to 0.12 higher)<SUP>a,b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>815<BR/>(5 studies)</P>
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>High</B>
<SUP>c</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Included studies: <LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>; <LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Blood lead level </B>&#8805; <B>10.0 µg/dL (dichotomous)</B>
<BR/>Blood lead level<BR/>
<B>Follow-up</B>: 6-18 months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Medium risk population</B>
<SUP>d</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>RR 1.02 </B>
<BR/>(0.79 to 1.30)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>520<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>Moderate</B>
<SUP>e</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Included studies: <LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>238 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>243 per 1000</B>
<BR/>(188 to 309)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Blood lead level </B>&#8805; <B>15.0 µg/dL (dichotomous)</B>
<BR/>Blood lead level<BR/>
<B>Follow-up</B>: 6-18 months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Medium risk population</B>
<SUP>d</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>RR 0.60 </B>
<BR/>(0.33 to 1.09)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>520<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>Moderate</B>
<SUP>e</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Included studies: <LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>; <LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>; <LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>110 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>66 per 1000</B>
<BR/>(36 to 120)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Floor dust - hard floor (continuous)</B>
<BR/>Floor dust lead levels</P>
<P>
<B>Scale</B>: 0-40<BR/>
<B>Follow-up</B>: 6-18 months</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>The mean floor dust level - hard floor - ranged across control groups from <B>1.65 to 2.28</B>
<SUP>b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>The mean floor dust level - hard floor - in the intervention groups was <B>0.07 lower </B>(0.37 lower to 0.24 higher)<SUP>b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>318<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>Moderate</B>
<SUP>f</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Included studies: <LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>; <LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% CI) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI</B>: confidence interval; <B>RR</B>: risk ratio.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality</B>: further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality</B>: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality</B>: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality</B>: we are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a</SUP>Change in blood lead level.<BR/>
<SUP>b</SUP>These are logged values.<BR/>
<SUP>c</SUP>Although two of five studies had high attrition rates, we did not downgrade for high risk of bias because a sensitivity analysis excluding them showed no relevant difference in the result, and we assessed all other risk of bias domains in all five included studies as being at low risk.<BR/>
<SUP>d</SUP>Baseline based on median of control groups.<BR/>
<SUP>e</SUP>We downgraded by one level because of imprecision: 95% CI around pooled estimate includes no effect and appreciable harm or benefit and because the total number of events is less than 300.<BR/>
<SUP>f</SUP>We downgraded by one level because of imprecision: total population is less than 400.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-02" MODIFIED="2016-10-06 13:48:39 +0100" MODIFIED_BY="[Empty name]" NO="2" READONLY="YES">
<TITLE MODIFIED="2016-09-15 14:33:17 +0100" MODIFIED_BY="[Empty name]">Environmental strategies (dust control) versus no intervention for preventing domestic lead exposure in children</TITLE>
<TABLE COLS="7" ROWS="14">
<TR>
<TD COLSPAN="7">
<P>
<B>Environmental strategies (dust control) versus no intervention for preventing domestic lead exposure in children</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population</B>: children<BR/>
<B>Settings</B>: households in Australia, Canada, USA<BR/>
<B>Intervention</B>: environmental strategies (dust control)<BR/>
<B>Comparison</B>: regular environment<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Outcomes</P>
</TH>
<TH ALIGN="CENTER" COLSPAN="2" VALIGN="BOTTOM">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Number of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="CENTER" VALIGN="BOTTOM">
<P>Assumed risk</P>
</TH>
<TH ALIGN="CENTER" VALIGN="BOTTOM">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Environmental strategies (dust control)</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Cognitive and neurobehavioural outcomes</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>None of the included studies assessed effects on cognitive or neurobehavioural outcomes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Adverse events</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>None of the included studies assessed adverse event outcomes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Blood lead level (continuous)</B>
<BR/>Blood lead level at end of duration</P>
<P>
<B>Scale</B>: 0-30<BR/>
<B>Follow-up</B>: 6-18 months</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>The mean blood lead level (continuous) ranged across control groups from <B>2.4 to 2.9 </B>
<SUP>a</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>The mean blood lead level (continuous) in the intervention groups was <B>0.15 lower </B>(0.42 lower to 0.11 higher) <SUP>a</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>298<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>Low</B>
<SUP>b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Included studies: <LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>; <LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Blood lead level </B>&#8805; <B>10.0 µg/dL (dichotomous)</B>
<BR/>Blood lead level<BR/>
<B>Follow-up</B>: 6-18 months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Medium risk population</B>
<SUP>c</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>RR 0.93 </B>
<BR/>(0.73 to 1.18)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>210<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>Moderate</B>
<SUP>d</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Included studies: <LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>573 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>533 per 1000</B>
<BR/>(418 to 676)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Blood lead level </B>&#8805; <B>15.0 µg/dL (dichotomous)</B>
<BR/>Blood lead level<BR/>
<B>Follow-up</B>: 6-18 months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Medium risk population</B>
<SUP>c</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>RR 0.86 </B>
<BR/>(0.35 to 2.07)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>210<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>Low</B>
<SUP>e</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Included studies: <LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>; <LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>205 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>176 per 1000</B>
<BR/>(72 to 424)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (for example, the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI</B>: confidence interval; <B>RR</B>: risk ratio.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality</B>: further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality</B>: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality</B>: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality</B>: we are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a</SUP> Change in blood lead level and logged values<BR/>
<SUP>b</SUP>We downgraded by two levels, one because of imprecision: total population size less than 400; one because of inconsistency: I² = 90%.<BR/>
<SUP>c</SUP>Baseline based on median of control groups.<BR/>
<SUP>d</SUP>We downgraded by one level because of imprecision: total number of events less than 300.<BR/>
<SUP>e</SUP>We downgraded by two levels, one because of imprecision: 95% CI around pooled estimate includes no effect and appreciable harm or benefit and total number of events less than 300; one because of inconsistency: I² = 56%.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2016-10-10 16:10:23 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2016-10-10 16:10:23 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2012-02-11 13:13:22 +0000" MODIFIED_BY="Berlinda Yeoh">Mean blood lead level and age at baseline</TITLE>
<TABLE COLS="3" ROWS="15">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Study ID</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Mean blood lead level</P>
<P>at baseline (µg/dL)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Age at baseline</P>
<P>(months)</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>15.0 - 19.0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>24 - 36</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>15.0 - 19.0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&gt; 36</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>15.0 - 19.0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 - 24</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2.6 - 2.7</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 - 14</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&gt; 20.0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&gt; 36</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10.0 - 14.0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 - 72</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10.0 - 14.0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>24 - 36</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&lt; 10.0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&lt; 12</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&lt; 10.0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 - 24</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&lt; 10.0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&lt; 12</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10.0 - 14.0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 - 24</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10.0 - 14.0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&gt; 36</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&lt; 10.0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 - 24</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10.0 - 14.0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 - 36</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2016-10-06 13:45:46 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2012-02-11 13:14:01 +0000" MODIFIED_BY="Berlinda Yeoh">Intervention type by study</TITLE>
<TABLE COLS="5" ROWS="15">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Study ID</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Education</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Dust control</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Soil abatement</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Combination</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2016-09-15 14:51:17 +0100" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2012-02-12 07:34:11 +0000" MODIFIED_BY="Joey Kwong">Outcome measures by study</TITLE>
<TABLE COLS="6" ROWS="15">
<TR>
<TH>
<P>Study ID</P>
</TH>
<TH>
<P>Blood lead (continuous)</P>
</TH>
<TH>
<P>Blood lead (dichotomous)</P>
</TH>
<TH>
<P>Household floor dust lead</P>
</TH>
<TH>
<P>
<B>Household window dust lead</B>
</P>
</TH>
<TH>
<P>Other</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Aschengrau-1998" TYPE="STUDY">Aschengrau 1998</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Boreland-2009" TYPE="STUDY">Boreland 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Brown-2006" TYPE="STUDY">Brown 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Parent - Child Interaction scale</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Campbell-2011" TYPE="STUDY">Campbell 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Chicago Parents Knowledge Test</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Charney-1983" TYPE="STUDY">Charney 1983</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Farrell-1998" TYPE="STUDY">Farrell 1998</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Total effect (blood lead levels)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Hilts-1995" TYPE="STUDY">Hilts 1995</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Jordan-2003" TYPE="STUDY">Jordan 2003</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Lanphear-1996a" TYPE="STUDY">Lanphear 1996a</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Lanphear-1999" TYPE="STUDY">Lanphear 1999</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Rhoads-1999" TYPE="STUDY">Rhoads 1999</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Maternal knowledge lead poisoning</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Sterling-2004" TYPE="STUDY">Sterling 2004</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Wasserman-2002" TYPE="STUDY">Wasserman 2002</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Chicago Parents Knowledge Test</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Weitzman-1993" TYPE="STUDY">Weitzman 1993</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2016-10-10 17:03:39 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2016-10-06 13:44:29 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Education interventions compared to no intervention or standard education</NAME>
<CONT_OUTCOME CHI2="2.1305133916540417" CI_END="0.11650397962205379" CI_START="-0.0861080821662336" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="0.015197948727910101" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.01" MODIFIED="2016-09-26 22:29:50 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7117689764556966" P_Q="1.0" P_Z="0.7687318127018792" Q="0.0" RANDOM="YES" SCALE="0.52" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="410" TOTAL_2="405" UNITS="" WEIGHT="100.0" Z="0.29403414468695843">
<NAME>Blood lead level (continuous)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.25557265077935787" CI_START="-0.11557265077935727" EFFECT_SIZE="0.07000000000000028" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="2.13" MODIFIED="2011-04-01 00:16:55 +0100" MODIFIED_BY="[Empty name]" ORDER="38" SD_1="0.55" SD_2="0.59" SE="0.09468166366480758" STUDY_ID="STD-Brown-2006" TOTAL_1="71" TOTAL_2="74" WEIGHT="29.801811115940477"/>
<CONT_DATA CI_END="0.387478986631818" CI_START="-0.3074789866318184" EFFECT_SIZE="0.039999999999999813" ESTIMABLE="YES" MEAN_1="1.65" MEAN_2="1.61" MODIFIED="2016-08-04 09:50:49 +0100" MODIFIED_BY="[Empty name]" ORDER="37" SD_1="1.48" SD_2="1.57" SE="0.17728845497809556" STUDY_ID="STD-Jordan-2003" TOTAL_1="142" TOTAL_2="154" WEIGHT="8.4998939659295"/>
<CONT_DATA CI_END="0.2550340943860589" CI_START="-0.29503409438605893" EFFECT_SIZE="-0.020000000000000018" ESTIMABLE="YES" MEAN_1="1.83" MEAN_2="1.85" MODIFIED="2011-03-18 01:57:53 +0000" MODIFIED_BY="[Empty name]" ORDER="36" SD_1="0.5" SD_2="0.8" SE="0.14032609606885266" STUDY_ID="STD-Lanphear-1996a" TOTAL_1="52" TOTAL_2="43" WEIGHT="13.567428212323424"/>
<CONT_DATA CI_END="0.10096766584598008" CI_START="-0.2409676658459802" EFFECT_SIZE="-0.07000000000000006" ESTIMABLE="YES" MEAN_1="1.69" MEAN_2="1.76" MODIFIED="2011-03-18 01:58:28 +0000" MODIFIED_BY="[Empty name]" ORDER="35" SD_1="0.67" SD_2="0.65" SE="0.0872300038136166" STUDY_ID="STD-Lanphear-1999" TOTAL_1="117" TOTAL_2="112" WEIGHT="35.11095446918315"/>
<CONT_DATA CI_END="0.4207574387930259" CI_START="-0.1407574387930261" EFFECT_SIZE="0.1399999999999999" ESTIMABLE="YES" MEAN_1="1.38" MEAN_2="1.24" MODIFIED="2016-08-04 09:50:49 +0100" MODIFIED_BY="[Empty name]" ORDER="34" SD_1="0.64" SD_2="0.36" SE="0.14324622340390172" STUDY_ID="STD-Wasserman-2002" TOTAL_1="28" TOTAL_2="22" WEIGHT="13.019912236623446"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="1.8669905442772055" CI_END="1.3047589357614453" CI_START="0.7902799284324307" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.015443153689624" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="71" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.11553027984334277" LOG_CI_START="-0.10221904815280947" LOG_EFFECT_SIZE="0.006655615845266642" METHOD="IV" MODIFIED="2016-10-06 13:44:23 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6004668456675758" P_Q="1.0" P_Z="0.9046300668339357" Q="0.0" RANDOM="YES" SCALE="106.01" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="269" TOTAL_2="251" WEIGHT="100.0" Z="0.11981453602361734">
<NAME>Blood lead level &#8805; 10.0 µg/dL (dichotomous)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.4983435797879885" CI_START="0.805491749999599" EFFECT_SIZE="1.0985915492957747" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="37" LOG_CI_END="0.17561141129185442" LOG_CI_START="-0.09393890334904409" LOG_EFFECT_SIZE="0.040836253971405154" MODIFIED="2010-08-31 11:58:20 +0100" MODIFIED_BY="Berlinda Yeoh" ORDER="41" O_E="0.0" SE="0.15833518911564046" STUDY_ID="STD-Brown-2006" TOTAL_1="71" TOTAL_2="74" VAR="0.02507003211228563" WEIGHT="65.25803020029913"/>
<DICH_DATA CI_END="1.5439999523767067" CI_START="0.3721395426064197" EFFECT_SIZE="0.7580128205128205" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.1886472826042939" LOG_CI_START="-0.42929418049351875" LOG_EFFECT_SIZE="-0.12032344894461244" MODIFIED="2010-08-31 11:58:20 +0100" MODIFIED_BY="Berlinda Yeoh" ORDER="42" O_E="0.0" SE="0.36298187428323014" STUDY_ID="STD-Lanphear-1996a" TOTAL_1="52" TOTAL_2="43" VAR="0.13175584105816668" WEIGHT="12.417065532477952"/>
<DICH_DATA CI_END="1.5534002694030424" CI_START="0.5284232069349107" EFFECT_SIZE="0.9060092449922958" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="22" LOG_CI_END="0.19128337613732896" LOG_CI_START="-0.2770181175857904" LOG_EFFECT_SIZE="-0.04286737072423074" MODIFIED="2010-08-31 11:58:20 +0100" MODIFIED_BY="Berlinda Yeoh" ORDER="43" O_E="0.0" SE="0.27508261554274055" STUDY_ID="STD-Lanphear-1999" TOTAL_1="118" TOTAL_2="112" VAR="0.0756704453738352" WEIGHT="21.620342058561434"/>
<DICH_DATA CI_END="78.59248386253566" CI_START="0.20008690677318955" EFFECT_SIZE="3.9655172413793105" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.8953810145749477" LOG_CI_START="-0.6987813296656364" LOG_EFFECT_SIZE="0.5982998424546556" MODIFIED="2010-08-31 11:58:20 +0100" MODIFIED_BY="Berlinda Yeoh" ORDER="44" O_E="0.0" SE="1.5238238023176252" STUDY_ID="STD-Wasserman-2002" TOTAL_1="28" TOTAL_2="22" VAR="2.322038980509745" WEIGHT="0.7045622086614832"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.6500083295457546" CI_END="1.0851111856848967" CI_START="0.3310174714794651" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.599325254731935" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.035474240355476756" LOG_CI_START="-0.4801490830615219" LOG_EFFECT_SIZE="-0.22233742135302262" METHOD="IV" MODIFIED="2016-10-06 13:44:29 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.7225244017090897" P_Q="1.0" P_Z="0.09097481285672711" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="269" TOTAL_2="251" WEIGHT="100.0" Z="1.690277838401849">
<NAME>Blood lead level &#8805; 15.0 µg/dL (dichotomous)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.7743859086466114" CI_START="0.3238122436663771" EFFECT_SIZE="0.7580025608194623" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="11" LOG_CI_END="0.2490480798525829" LOG_CI_START="-0.489706734161344" LOG_EFFECT_SIZE="-0.12032932715438052" MODIFIED="2010-08-31 11:59:39 +0100" MODIFIED_BY="Berlinda Yeoh" ORDER="48" O_E="0.0" SE="0.4339482346470877" STUDY_ID="STD-Brown-2006" TOTAL_1="71" TOTAL_2="74" VAR="0.18831107035332387" WEIGHT="48.71519660959196"/>
<DICH_DATA CI_END="1.556630769157137" CI_START="0.1098208047625489" EFFECT_SIZE="0.41346153846153844" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.19218561068366824" LOG_CI_START="-0.9593153781220559" LOG_EFFECT_SIZE="-0.38356488371919384" MODIFIED="2010-08-31 11:59:39 +0100" MODIFIED_BY="Berlinda Yeoh" ORDER="46" O_E="0.0" SE="0.6763973808463057" STUDY_ID="STD-Lanphear-1996a" TOTAL_1="52" TOTAL_2="43" VAR="0.4575134168157424" WEIGHT="20.051020317332963"/>
<DICH_DATA CI_END="1.525354340977399" CI_START="0.1822872437018777" EFFECT_SIZE="0.527306967984934" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" LOG_CI_END="0.18337074234223022" LOG_CI_START="-0.7392437218207301" LOG_EFFECT_SIZE="-0.2779364897392499" MODIFIED="2010-08-31 11:59:39 +0100" MODIFIED_BY="Berlinda Yeoh" ORDER="47" O_E="0.0" SE="0.5419483032645763" STUDY_ID="STD-Lanphear-1999" TOTAL_1="118" TOTAL_2="112" VAR="0.29370796341135325" WEIGHT="31.233783073075067"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-08-31 11:59:39 +0100" MODIFIED_BY="Berlinda Yeoh" ORDER="45" O_E="0.0" SE="0.0" STUDY_ID="STD-Wasserman-2002" TOTAL_1="28" TOTAL_2="22" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.03666163916696611" CI_END="0.24057642895330097" CI_START="-0.37077341339394654" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.0650984922203228" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2016-04-12 12:22:09 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.8481556562332307" P_Q="1.0" P_Z="0.6763810994974477" Q="0.0" RANDOM="YES" SCALE="2.702466144102257" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="166" TOTAL_2="152" UNITS="" WEIGHT="100.0" Z="0.41740650397427237">
<NAME>Floor dust - hard floor</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.5762481333350327" CI_START="-2.056248133335032" EFFECT_SIZE="-0.23999999999999977" ESTIMABLE="YES" MEAN_1="2.04" MEAN_2="2.28" MODIFIED="2011-03-18 02:02:35 +0000" MODIFIED_BY="[Empty name]" ORDER="40" SD_1="3.89" SD_2="3.82" SE="0.9266742387418166" STUDY_ID="STD-Lanphear-1996a" TOTAL_1="39" TOTAL_2="31" WEIGHT="2.832495677957201"/>
<CONT_DATA CI_END="0.2500982281227422" CI_START="-0.37009822812274185" EFFECT_SIZE="-0.05999999999999983" ESTIMABLE="YES" MEAN_1="1.59" MEAN_2="1.65" MODIFIED="2011-03-18 02:03:12 +0000" MODIFIED_BY="[Empty name]" ORDER="39" SD_1="1.15" SD_2="1.33" SE="0.15821628895671414" STUDY_ID="STD-Lanphear-1999" TOTAL_1="127" TOTAL_2="121" WEIGHT="97.1675043220428"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2016-10-10 17:03:39 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Environmental interventions (dust control) compared to no intervention or another intervention not aimed to influence domestic lead exposure</NAME>
<CONT_OUTCOME CHI2="19.184172046446438" CI_END="0.11473803939006055" CI_START="-0.42218605324595926" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.15372400692794935" ESTIMABLE="YES" I2="89.57473903404411" I2_Q="0.0" ID="CMP-002.01" MODIFIED="2016-09-26 22:30:01 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="6.826763680878312E-5" P_Q="1.0" P_Z="0.2617372003006966" Q="0.0" RANDOM="YES" SCALE="1.4" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.04964721732293251" TOTALS="YES" TOTAL_1="146" TOTAL_2="152" UNITS="" WEIGHT="100.0" Z="1.1222946456314562">
<NAME>Blood lead level (continuous)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.10125308481594965" CI_START="-0.14125308481594967" EFFECT_SIZE="-0.020000000000000018" ESTIMABLE="YES" MEAN_1="2.86" MEAN_2="2.88" MODIFIED="2015-11-05 17:34:09 +0000" MODIFIED_BY="Barbara Nussbaumer" ORDER="71" SD_1="0.28" SD_2="0.3" SE="0.06186495556672394" STUDY_ID="STD-Boreland-2009" TOTAL_1="44" TOTAL_2="44" WEIGHT="35.08511938930521"/>
<CONT_DATA CI_END="0.16031401475377718" CI_START="-0.10031401475377758" EFFECT_SIZE="0.029999999999999805" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="2.37" MODIFIED="2015-11-05 17:34:11 +0000" MODIFIED_BY="Barbara Nussbaumer" ORDER="72" SD_1="0.34" SD_2="0.36" SE="0.06648796395325511" STUDY_ID="STD-Hilts-1995" TOTAL_1="56" TOTAL_2="55" WEIGHT="34.700072022822674"/>
<CONT_DATA CI_END="-0.3013361662952205" CI_START="-0.7386638337047795" EFFECT_SIZE="-0.52" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="2.72" MODIFIED="2015-11-05 17:34:14 +0000" MODIFIED_BY="Barbara Nussbaumer" ORDER="68" SD_1="0.51" SD_2="0.6" SE="0.11156523049891322" STUDY_ID="STD-Rhoads-1999" TOTAL_1="46" TOTAL_2="53" WEIGHT="30.214808587872124"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0029588937524320947" CI_END="1.1808629328333218" CI_START="0.7332378536267601" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9305124407003411" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="62" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.07219949035797277" LOG_CI_START="-0.13475512254661254" LOG_EFFECT_SIZE="-0.03127781609431987" METHOD="MH" MODIFIED="2016-10-06 13:44:35 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9566199184666163" P_Q="1.0" P_Z="0.5535605347917467" Q="0.0" RANDOM="YES" SCALE="4.79" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="102" TOTAL_2="108" WEIGHT="100.0" Z="0.5924332122830974">
<NAME>Blood lead level &#8805; 10.0 µg/dL (dichotomous)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2452288902896604" CI_START="0.688639496739743" EFFECT_SIZE="0.9260204081632653" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="35" LOG_CI_END="0.09524918810092907" LOG_CI_START="-0.16200807206961856" LOG_EFFECT_SIZE="-0.033379441984344754" MODIFIED="2010-08-31 12:04:14 +0100" MODIFIED_BY="Berlinda Yeoh" ORDER="57" O_E="0.0" SE="0.15111418806815538" STUDY_ID="STD-Hilts-1995" TOTAL_1="56" TOTAL_2="55" VAR="0.022835497835497834" WEIGHT="64.71648812393487"/>
<DICH_DATA CI_END="1.4021077561799538" CI_START="0.6285973089014328" EFFECT_SIZE="0.9388083735909822" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="27" LOG_CI_END="0.146781391744776" LOG_CI_START="-0.20162748257990826" LOG_EFFECT_SIZE="-0.027423045417566128" MODIFIED="2010-08-31 12:04:14 +0100" MODIFIED_BY="Berlinda Yeoh" ORDER="58" O_E="0.0" SE="0.20465709743006227" STUDY_ID="STD-Rhoads-1999" TOTAL_1="46" TOTAL_2="53" VAR="0.041884527528498" WEIGHT="35.28351187606513"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.2514373662630667" CI_END="2.0675957764881487" CI_START="0.35384797809079716" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8553447170699093" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="22" I2="55.58392984923232" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="0.31546563635608826" LOG_CI_START="-0.4511832816371279" LOG_EFFECT_SIZE="-0.0678588226405198" METHOD="MH" MODIFIED="2016-10-06 13:44:40 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.13349046214645754" P_Q="1.0" P_Z="0.7286162860556726" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.22612733110326425" TOTALS="YES" TOTAL_1="102" TOTAL_2="108" WEIGHT="100.0" Z="0.3469667674138345">
<NAME>Blood lead level &#8805; 15.0 µg/dL (dichotomous)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.8568878994567455" CI_START="0.600251976297649" EFFECT_SIZE="1.3095238095238095" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="9" LOG_CI_END="0.4558931995698266" LOG_CI_START="-0.22166640137713978" LOG_EFFECT_SIZE="0.11711339909634338" MODIFIED="2010-08-31 12:08:49 +0100" MODIFIED_BY="Berlinda Yeoh" ORDER="72" O_E="0.0" SE="0.39800186357036493" STUDY_ID="STD-Hilts-1995" TOTAL_1="56" TOTAL_2="55" VAR="0.15840548340548338" WEIGHT="52.73935954114847"/>
<DICH_DATA CI_END="1.285946425902309" CI_START="0.21990190733683693" EFFECT_SIZE="0.5317725752508361" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="13" LOG_CI_END="0.109222875726883" LOG_CI_START="-0.6577710037348393" LOG_EFFECT_SIZE="-0.2742740640039782" MODIFIED="2010-08-31 12:08:49 +0100" MODIFIED_BY="Berlinda Yeoh" ORDER="71" O_E="0.0" SE="0.4505360014767511" STUDY_ID="STD-Rhoads-1999" TOTAL_1="46" TOTAL_2="53" VAR="0.20298268862665908" WEIGHT="47.26064045885153"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.005204236925918055" CI_END="1.1838705792318593" CI_START="0.7273555731859027" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.927951972752424" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="60" I2="0.0" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="0.07330422789568838" LOG_CI_START="-0.13825322913977084" LOG_EFFECT_SIZE="-0.03247450062204128" METHOD="MH" MODIFIED="2016-10-06 13:44:45 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.9424901776206289" P_Q="1.0" P_Z="0.5473625827230014" Q="0.0" RANDOM="YES" SCALE="2.89" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="99" TOTAL_2="105" WEIGHT="100.0" Z="0.6017169286021078">
<NAME>Blood lead level &#8805; 10.0 µg/dL (dichotomous): ICC 0.01</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2522962230735035" CI_START="0.6783336869336452" EFFECT_SIZE="0.9216695254431103" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="33" LOG_CI_END="0.09770707075107042" LOG_CI_START="-0.1685566147702798" LOG_EFFECT_SIZE="-0.0354247720096047" MODIFIED="2011-03-22 22:29:13 +0000" MODIFIED_BY="[Empty name]" ORDER="36" O_E="0.0" SE="0.1564046069017413" STUDY_ID="STD-Hilts-1995" TOTAL_1="53" TOTAL_2="52" VAR="0.02446240106008822" WEIGHT="63.12956518035933"/>
<DICH_DATA CI_END="1.4021077561799538" CI_START="0.6285973089014328" EFFECT_SIZE="0.9388083735909822" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="27" LOG_CI_END="0.146781391744776" LOG_CI_START="-0.20162748257990826" LOG_EFFECT_SIZE="-0.027423045417566128" MODIFIED="2011-03-22 22:28:40 +0000" MODIFIED_BY="[Empty name]" ORDER="37" O_E="0.0" SE="0.20465709743006227" STUDY_ID="STD-Rhoads-1999" TOTAL_1="46" TOTAL_2="53" VAR="0.041884527528498" WEIGHT="36.870434819640664"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.004629261897916737" CI_END="1.2428879405223758" CI_START="0.7237368765259661" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9484323043556957" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="50" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="0.09443197417131102" LOG_CI_START="-0.1404192982268976" LOG_EFFECT_SIZE="-0.022993662027793293" METHOD="MH" MODIFIED="2016-10-10 17:03:28 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.945754843931383" P_Q="1.0" P_Z="0.701134325149855" Q="0.0" RANDOM="YES" SCALE="2.54" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="83" TOTAL_2="90" WEIGHT="100.0" Z="0.3837896979391017">
<NAME>Blood lead level &#8805; 10.0 µg/dL (dichotomous): ICC 0.1</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3793167249035476" CI_START="0.6633239638945803" EFFECT_SIZE="0.9565217391304348" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="23" LOG_CI_END="0.1396640022774038" LOG_CI_START="-0.1782743126681771" LOG_EFFECT_SIZE="-0.01930515519538663" MODIFIED="2011-03-18 10:01:32 +0000" MODIFIED_BY="[Empty name]" ORDER="64" O_E="0.0" SE="0.18675854001907546" STUDY_ID="STD-Hilts-1995" TOTAL_1="37" TOTAL_2="37" VAR="0.034878752270056615" WEIGHT="54.56323340849051"/>
<DICH_DATA CI_END="1.4021077561799538" CI_START="0.6285973089014328" EFFECT_SIZE="0.9388083735909822" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="27" LOG_CI_END="0.146781391744776" LOG_CI_START="-0.20162748257990826" LOG_EFFECT_SIZE="-0.027423045417566128" MODIFIED="2010-08-31 12:04:14 +0100" MODIFIED_BY="Berlinda Yeoh" ORDER="63" O_E="0.0" SE="0.20465709743006227" STUDY_ID="STD-Rhoads-1999" TOTAL_1="46" TOTAL_2="53" VAR="0.041884527528498" WEIGHT="45.43676659150949"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.045996168744745713" CI_END="1.2935657538640115" CI_START="0.7235015265937434" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9674175921855044" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="44" I2="0.0" I2_Q="0.0" ID="CMP-002.06" LOG_CI_END="0.11178850944568637" LOG_CI_START="-0.14056054817930527" LOG_EFFECT_SIZE="-0.014386019366809452" METHOD="MH" MODIFIED="2016-10-10 17:03:32 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.8301829184956853" P_Q="1.0" P_Z="0.8231706059887209" Q="0.0" RANDOM="YES" SCALE="2.71" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="74" TOTAL_2="81" WEIGHT="100.0" Z="0.22346887367214663">
<NAME>Blood lead level &#8805; 10.0 µg/dL (dichotomous): ICC 0.2</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.524036749491715" CI_START="0.6561521566546951" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" LOG_CI_END="0.18299543938484025" LOG_CI_START="-0.1829954393848402" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-03-22 22:32:31 +0000" MODIFIED_BY="[Empty name]" ORDER="62" O_E="0.0" SE="0.21498485387337868" STUDY_ID="STD-Hilts-1995" TOTAL_1="28" TOTAL_2="28" VAR="0.046218487394957986" WEIGHT="47.54040206783767"/>
<DICH_DATA CI_END="1.4021077561799538" CI_START="0.6285973089014328" EFFECT_SIZE="0.9388083735909822" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="27" LOG_CI_END="0.146781391744776" LOG_CI_START="-0.20162748257990826" LOG_EFFECT_SIZE="-0.027423045417566128" MODIFIED="2010-08-31 12:04:14 +0100" MODIFIED_BY="Berlinda Yeoh" ORDER="61" O_E="0.0" SE="0.20465709743006227" STUDY_ID="STD-Rhoads-1999" TOTAL_1="46" TOTAL_2="53" VAR="0.041884527528498" WEIGHT="52.45959793216233"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.8061386448183376" CI_END="1.8137126216625463" CI_START="0.36885135284346404" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8179183053150823" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="22" I2="44.63326484548031" I2_Q="0.0" ID="CMP-002.07" LOG_CI_END="0.2585684752746162" LOG_CI_START="-0.43314861933214666" LOG_EFFECT_SIZE="-0.08729007202876524" METHOD="MH" MODIFIED="2016-10-06 13:45:05 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.17897227922498005" P_Q="1.0" P_Z="0.6208340021898485" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.14788782602864176" TOTALS="YES" TOTAL_1="99" TOTAL_2="105" WEIGHT="100.0" Z="0.4946686982820574">
<NAME>Blood lead level &#8805; 15.0 µg/dL (dichotomous): ICC 0.01</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.6515846830211793" CI_START="0.5423127286103823" EFFECT_SIZE="1.19916142557652" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="9" LOG_CI_END="0.42350550163430156" LOG_CI_START="-0.2657502021284811" LOG_EFFECT_SIZE="0.0788776497529103" MODIFIED="2011-03-22 22:36:38 +0000" MODIFIED_BY="[Empty name]" ORDER="70" O_E="0.0" SE="0.4048722122610181" STUDY_ID="STD-Hilts-1995" TOTAL_1="53" TOTAL_2="52" VAR="0.1639215082611309" WEIGHT="52.94721353212339"/>
<DICH_DATA CI_END="1.285946425902309" CI_START="0.21990190733683693" EFFECT_SIZE="0.5317725752508361" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="13" LOG_CI_END="0.109222875726883" LOG_CI_START="-0.6577710037348393" LOG_EFFECT_SIZE="-0.2742740640039782" MODIFIED="2010-08-31 12:08:49 +0100" MODIFIED_BY="Berlinda Yeoh" ORDER="69" O_E="0.0" SE="0.4505360014767511" STUDY_ID="STD-Rhoads-1999" TOTAL_1="46" TOTAL_2="53" VAR="0.20298268862665908" WEIGHT="47.0527864678766"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.9207101887353366" CI_END="2.0340217894741026" CI_START="0.3357165483035321" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8263502733928387" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="19" I2="47.93592464574599" I2_Q="0.0" ID="CMP-002.08" LOG_CI_END="0.3083556009946312" LOG_CI_START="-0.47402725076933216" LOG_EFFECT_SIZE="-0.08283582488735047" METHOD="MH" MODIFIED="2016-10-10 17:03:35 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.16577864363047645" P_Q="1.0" P_Z="0.6781217094486569" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.20283029147995613" TOTALS="YES" TOTAL_1="83" TOTAL_2="90" WEIGHT="100.00000000000001" Z="0.4150275866676446">
<NAME>Blood lead level &#8805; 15.0 µg/dL (dichotomous): ICC 0.1</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.4662620355837483" CI_START="0.5128803764768998" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.539861390549433" LOG_CI_START="-0.28998391733283313" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2011-03-22 22:37:48 +0000" MODIFIED_BY="[Empty name]" ORDER="68" O_E="0.0" SE="0.4874552416505669" STUDY_ID="STD-Hilts-1995" TOTAL_1="37" TOTAL_2="37" VAR="0.23761261261261257" WEIGHT="47.95393304598858"/>
<DICH_DATA CI_END="1.285946425902309" CI_START="0.21990190733683693" EFFECT_SIZE="0.5317725752508361" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="13" LOG_CI_END="0.109222875726883" LOG_CI_START="-0.6577710037348393" LOG_EFFECT_SIZE="-0.2742740640039782" MODIFIED="2010-08-31 12:08:49 +0100" MODIFIED_BY="Berlinda Yeoh" ORDER="67" O_E="0.0" SE="0.4505360014767511" STUDY_ID="STD-Rhoads-1999" TOTAL_1="46" TOTAL_2="53" VAR="0.20298268862665908" WEIGHT="52.04606695401144"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.332268149688593" CI_END="1.6644439405905609" CI_START="0.3423827263213004" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7549018838156154" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="18" I2="24.940035515091918" I2_Q="0.0" ID="CMP-002.09" LOG_CI_END="0.22126917245623562" LOG_CI_START="-0.46548815419517026" LOG_EFFECT_SIZE="-0.12210949086946728" METHOD="MH" MODIFIED="2016-10-10 17:03:39 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.24840225859083276" P_Q="1.0" P_Z="0.4858114084692583" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0827714489955712" TOTALS="YES" TOTAL_1="74" TOTAL_2="81" WEIGHT="100.0" Z="0.6969862424086264">
<NAME>Blood lead level &#8805; 15.0 µg/dL (dichotomous): ICC 0.2</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.480876014725685" CI_START="0.41368896619935513" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5416885544306737" LOG_CI_START="-0.383326062335424" LOG_EFFECT_SIZE="0.07918124604762482" MODIFIED="2011-03-22 22:41:08 +0000" MODIFIED_BY="[Empty name]" ORDER="66" O_E="0.0" SE="0.5433581647846062" STUDY_ID="STD-Hilts-1995" TOTAL_1="28" TOTAL_2="28" VAR="0.2952380952380953" WEIGHT="43.050583428014"/>
<DICH_DATA CI_END="1.285946425902309" CI_START="0.21990190733683693" EFFECT_SIZE="0.5317725752508361" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="13" LOG_CI_END="0.109222875726883" LOG_CI_START="-0.6577710037348393" LOG_EFFECT_SIZE="-0.2742740640039782" MODIFIED="2010-08-31 12:08:49 +0100" MODIFIED_BY="Berlinda Yeoh" ORDER="65" O_E="0.0" SE="0.4505360014767511" STUDY_ID="STD-Rhoads-1999" TOTAL_1="46" TOTAL_2="53" VAR="0.20298268862665908" WEIGHT="56.949416571986"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2016-10-06 15:22:32 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2016-10-06 13:44:09 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA60AAAK8CAYAAAAEWFlVAACAAElEQVR42uz9DaRWy///j39IkiSb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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2016-10-06 15:22:32 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAApAAAAEZCAMAAAAXPOXvAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2016-10-06 15:22:32 +0100" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAWwAAAMrCAIAAADiPz8TAAAvRUlEQVR42u3dv24Uyfr/8ZGQEIED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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2016-10-06 13:41:30 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2016-10-06 13:38:26 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2015-08-03 15:48:08 +0100" MODIFIED_BY="Margaret J Anderson">Search strategies used up to 2006</TITLE>
<APPENDIX_BODY MODIFIED="2016-10-06 13:38:26 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library</HEADING>
<P>#1 LEAD POISONING NERVOUS SYSTEM CHILDHOOD<BR/>#2 LEAD POISONING<BR/>#3LEAD<BR/>#4 (lead near poison*)<BR/>#5 (#1 or #2 or #3 or #4)<BR/>#6 CHILD<BR/>#7 INFANT<BR/>#8 (child* or baby or babies or infant* or preschool* or (pre next school*) or boy* or girl*)<BR/>#9 (#6 or #7 or #8)<BR/>#10 (#5 and #9)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Ovid MEDLINE</HEADING>
<P>1. Lead Poisoning, Nervous System, Childhood/ or Lead Poisoning/ or Lead/ or lead.mp. or Lead Poisoning, Nervous System/ or Lead Radioisotopes/<BR/>2. lead poisoning.mp.<BR/>3. lead exposure.mp.<BR/>4. lead blood level.mp.<BR/>5. lead reduction.mp.<BR/>6. 1 or 2 or 3 or 4 or 5<BR/>7. randomized controlled trial.pt.<BR/>8. controlled clinical trial.pt.<BR/>9. randomized controlled trials/<BR/>10. random allocation/<BR/>11. double blind method/<BR/>12. single blind method/<BR/>13. or/7-12<BR/>14. animal/ not (animal/ and human/)<BR/>15. 13 not 14<BR/>16. clinical trial.pt.<BR/>17. exp clinical trials/<BR/>18. (clinic$ adj25 trial$).ti,ab.<BR/>19. cross-over studies/<BR/>20. (crossover or cross-over or cross over).tw.<BR/>21. ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).ti,ab.<BR/>22. placebos/<BR/>23. placebo$.ti,ab.<BR/>24. random$.ti,ab.<BR/>25. research design/<BR/>26. or/16-25<BR/>27. 26 not 14<BR/>28. 15 or 27<BR/>29. adolescent/ or child/ or infant.mp.<BR/>30. (child$ or boy$ or girl$ or baby or babies or infant$ or toddler$ or teen$ or adolescen$).tw.<BR/>31. 29 or 30<BR/>32. 28 and 31<BR/>33. limit 28 to ("newborn infant (birth to 1 month)" or "infant (1 to 23 months)" or "preschool child (2 to 5 years)" or "child (6 to 12 years)" or "adolescent (13 to 18 years)")<BR/>34. 32 or 33<BR/>35. 6 and 34</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Embase Ovid</HEADING>
<P>1. LEAD 203/ or LEAD 212/ or LEAD/ or LEAD POISONING/ or lead.mp. or LEAD 210/ or LEAD BLOOD LEVEL/<BR/>2. lead poisoning.mp.<BR/>3. lead exposure.mp.<BR/>4. lead reduction.mp.<BR/>5. lead control.mp.<BR/>6. 1 or 2 or 3 or 4 or 5<BR/>7. exp clinical trial/<BR/>8. comparative study/<BR/>9. drug comparison/<BR/>10. major clinical study/<BR/>11. randomization/<BR/>12. crossover procedure/<BR/>13. double blind procedure/<BR/>14. single blind procedure/<BR/>15. placebo/<BR/>16. prospective study/<BR/>17. ((clinical or controlled or comparative or placebo or prospective or randomi#ed) adj3 (trial or study)).ti,ab.<BR/>18. (random$ adj7 (allocat$ or allot$ or assign$ or basis$ or divid$ or order$)).ti,ab.<BR/>19. ((singl$ or doubl$ or trebl$ or tripl$) adj7 (blind$ or mask$)).ti,ab.<BR/>20. (cross?over$ or (cross adj1 over$)).ti,ab.<BR/>21. ((allocat$ or allot$ or assign$ or divid$) adj3 (condition$ or experiment$ or intervention$ or treatment$ or therap$ or control$ or group$)).ti,ab.<BR/>22. or/7-16<BR/>23. or/17-21<BR/>24. 22 or 23<BR/>25. (baby or babies).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer name]<BR/>26. youth.mp.<BR/>27. child$.mp.<BR/>28. adolescen$.mp.<BR/>29. teenage$.mp.<BR/>30. or/25-29<BR/>31. limit 24 to (infant or child or preschool child &lt;1 to 6 years&gt; or school child &lt;7 to 12 years&gt; or adolescent &lt;13 to 17 years&gt;)<BR/>32. 24 and 30<BR/>33. 31 or 32<BR/>34. 6 and 33</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">PsycINFO Ovid</HEADING>
<P>1. exp LEAD POISONING/ or exp "LEAD (METAL)"/ or lead.mp.<BR/>2. lead poisoning.mp.<BR/>3. lead control.mp.<BR/>4. lead reduction.mp.<BR/>5. lead exposure.mp.<BR/>6. lead blood level.mp.<BR/>7. 1 or 2 or 3 or 4 or 5 or 6<BR/>8. random$.af.<BR/>9. (random$ adj25 (alloc$ or assign$ or divid$)).mp.<BR/>10. (random$ adj25 (trial$ or study or studies)).mp.<BR/>11. ((control$ or clinic$ or prospectiv$) adj25 (trial$ or stud$)).mp.<BR/>12. ((alloc$ or assign$ or divi$) adj25 (condition$ or experiment$ or treatment$ or control$ or group$)).mp.<BR/>13. ((singl$ or doubl$) adj (blind$ or mask$)).mp.<BR/>14. "CROSS?OVER".mp.<BR/>15. exp placebo/<BR/>16. (compar$ adj25 (trial$ or stud$)).mp.<BR/>17. or/8-16<BR/>18. child$.af.<BR/>19. adolesc$.af.<BR/>20. teenage$.af.<BR/>21. or/18-20<BR/>22. limit 17 to (100 childhood or 120 neonatal or 140 infancy or 160 preschool age or 180 school age or 200 adolescence )<BR/>23. 17 and 21<BR/>24. 22 or 23<BR/>25. 7 and 24<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">CINAHL Ovid (Cumulative Index to Nursing and Allied Health Literature)</HEADING>
<P>1. LEAD POISONING/ or LEAD/ or lead.mp.<BR/>2. lead poisoning.mp.<BR/>3. lead reduction.mp.<BR/>4. lead control.mp.<BR/>5. lead exposure.mp.<BR/>6. lead blood level.mp.<BR/>7. 1 or 2 or 3 or 4 or 5 or 6<BR/>8. experimental studies/<BR/>9. exp clinical trials/<BR/>10. ((control$ or clinic$ or prospectiv$) adj25 (trial$ or study or studies)).tw.<BR/>11. ((allocat$ or assign$ or divid$) adj25 (condition$ or experiment$ or treatment$ or control$ or group$)).tw.<BR/>12. cross?over$.tw.<BR/>13. placebo$.tw.<BR/>14. (comp$ adj25 (trial$ or study or studies)).mp.<BR/>15. exp clinical research/<BR/>16. exp Comparative Studies/<BR/>17. exp evaluation research/<BR/>18. exp "control (research)"/<BR/>19. exp Random Assignment/<BR/>20. exp prospective studies/<BR/>21. random$.tw.<BR/>22. or/8-21<BR/>23. child$.tw.<BR/>24. adolescenc$.tw.<BR/>25. teenage$.tw.<BR/>26. exp child/<BR/>27. or/23-26<BR/>28. 22 and 27<BR/>29. limit 22 to (newborn infant or infant &lt;1 to 23 months&gt; or preschool child &lt;2 to 5 years&gt; or child &lt;6 to 12 years&gt; or adolescence &lt;13 to 18 years&gt;)<BR/>30. 28 or 29<BR/>31. 7 and 30</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sociofile Cambridge Scientific Abstracts</HEADING>
<P>Lead (KY) or lead (De) or lead poisoning (De)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">ERIC EBSCO</HEADING>
<P>Lead poisoning.mp. and Lead poisoning (subject heading)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Science Citation Index ProQuest (SCI)</HEADING>
<P>TS=(lead same poison*) AND TS=(child* or baby or babies or infant* or preschool* or boy* or girl*)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">ZETOC</HEADING>
<P>(<A HREF="http://zetoc.jisc.ac.uk/">zetoc.jisc.ac.uk</A>)</P>
<P>"childhood lead poisoning prevention"</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">LILACS (Latin American and Caribbean Health Science Information database)</HEADING>
<P>(<A HREF="http://lilacs.bvsalud.org/en/">lilacs.bvsalud.org/en</A>)</P>
<P>lead poison$ and (child$ or baby or babies or infant$ or preschool$ or girl$ or boy$)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dissertation Abstracts ProQuest</HEADING>
<P>Searched using the phrase "childhood lead poisoning prevention"</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Other databases and websites</HEADING>
<P>ClinicalTrials.gov (<A HREF="https://clinicaltrials.gov/">clinicaltrials.gov</A>), Current Controlled Trials (<A HREF="https://s3-us-west-2.amazonaws.com/webcitation/6fc2d850dde348335d1ab0b66828190d475a6967">s3-us-west-2.amazonaws.com/webcitation/6fc2d850dde348335d1ab0b66828190d475a6967</A>), Australian New Zealand Clinical Trials Registry (ANZCTR; <A HREF="http://www.anzctr.org.au/">anzctr.org.au</A>), and National Research Register (no longer available. For more information, see <A HREF="http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/aboutus/researchanddevelopment/atoz/dh_4002357">webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/aboutus/researchanddevelopment/atoz/dh_4002357</A>) were searched using the terms "lead" and "children"</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2016-10-06 13:40:07 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2016-05-17 15:05:51 +0100" MODIFIED_BY="[Empty name]">Search strategies used from 2006 to 2016</TITLE>
<APPENDIX_BODY MODIFIED="2016-10-06 13:40:07 +0100" MODIFIED_BY="[Empty name]">
<P>The same strategy was used each time the search was run, unless indicated otherwise.</P>
<SUBSECTION>
<HEADING LEVEL="3">Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library</HEADING>
<P>#1MeSH descriptor: [Lead Poisoning, Nervous System, Childhood] this term only<BR/>#2MeSH descriptor: [Lead Poisoning] this term only<BR/>#3MeSH descriptor: [Lead] this term only<BR/>#4lead near poison*<BR/>#5lead near expos*<BR/>#6lead near blood*<BR/>#7lead near toxic*<BR/>#8lead near environ*<BR/>#9lead near reduc*<BR/>#10lead near hazard*<BR/>#11lead near control*<BR/>#12lead near pollut*<BR/>#13lead near contamin*<BR/>#14lead near (domestic* or home* or hous*)<BR/>#15{or #1-#14}<BR/>#16[mh infant]<BR/>#17[mh child]<BR/>#18[mh adolescent]<BR/>#19child* or baby or babies or toddler* or boy* or girl* or preschool* or pre-school* or (pre next school*) or teen* or adolescen*<BR/>#20{or #16-#19}<BR/>#21#20 and #15</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Ovid MEDLINE</HEADING>
<P>1 Lead Poisoning, Nervous System, Childhood/ or Lead Poisoning/ or Lead/ or Lead Poisoning, Nervous System/ or Lead Radioisotopes/<BR/>2 lead.rn. or Pb.tw.<BR/>3 (lead adj5 poison$).tw.<BR/>4 (lead adj5 expos$).tw.<BR/>5 (lead adj5 blood$).tw.<BR/>6 (lead adj5 reduc$).tw.<BR/>7 (lead adj5 toxic$).tw.<BR/>8 (lead adj5 environ$).tw.<BR/>9 (lead adj5 hazard$).tw.<BR/>10 (lead adj5 control$).tw.<BR/>11 (lead adj5 (domestic$ or home$ or hous$)).tw.<BR/>12 (lead adj5 contamin$).tw.<BR/>13 (lead adj5 pollut$).tw.<BR/>14 or/1-13<BR/>15 exp Infant/<BR/>16 Adolescent/<BR/>17 exp Child/<BR/>18 15 or 16 or 17<BR/>19 (child$ or baby or babies or toddler$ or boy$ or girl$ or preschool$ or pre-school$ or pre school$ or teen$ or adolescen$).tw.<BR/>20 18 or 19<BR/>21 randomized controlled trial.pt.<BR/>22 controlled clinical trial.pt.<BR/>23 randomized.ab.<BR/>24 placebo.ab.<BR/>25 drug therapy.fs.<BR/>26 randomly.ab.<BR/>27 trial.ab.<BR/>28 groups.ab.<BR/>29 or/21-28<BR/>30 exp animals/ not humans.sh.<BR/>31 29 not 30 [Note: Lines 12 to 31 are the Cochrane highly sensitive search strategy for identifying randomised trials (<LINK REF="REF-Lefebvre-2008" TYPE="REFERENCE">Lefebvre 2008</LINK>)]<BR/>32 14 and 20 and 31</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Embase OVID</HEADING>
<P>1 lead chloride/ or lead sulfide/ or lead 212/ or lead chromate/ or lead oxide/ or lead 210/ or lead nitrate/ or lead acetate/ or lead 203/ or lead/ or "pb".tw.<BR/>2 lead poisoning/<BR/>3 lead blood level/<BR/>4 (lead adj5 poison$).tw.<BR/>5 (lead adj5 expos$).tw.<BR/>6 (lead adj5 blood$).tw.<BR/>7 (lead adj5 reduc$).tw.<BR/>8 (lead adj5 toxic$).tw.<BR/>9 (lead adj5 environ$).tw.<BR/>10 (lead adj5 hazard$).tw.<BR/>11 (lead adj5 control$).tw.<BR/>12 (lead adj5 (domestic$ or home$ or hous$)).tw.<BR/>13 (lead adj5 contamin$).tw.<BR/>14 (lead adj5 pollut$).tw.<BR/>15 or/1-14<BR/>16 exp child/<BR/>17 exp adolescent/<BR/>18 (child$ or baby or babies or toddler$ or boy$ or girl$ or preschool$ or pre-school$ or pre school$ or teen$ or adolescen$).tw.<BR/>19 or/16-18<BR/>20 Randomized controlled trial/<BR/>21 controlled clinical trial/<BR/>22 Single blind procedure/<BR/>23 Double blind procedure/<BR/>24 triple blind procedure/<BR/>25 Crossover procedure/<BR/>26 (crossover or cross-over).tw.<BR/>27 ((singl$ or doubl$ or tripl$ or trebl$) adj1 (blind$ or mask$)).tw.<BR/>28 Placebo/<BR/>29 placebo.tw.<BR/>30 prospective.tw.<BR/>31 factorial$.tw.<BR/>32 random$.tw.<BR/>33 assign$.ab. (2)<BR/>34 allocat$.tw.<BR/>35 volunteer$.ab.<BR/>36 or/20-35<BR/>37 15 and 19 and 36</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">PsycINFO OVID</HEADING>
<P>1 "Lead (Metal)"/<BR/>2 Lead Poisoning/<BR/>3 Pb.tw.<BR/>4 (lead adj5 poison$).tw.<BR/>5 (lead adj5 expos$).tw.<BR/>6 (lead adj5 blood$).tw.<BR/>7 (lead adj5 reduc$).tw.<BR/>8 (lead adj5 toxic$).tw.<BR/>9 (lead adj5 environ$).tw.<BR/>10 (lead adj5 hazard$).tw.<BR/>11 (lead adj5 control$).tw.<BR/>12 (lead adj5 (domestic$ or home$ or hous$)).tw.<BR/>13 (lead adj5 contamin$).tw.<BR/>14 (lead adj5 pollut$).tw.<BR/>15 or/1-14<BR/>16 ("100" or "120" or "140" or "160" or "180" or "200").ag.<BR/>17 (child$ or baby or babies or toddler$ or boy$ or girl$ or preschool$ or pre-school$ or pre school$ or teen$ or adolescen$).tw.<BR/>18 16 or 17<BR/>19 clinical trials/<BR/>20 (randomis* or randomiz*).tw.<BR/>21 (random$ adj3 (allocat$ or assign$)).tw.<BR/>22 ((clinic$ or control$) adj trial$).tw.<BR/>23 ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$)).tw.<BR/>24 (crossover$ or "cross over$").tw.<BR/>25 random sampling/<BR/>26 Experiment Controls/<BR/>27 Placebo/<BR/>28 placebo$.tw.<BR/>29 exp program evaluation/<BR/>30 treatment effectiveness evaluation/<BR/>31 ((effectiveness or evaluat$) adj3 (stud$ or research$)).tw.<BR/>32 or/19-31<BR/>33 15 and 18 and 32</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">PsycINFO EBSCO</HEADING>
<P>S32 S16 and S20 and S30<BR/>S31 S16 and S20 and S30<BR/>S30 S21 or S22 or S23 or S24 or S25 or S26 or S27 or S28 or S29<BR/>S29 AB (placebo*) or TI (placebo*)<BR/>S28 AB (randomly) or TI (randomly)<BR/>S27 AB (randomi?ed) or TI (randomi?ed)<BR/>S26 AB (trebl* blind* or trebl* mask* or tripl* blind* or tripl* mask*) or TI (trebl* blind* or trebl* mask* or tripl* blind* or tripl* mask*)<BR/>S25 AB (double* blind* or doubl* mask*) or TI (double* blind* or doubl* mask*)<BR/>S24 AB (singl* blind* or singl* mask*) or TI (singl* blind* or singl* mask*)<BR/>S23 AB (clinic* trial*) or TI (clinic* trial*)<BR/>S22 MR Quantitative Study<BR/>S21 MR Treatment Outcome/Clinical Trial<BR/>S20 S17 or S18 or S19<BR/>S19 TI (baby or babies or infant* or toddler* or child* or pre school* or preschool* or pre-school* or teen* or adolescen* or boy* or girl*)<BR/>S18 AB (baby or babies or infant* or toddler* or child* or pre school* or preschool* or pre-school* or teen* or adolescen* or boy* or girl*)<BR/>S17 AG (100 or 120 or 140 or 160 or 180 or 200)<BR/>S16 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or S12 or S13 or S14 or S15<BR/>S15 DE "Lead (Metal)" or DE "Lead Poisoning"<BR/>S14 AB ("Pb") or TI ("Pb")<BR/>S13 AB (lead N5 poison*) or TI (lead N5 poison*)<BR/>S12 AB (lead N5 pollut*) or TI (lead N5 pollut*)<BR/>S11 AB (lead N5 contamin*) or TI (lead N5 contamin*)<BR/>S10 AB (lead N5 hous*) or TI (lead N5 hous*)<BR/>S9 AB (lead N5 home*) or TI (lead N5 home*)<BR/>S8 AB (lead N5 domestic*) or TI (lead N5 domestic*)<BR/>S7 AB (lead N5 control*) or TI (lead N5 control*)<BR/>S6 AB (lead N5 hazard*) or TI (lead N5 hazard*)<BR/>S5 AB (lead N5 environ*) or TI (lead N5 environ*)<BR/>S4 AB (lead N5 toxic*) or TI (lead N5 toxic*)<BR/>S3 AB (lead N5 reduc*) or TI (lead N5 reduc*)<BR/>S2 AB (lead N5 blood*) or TI (lead N5 blood*)<BR/>S1 AB (lead N5 expos*) or TI (lead N5 expos*)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">CINAHL EBSCO (Cumulative Index to Nursing and Allied Health Literature)</HEADING>
<P>S39 S16 AND S20 AND S38<BR/>S38 S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37<BR/>S37 (MH "Quantitative Studies")<BR/>S36 (MH "Treatment Outcomes")<BR/>S35 (MH "Program Evaluation")<BR/>S34 TI (evaluat* study or evaluat* research) or AB (evaluate* study or evaluat* research) or TI (effectiv* study or effectiv* research) or AB(effectiv* study or effectiv* research)<BR/>S33 TI (prospectiv* study or prospectiv* research) or AB(prospectiv* study or prospectiv* research)<BR/>S32 TI ("follow-up study" or "follow-up research") or AB ("follow-up study" or "follow-up research")<BR/>S31 AB("cross over")<BR/>S29 AB((tripl* N3 mask*) or (tripl* N3 blind*))<BR/>S28 AB((trebl* N3 mask*) or (trebl* N3 blind*))<BR/>S27 AB ((doubl* N3 mask*) or (doubl* N3 blind*))<BR/>S26 AB ((singl* N3 mask*) or(singl* N3 blind*))<BR/>S25 AB ((clinical trial*) or(control* trial*))<BR/>S24 AB((random* N3 allocat* ) or(random* N3 assign*))<BR/>S23 (MH "Meta Analysis")<BR/>S22 MH random assignment<BR/>S21 (MH "Clinical Trials+")<BR/>S20 S17 OR S18 OR S19<BR/>S19 (MH "Adolescence+")<BR/>S18 (MH "Child+")<BR/>S17 (baby or babies or infant* or toddler* or child* or pre school* or preschool* or pre-school* or teen* or adolescen* or boy* or girl*)<BR/>S16 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15<BR/>S15 AB ("Pb") or TI ("Pb")<BR/>S14 AB (lead N5 pollut*) or TI (lead N5 pollut*)<BR/>S13 AB (lead N5 contamin*) or TI (lead N5 contamin*)<BR/>S12 AB (lead N5 (home* or hous*)) or TI (lead N5 (home* or hous*))<BR/>S11 AB (lead N5 domestic*) or TI (lead N5 domestic*)<BR/>S10 AB (lead N5 control*) or TI (lead N5 control*)<BR/>S9 AB (lead N5 hazard*) or TI (lead N5 hazard*)<BR/>S8 AB (lead N5 environ*) or TI (lead N5 environ*)<BR/>S7 AB (lead N5 toxic*) or TI (lead N5 toxic*)<BR/>S6 AB (lead N5 reduc*) or TI (lead N5 reduc*)<BR/>S5 AB (lead N5 blood*) or TI (lead N5 blood*)<BR/>S4 AB (lead N5 expos*) or TI (lead N5 expos*)<BR/>S3 AB (lead N5 poison*) or TI (lead N5 poison*)<BR/>S2 (MH "Lead Poisoning")<BR/>S1 (MH "Lead")</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sociological Abstracts Cambridge Scientific Abstracts (previously searched as Sociofile)</HEADING>
<P>((DE="lead poisoning") or(KW= ((lead within 5 poison*) or (lead within 5 expos*) or (lead within 5 blood*) or (lead within 5 reduc*) or (lead within 5 toxic*) or (lead within 5 environ*) or (lead within 5hazard*) or (lead within 5 control*) or (lead within 5 domestic*) or (lead within 5 home*) or (lead within 5 house*) or (lead within 5 contamin*) or (lead within 5 pollut*) or "pb"))) AND ((DE=("children" or "adolescents" or"infants")) or(KW=(baby or babies or infant* or child* or toddler* or pre-school* or "pre school*" or pre-school* or boy* or girl* or teen* or adolescen*)))</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sociological Abstracts ProQuest</HEADING>
<P>(SU.EXACT("Children") OR SU.EXACT("Infants") OR SU.EXACT("Adolescents") or (baby or babies or infant* or child* or toddler* or pre-school* or "pre school*" or pre-school* or boy* or girl* or teen* or adolescen*)) AND (SU.EXACT("Lead Poisoning") or (lead near/5 poison*) or (lead near/5 expos*) or (lead near/5 blood*) or (lead near/5 reduc*) or (lead near/5 toxic*) or (lead near/5 environ*) or (lead near/5 hazard*) or (lead near/5 control*) or (lead near/5 domestic*) or (lead near/5 home*) or (lead near/5 house*) or (lead near/5 contamin*) or (lead near/5 pollut*) or "pb")</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">ERIC Cambridge Scientific Abstracts (Education Resources Information Center)</HEADING>
<P>((DE="lead poisoning") or(KW=(lead within 5 poison*)or (lead within 5 expos*) or (lead within 5 blood*)or (lead within 5 reduc*)or (lead within 5 toxic*)or (lead within 5 environ*) or (lead within 5 hazard*)or(lead within 5 control*)or (lead within 5 domestic*)or (lead within 5 home*) or (lead within 5 hous*) or (lead within 5 contamin*) or (lead within 5 pollut) or ("Pb"))) AND ((DE=("adolescents" or "children" or "infants" or "toddlers" or "young children")) Or (KW= (baby or babies or infant* or toddler* or child* or preschool* or pre-school* or pre school* or teen* or adolescen* or boy* or girl*)))</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">ERIC EBSCO</HEADING>
<P>S23 S17 AND S22<BR/>S22 S18 OR S19 OR S20 OR S21<BR/>S21 DE "Adolescents"<BR/>S20 DE "Young Children" OR DE "Infants" OR DE "Preschool Children" OR DE "Toddlers"<BR/>S19 DE "Children" OR DE "Preadolescents" OR DE "Young Children"<BR/>S18 (baby or babies or infant* or toddler* or child* or pre school* or preschool* or pre-school* or teen* or adolescen* or boy* or girl*)<BR/>S17 S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16<BR/>S16 (AB ("Pb") or TI ("Pb"))<BR/>S15 AB (lead N5 pollut*) or TI (lead N5 pollut*)<BR/>S14 AB (lead N5 contamin*) or TI (lead N5 contamin*)<BR/>S13 AB (lead N5 (home* or hous*)) or TI (lead N5 (home* or hous*))<BR/>S12 AB (lead N5 domestic*) or TI (lead N5 domestic*)<BR/>S11 AB (lead N5 control*) or TI (lead N5 control*)<BR/>S10 AB (lead N5 hazard*) or TI (lead N5 hazard*)<BR/>S9 AB (lead N5 environ*) or TI (lead N5 environ*)<BR/>S8 AB (lead N5 toxic*) or TI (lead N5 toxic*)<BR/>S7 AB (lead N5 reduc*) or TI (lead N5 reduc*)<BR/>S6 AB (lead N5 blood*) or TI (lead N5 blood*)<BR/>S5 AB (lead N5 expos*) or TI (lead N5 expos*)<BR/>S4 AB (lead N5 poison*) or TI (lead N5 poison*)<BR/>S3 S1 AND S2<BR/>S2 TI (lead) or AB(lead)<BR/>S1 DE "Hazardous Materials" OR DE "Poisoning" OR DE "Wastes"</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">ERIC ProQuest</HEADING>
<P>(((SU.EXACT("Lead poisoning")) OR ((lead NEAR/5 poison*) OR (lead NEAR/5 expos*) OR (lead NEAR/5 blood*) OR (lead NEAR/5 reduc*) OR (lead NEAR/5 toxic*) OR (lead NEAR/5 environ*) OR (lead NEAR/5 hazard*) OR (lead NEAR/5 control*) OR (lead NEAR/5 domestic*) OR (lead NEAR/5 home*) OR (lead NEAR/5 hous*) OR (lead NEAR/5 contamin*) OR (lead NEAR/5 pollut) OR ("Pb"))) AND ((baby OR babies OR infant* OR toddler* OR child* OR preschool* OR pre-school* OR "pre school*" OR teen* OR adolescen* OR boy* OR girL*) OR (SU.EXACT("Adolescents") OR SU.EXACT("Young<BR/>Children" OR "Children" OR "Preadolescents") OR SU.EXACT("Toddlers" OR "Infants")))) AND pd(20100101-20121231)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Science Citation Index Web of Science (SCI)</HEADING>
<P># 6 #5 AND #4 AND #3<BR/># 5 TS=(random* or RCT or intervention*)<BR/># 4 TS=(baby or babies or infant* or child* or toddler* or boy* or girl* or preschool* or preschool* or teen* or adolescen*)<BR/># 3 #2 OR #1<BR/># 2 TS= ("Pb" near/3 (poison* or expos* or blood* or reduc* or toxic* or environ* or hazard* or control* or pollut* or contamin* or domestic* or home* or hous*))<BR/># 1 TS= (lead near/3 (poison* or expos* or blood* or reduc* or toxic* or environ* or hazard* or control* or pollut* or contamin* or domestic* or home* or hous*))</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">ZETOC MIMAS</HEADING>
<P>(<A HREF="http://zetoc.jisc.ac.uk/">zetoc.jisc.ac.uk</A>)</P>
<P>ZETOC was used as a source of conference papers up to 2012, after which Conference Proceedings Citation Index was preferred because of more flexible search options.</P>
<P>Lead and child*</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Conference Proceedings Citation Index - Science Web of Science (CPCI-S)</HEADING>
<P>CPCI-S was substituted for ZETOC in 2016 because of more advanced search options</P>
<P># 6 #5 AND #4 AND #3<BR/># 5 TS=(random* or RCT or intervention*)<BR/># 4 TS=(baby or babies or infant* or child* or toddler* or boy* or girl* or preschool* or preschool* or teen* or adolescen*)<BR/># 3 #2 OR #1<BR/># 2 TS= ("Pb" near/3 (poison* or expos* or blood* or reduc* or toxic* or environ* or hazard* or control* or pollut* or contamin* or domestic* or home* or hous*))<BR/># 1 TS= (lead near/3 (poison* or expos* or blood* or reduc* or toxic* or environ* or hazard* or control* or pollut* or contamin* or domestic* or home* or hous*))</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Cochrane Database of Systematic Reviews (CDSR) and Database of Abstracts of Reviews of Effects (DARE) in the Cochrane Library</HEADING>
<P>#1MeSH descriptor: [Lead Poisoning, Nervous System, Childhood] this term only<BR/>#2MeSH descriptor: [Lead Poisoning] this term only<BR/>#3MeSH descriptor: [Lead] this term only<BR/>#4(lead near poison*):ti,ab<BR/>#5(lead near expos*):ti,ab<BR/>#6lead near blood*:ti,ab<BR/>#7(lead near toxic*):ti,ab<BR/>#8(lead near environ*):ti,ab<BR/>#9(lead near reduc*):ti,ab<BR/>#10(lead near hazard*):ti,ab<BR/>#11(lead near control*):ti,ab<BR/>#12(lead near pollut*):ti,ab<BR/>#13(lead near contamin*):ti,ab<BR/>#14(lead near (domestic* or home* or hous*)):ti,ab<BR/>#15{or #1-#14}<BR/>#16[mh infant]<BR/>#17[mh child]<BR/>#18[mh adolescent]<BR/>#19(child* or baby or babies or toddler* or boy* or girl* or preschool* or pre-school* or (pre next school*) or teen* or adolescen*):ti,ab<BR/>#20{or #16-#19}<BR/>#21#15 and #20</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">LILACS iAH form (Latin American and Caribbean Health Science Information database)</HEADING>
<P>
<A HREF="http://lilacs.bvsalud.org/en/">lilacs.bvsalud.org/en/</A>
</P>
<P>Mh lead or Mh lead poison$ or TW lead and poison$ or TW lead and expos$ or TW lead and toxic$ or TW lead and contamin$ or TW lead and blood$ or tw lead and reduc$ or TW lead and control$ orTW lead and pollut$ or TW lead and hazard$ or TW lead and hous$ or TW lead and home$ or TW lead and domestic$ or TW lead and environ$ or tw Pb [Words] and (Mh infant or Mh child or Mh child,preschool or Mh adolescent or tw baby or tw babies or tw infant$ or tw child$ or tw preschool or tw pre-school or Tw adolescen$ or Tw teen$) AND ((Pt randomized controlled trial OR Pt controlled clinical trial OR Mh randomized controlled trials OR Mh random allocation OR Mh double-blind method OR Mh single-blind method) AND NOT (Ct animal AND NOT (Ct human and Ct animal)) OR (Pt clinical trial OR Ex E05.318.760.535$ OR (Tw clin$ AND (Tw trial$ OR Tw ensa$ OR Tw estud$ OR Tw experim$ OR Tw investiga$)) OR ((Tw singl$ OR Tw simple$ OR Tw doubl$ OR Tw doble$ OR Tw duplo$ OR Tw trebl$ OR Tw trip$) AND (Tw blind$ OR Tw cego$ OR Tw ciego$ OR Tw mask$ OR Tw mascar$)) OR Mh placebos OR Tw placebo$ OR (Tw random$ OR Tw randon$ OR Tw casual$ OR Tw acaso$ OR Tw azar OR Tw aleator$) OR Mh research design) AND NOT (Ct animal AND NOT (Ct human and Ct animal)) OR (Ct comparative study OR Ex E05.337$ OR Mh follow-up studies OR Mh prospective studies OR Tw control$ OR Tw prospectiv$ OR Tw volunt$ OR Tw volunteer$) AND NOT (Ct animal AND NOT (Ct human and Ct animal))) [Words]</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">World Health Organisation International Clinical Trial Registry Portal (WHO ICTRP)</HEADING>
<P>(<A HREF="http://www.who.int/ictrp/en/">who.int/ictrp/en</A>)</P>
<P>Advanced search. CONDITION| lead exposure OR lead poisoning AND Recruitment status| ALL [23 records]<BR/>Basic search. domestic AND lead OR house AND lead OR home AND lead OR housing AND lead OR household AND lead [48 records]</P>
<P>All available years searched.Two separate searches were run using different search strings, Records from both searches were imported into Excel and duplicates removed leaving 70 records</P>
<P>"lead" AND "children"</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Clinical Trials.gov</HEADING>
<P>(<A HREF="https://clinicaltrials.gov/">clinicaltrials.gov</A>)</P>
<P>Search 1: Interventional studies | Lead | Child [41 records]<BR/>Search 2: Interventional Studies | Lead poisoning OR Lead,blood OR Lead toxicity OR Lead and injury reduction OR Evironmental exposures [57 records]</P>
<P>All available years searched. Two separate searches were run using different search strings, Records from both searches were imported into Excel and duplicates removed leaving 70 records</P>
<P>"lead" AND "children"</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2016-10-06 13:41:30 +0100" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2016-05-17 15:05:34 +0100" MODIFIED_BY="[Empty name]">Record of searches between 2006 and 2016</TITLE>
<APPENDIX_BODY MODIFIED="2016-10-06 13:41:30 +0100" MODIFIED_BY="[Empty name]">
<TABLE COLS="5" ROWS="53">
<TR>
<TH ALIGN="CENTER" COLSPAN="5" VALIGN="BOTTOM">
<P>Record of searches from 2006 to 2016</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Database</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Search date</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Database date range</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Number of records</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<BR/>Limits<BR/>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>29 April 2010</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2010, Issue 2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>171</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2010-2012</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20 January 2012</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2012, Issue 1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>61</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2010-2012</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 May 2015</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2015, Issue 4</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>75</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2012-2015</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 May 2016</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2016, Issue 4</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>19</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2015-2016</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Ovid MEDLINE</P>
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>29 April 2010</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1950 to April Week 3 2010</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>373</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2006-current</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>17 January 2012</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1948 to 2012 January Week 1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>192</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>ED = 20100427-20120112</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 May 2015</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1946 to May Week 1 2015</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>453</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>ED = 20120101-20150430</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 May 2016</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1946 to April Week 3 2016</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>156</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>ED=20150430-20160421</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Embase Ovid</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>28 May 2010</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1980 to 2010 Week 16</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>144</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2006-current. Searched 29 April 2010; rerun with revised filter 28 May 2010</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>17 January 2012</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1980 to 2012 Week 2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>122</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>EM = 201021-201201</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 May 2015</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1980 to 2015 Week 19</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>447</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>EM = 201201-201519</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 May 2016</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1980 to 2016 Week 18</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>167</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>EM =201519-201618</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>PsycINFO Ovid</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>17 January 2012</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1806 to December Week 2 2011</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>35</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2010-current</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 May 2015</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1806 to May Week 1 2015</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>58</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>UP = 20111205-20150504</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 May 2016</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1806 to April Week 4 2016</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>15</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>UP = 20150504-20160425</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>PsycINFO EBSCO</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>04 May 2010</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1806 to current</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>271</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2006-current</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>CINAHL EBSCO (Cumulative Index to Nursing and Allied Health Literature)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>04 May 2010</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1937 to current</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>48</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2006-2010</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20 January 2012</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1937 to current</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>21</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>EM 20100504 onwards</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 May 2015</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1937 to current</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>87</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>EM 20120101 onwards</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 May 2016</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1937 to current</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>25</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>EM 20150430 onwards</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Sociological Abstracts Cambridge Scientific Abstracts</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>29 April 2010</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1952 to current</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>45</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2006-2010</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Sociological Abstracts ProQuest</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20 January 2012</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1952 to current</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>137</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2010-2012</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 May 2015</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1952 to current</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>62</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2012-2015</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 May 2016</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1952 to current</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>18</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2015-2016</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>ERIC Cambridge Scientific Abstracts (Education Resources Information Center)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 April 2010</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1966 to current</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>81</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2006-2010</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>ERIC EBSCOhost</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 May 2015</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1966 to current</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>79</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>EM 2012 onwards</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 May 2016</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1966 to current</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>EM 2015 onwards</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>ERIC ProQuest</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>17 January 2012</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1966 to current</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>63</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2010-2012</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Science Citation Index Web of Science (SCI)</P>
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>04 May 2010</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1970 to current</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1827</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2006-2010</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20 January 2012</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1970 to current</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>176</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2010-2012</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 May 2015</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1970 to 11 May 2015</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>389</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2012-2015</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 May 2016</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1970 to 2 May 2016</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>175</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2015-2016</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>ZETOC MIMAS</P>
<P>Conference papers only</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>04 May 2010</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>All available years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>399</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2006 onwards</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20 January 2012</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>All available years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>173</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2010 onwards</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Conference Proceedings Citation Index - Science Web of Science (CPCI-S)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 May 2015</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1990 to 11 May 2015</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>71</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>All available years</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 May 2016</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1990 to 2 May 2016</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2015-2016</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<I>Cochrane Database of Systematic Reviews</I> (CDSR) in the Cochrane Library</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 May 2015</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2015, Issue 5</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>All available years</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 May 2016</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2016, Issue 6</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2015-2016</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Database of Abstracts of Reviews of Effects (DARE) in the Cochrane Library)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 May 2015</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2015, Issue 2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>All available years</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 May 2016</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>NA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>NA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not searched because no new content added</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>LILACS iAH Search form (Latin American and Caribbean Health Science Information database)</P>
<P>(<A HREF="http://lilacs.bvsalud.org/en/">lilacs.bvsalud.org/en</A>)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>04 May 2010</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>All available years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>113</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2006-2010</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20 January 2012</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>All available years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>36</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2010-2012</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 May 2015</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>All available years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>83</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2012-2015</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 May 2016</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>All available years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>21</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Year = 2015-2016</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Trials registers</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Search date</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Register date range</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Number of records</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Limits</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>World Health Organization International Clinical Trial Registry Portal (WHO ICTRP)</P>
<P>(<A HREF="http://apps.who.int/trialsearch/">apps.who.int/trialsearch</A>)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20 January 2012</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>All available years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>24</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13 May 2015</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>All available years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>70</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 May 2016</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>All available years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Registered May 2015 or later</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>ClinicalTrials.gov</P>
<P>(<A HREF="https://clinicaltrials.gov/.">clinicaltrials.gov</A>)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20 January 2012</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>All available years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>54</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13 May 2015</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>All available years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>84</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 May 2016</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>All available years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Received 1 May 2015 or later</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2016-09-15 15:47:55 +0100" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2015-10-27 11:57:05 +0000" MODIFIED_BY="Barbara Nussbaumer">Unused methods</TITLE>
<APPENDIX_BODY MODIFIED="2016-09-15 15:47:55 +0100" MODIFIED_BY="[Empty name]">
<TABLE COLS="3" ROWS="7">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Analysis</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Method not used</P>
</TH>
<TH>
<P>Explanation</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Measures of treatment effect</B>
</P>
</TH>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Dichotomous data</B>
</P>
<P>We will calculate numbers needed to treat, where appropriate.</P>
<P>
<B>Continuous data</B>
</P>
<P>We will compare mean changes from baseline to postintervention between groups. Also, if we find a study reporting only change from baseline, we will contact the authors to receive the post-treatment means.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Dichotomous data</B>
</P>
<P>We were unable to calculate numbers needed to treat on this occasion because we could not identify evidence on patient-relevant outcomes of interest (cognitive and neurobehavioural outcomes in children or adverse events in children).</P>
<P>
<B>Continuous data</B>
</P>
<P>We did not compare mean changes from baseline to postintervention between groups, because baseline blood lead levels were similar between arms in each study included in the meta-analyses. Also, we did not find a study reporting only change from baseline.</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Unit of analysis issues</P>
</TH>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Studies with multiple treatment groups</B>
</P>
<P>For eligible trials that consist of multiple treatment groups, we will include data for the treatment arms and halve the data from the control arm, or collapse the data for the treatment groups into one group when this considered appropriate.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>We were unable to include the one trial that included multiple treatment groups in the meta-analysis.</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Dealing with missing data</P>
</TH>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>For continuous outcomes, we will impute missing SDs using relevant data (e.g. SDs or correlation coefficients) from other similar studies, where possible (<A HREF="https://archie.cochrane.org/sections/documents/view?version=3AC1294C82E26AA2010BFEDDE2D56AB9&amp;format=REVMAN#Follman 1992">Follman 1992</A>).</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>There were insufficient data to impute results.</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assessment of reporting biases</P>
</TH>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>If 10 or more studies are included in a meta-analysis, we will draw funnel plots to investigate any relationship between effect size and study precision (closely related to sample size). Such a relationship could be due to publication or related biases or due to systematic differences between small and large studies. If a relationship is identified, clinical diversity of the studies will be further examined as a possible explanation (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>).</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>We were unable to draw funnel plots to assess reporting biases due to the small number of studies (2-5) included in meta-analyses.</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Subgroup analyses</P>
</TH>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>We will conduct subgroup analyses, providing there are clinically relevant differences between groups of participants (e.g. age, baseline blood lead levels, household setting), in either intervention, and if mode of delivery of intervention differs significantly (e.g. written information rather than delivered directly by health professional/paraprofessional).</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Due to the limited number of studies within each intervention type, there were insufficient data for subgroup analyses according to baseline age, baseline blood lead level, or mode of delivery of intervention.</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Sensitivity analysis</P>
</TH>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>If there are studies at different risk of bias levels, we will conduct sensitivity analysis based on different risks of bias. We will conduct the sensitivity analysis to assess the impact of study quality on the results of meta-analyses. We will also conduct a sensitivity analysis on a 'best-case/worst case' basis.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>We did not conduct a sensitivity analysis based on different risks of bias because the studies included in the meta-analysis were at similarly low risk of bias. Also, there were insufficient data to conduct a sensitivity analysis on a 'best-case/worst-case' basis.</P>
</TD>
</TR>
</TABLE>
<P/>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS MODIFIED="2016-09-15 14:04:45 +0100" MODIFIED_BY="[Empty name]">
<EXTENSION ID="AFF_z1303280937296104860128207607784_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS">
<ALIAS ALIAS_ID="z1303280937296104860128207607784">
<ADDRESS>
<DEPARTMENT>Cochrane Austria</DEPARTMENT>
<ORGANISATION>Danube University Krems</ORGANISATION>
<ADDRESS_1>Dr.-Karl-Dorrek-Str. 30</ADDRESS_1>
<ADDRESS_2/>
<CITY>Krems</CITY>
<ZIP>3500</ZIP>
<REGION/>
<COUNTRY CODE="AT">Austria</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
</ALIAS>
</EXTENSION>
<EXTENSION ID="AFF_AB61F02382E26AA200AED5649D9D6048_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS">
<ALIAS ALIAS_ID="AB61F02382E26AA200AED5649D9D6048">
<ADDRESS>
<DEPARTMENT>Department for Evidence-based Medicine and Clinical Epidemiology</DEPARTMENT>
<ORGANISATION>Danube University Krems</ORGANISATION>
<ADDRESS_1>Dr.-Karl-Dorrek-Str. 30</ADDRESS_1>
<ADDRESS_2/>
<CITY>Krems</CITY>
<ZIP>3500</ZIP>
<REGION/>
<COUNTRY CODE="AT">Austria</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
</ALIAS>
</EXTENSION>
<EXTENSION ID="AFF_60094736931777252270120104123702_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS">
<ALIAS ALIAS_ID="60094736931777252270120104123702">
<ADDRESS>
<DEPARTMENT>Cochrane Austria</DEPARTMENT>
<ORGANISATION>Danube University Krems</ORGANISATION>
<ADDRESS_1>Dr.-Karl-Dorrek-Strasse 30</ADDRESS_1>
<ADDRESS_2/>
<CITY>Krems</CITY>
<ZIP>3500</ZIP>
<REGION/>
<COUNTRY CODE="AT">Austria</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
</ALIAS>
</EXTENSION>
<EXTENSION ID="AFF_43936511308735444981120201135610_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS">
<ALIAS ALIAS_ID="43936511308735444981120201135610">
<ADDRESS>
<DEPARTMENT>Institute for Public Health and Nursing Research, Health Sciences Bremen</DEPARTMENT>
<ORGANISATION>University of Bremen</ORGANISATION>
<ADDRESS_1>Bibliotheksstr. 1</ADDRESS_1>
<ADDRESS_2/>
<CITY>Bremen</CITY>
<ZIP>28359</ZIP>
<REGION/>
<COUNTRY CODE="DE">Germany</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
</ALIAS>
</EXTENSION>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;14 included studies (from 20 reports)&lt;/p&gt;&lt;p&gt;(1 report of an ongoing study)&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;14 studies (19 reports) included in previous version of review&lt;/p&gt;" WIDTH="210"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;1 report (adding information to a study included in a former version of this review)&lt;/p&gt;&lt;p&gt;1 report of an ongoing study&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;18 full-text reports assessed for eligibility&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" WIDTH="138">
<FLOWCHARTBOX TEXT="&lt;p&gt;2182 titles and abstracts screened&lt;span&gt; for relevance after removing duplicates&lt;/span&gt;&lt;/p&gt;" WIDTH="175">
<FLOWCHARTBOX TEXT="&lt;p&gt;2594 records identified through electronic searches in 2016&lt;/p&gt;" WIDTH="207"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;80 additional records identified through other sources (citation tracking and handsearching) in 2016&lt;/p&gt;" WIDTH="244"/>
<OUT TEXT="&lt;p&gt;2164 records discarded because: not RCTs or quasi-RCTs, ineligible intervention, or not about children or their parents or carers&lt;/p&gt;" WIDTH="286"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;16 full-text reports excluded:&lt;/p&gt;&lt;p&gt;11 - ineligible study design&lt;/p&gt;&lt;p&gt;1 - ineligible intervention or control&lt;/p&gt;&lt;p&gt;&lt;span&gt;3 - no outcome measured, which is relevant for this Cochrane review&lt;/span&gt;&lt;/p&gt;&lt;p&gt;1 - does not answer the key question of the review&lt;/p&gt;" WIDTH="270"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>